Home› India› Ministry of Chemicals and Fertilizers› In exercise of the powers, conferred by paragraphs 4 6 10, 1...
Date: 2019-03-29 Category: Extra Ordinary State: Union Government Country: India

In exercise of the powers, conferred by paragraphs 4 6 10, 11 14 16, 17 and 18 of the Drugs

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Executive Summary: This document issued by the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, fixes and revises the ceiling prices of various scheduled formulations as specified in the attached table. The price revision is based on an annual Wholesale Price Index (WPI) increase of 4.2662%. These prices are effective from April 1, 2019. Key Points / Main Content: * **Price Fixation and Revision:** * The NPPA fixes the ceiling prices for scheduled formulations listed in the table, excluding goods and services tax. * Prices are revised based on an annual Wholesale Price Index (WPI) increase of 4.2662%, effective from April 1, 2019. * The mentioned S.O. Number and date specified in column No. 6a 6b mentioned in the table below are superseded. * **Specific Provisions for Manufacturers:** * For pack sizes not listed, manufacturers should contact NPPA for price approval as per paragraph 11 of the Drugs Prices Control Order, 2013. * Marketing data must be authenticated for price fixation. * Manufacturers launching new drugs must apply for price fixation to the NPPA. * Manufacturers must issue a price list to NPPA, State Drug Controllers, and distributors in Form V under paragraph 24 of the Drugs Prices Control Order, 2013. * **Retailer and Distributor Obligations:** * Retailers and distributors must display price lists and supplementary lists as provided by manufacturers in a visible part of the premises. * **Reporting and Compliance:** * Manufacturers must submit quarterly reports on production, import, and sales of scheduled formulations to the NPPA in Form III. * Manufacturers intending to discontinue production/import must notify the NPPA six months prior in Form IV. * **Enforcement:** * Manufacturers not complying with ceiling prices and provisions are liable to deposit overcharged amounts with interest under the Essential Commodities Act, 1955, and DPCO 2013. * Existing price fixation orders issued before this order are superseded. Impact Analysis: * **Scheduled Formulation Manufacturers:** * Impact: Must comply with the newly fixed/revised ceiling prices and associated regulations. * Action Required: Revise prices, submit necessary reports, and ensure compliance with the DPCO 2013. * **Retailers and Distributors:** * Impact: Affected by the price revisions and display requirements. * Action Required: Update price lists and display them prominently. * **Consumers:** * Impact: Directly benefit from regulated drug prices. * Action Required: Be aware of the revised prices. * **National Pharmaceutical Pricing Authority (NPPA):** * Impact: Responsible for monitoring and enforcing the order. * Action Required: Oversee implementation and compliance.

Key Entities Referenced

National Pharmaceutical Pricing Authority: A government agency in India responsible for fixing and revising prices of pharmaceutical products, mentioned as the authority issuing the order. Drugs Prices Control Order, 2013: A legal framework in India that empowers the National Pharmaceutical Pricing Authority to regulate the prices of drugs. Ministry of Chemicals and Fertilizers: The Indian government ministry under which the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority operate. New Delhi: Capital of India, place of publication of the order. Wholesale Price Index (WPI): An index used to measure inflation in India, used here to revise medicine prices by 4.2662%. Goods and Services Tax: A value-added tax levied on most goods and services sold for domestic consumption, excluded from the ceiling prices fixed in the order. IPDMS: Stands for Integrated Pharmaceutical Database Management System , as per notification manufacturers need to fill form V through IPDMS to NPPA and a copy to State Drug Controllers and manufacturer distributors. Essential Commodities Act, 1955: The Essential Commodities Act 1955 is an act of Parliament of India which seeks to control the production, supply and distribution of certain commodities.
Official Source Record View Original Source →
See Full Document Text
jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 1318] ubZ fnYyh] 'kqØokj] ekpZ 29] 2019@pS=k 8] 1941 No. 1318] NEW DELHI, FRIDAY, MARCH 29, 2019/CHAITRA 8, 1941 jlk;u vkSj moZjd ea=ky; ¼vkS’k/k foHkkx½ ¼jk’Vªh; vkS’k/k ewY; fu/kkZj.k izkf/kdj.k½ vkns’k ubZ fnYyh] 29 ekpZ] 2019 dk-vk 1485¼v½.—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjk 4, 6, 10, 11, 14, 16, 17 vkSj 18 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k dk- vk- la[;k vkSj fnukad fofufnZ"V uhps LraHk 6¼a½ vkSj 6¼b½ dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ es fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh lkj.kh % okf"kZd Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij la'kksf/kr ewY; @ (4.2662%) c<+kdj Ø- vuqlwfpr fofufeZfr [kqjkd :i ,oa izcyrk bdkbZ vf/kdre orZeku dk- vk- la- dk uke dher la[;k vkSj fnukad (@ 4.2662% dh nj ls 01-04-2019 ls izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 6(a) 6(b) 1 5&,feukslys hflfyd lqIikfstVªh 500 fexzk- fjVus 'ku 1 lqIikfstVªh 16.55 1461¼v½ 02.04.2018 ,flM ,fuek 1950 GI/2019 (!)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 2 5&,feukslys hflfyd xkys h 400 fexzk- 1 xkys h 7.31 1461¼v½ 02.04.2018 ,flM 3 5&¶ywjksjkfly bta SD'ku 250 fexzk-@5 fefy- 1 fefy- 2.29 1461¼v½ 02.04.2018 4 6&eds sZiVkWI;fwju xkys h 50 fexzk- 1 xkys h 6.32 1461¼v½ 02.04.2018 5 ,cdkohj xkys h 300 fexzk- 1 xkys h 46.15 1461¼v½ 02.04.2018 6 ,cdkohj ¼,½ $ xkys h 60 fexzk- ¼,½ $ 30 fexzk- ¼ch½ 1 xkys h 19.65 1461¼v½ 02.04.2018 yfseoqMhu ¼ch½ 7 ,cdkohj ¼,½ $ xkys h 600 fexzk-¼,½$300 fexzk- ¼ch½ 1 xkys h 89.18 1461¼v½ 02.04.2018 yfseoqMhu ¼ch½ 8 ,flVktkys kekbM dSIlyw 250 fexzk- 1 dSIlyw 4.43 1461¼v½ 02.04.2018 9 ,flVktkys kekbM xkys h 250 fexzk- 1 xkys h 3.58 1461¼v½ 02.04.2018 10 ,lhVkbylSyhflfyd bQsjoslVsa @fMLijflcy@,faVªd 1 xkys h 0.18 1461¼v½ 02.04.2018 ,flM dkfsVM xkys h 100 fexzk- 11 ,lhVkbylSyhflfyd bQsjoslVsa @fMLijflcy@,faVªd 1 xkys h 1.18 1461¼v½ 02.04.2018 ,flM dkfsVM xkys h 150 fexzk- 12 ,lhVkbylSyhflfyd bQsjoslVsa @fMLijflcy@,faVªd 1 xkys h 1.20 1461¼v½ 02.04.2018 ,flM dkfsVM xkys h 75 fexzk- 13 ,lhVkbylSyhflfyd xkys h 100 fexzk- 1 xkys h 0.17 1461¼v½ 02.04.2018 ,flM 14 ,lhVkbylSyhflfyd xkys h 150 fexzk- 1 xkys h 0.40 1461¼v½ 02.04.2018 ,flM 15 ,lhVkbylSyhflfyd xkys h 325 fexzk- 1 xkys h 0.54 1461¼v½ 02.04.2018 ,flM 16 ,lhVkbylSyhflfyd xkys h 350 fexzk- 1 xkys h 0.30 1461¼v½ 02.04.2018 ,flM 17 ,lhVkbylSyhflfyd xkys h 75 fexzk- 1 xkys h 0.30 1461¼v½ 02.04.2018 ,flM 18 ,fDVukes kbflu Mh bta SD'ku d s fy, ikmMj 0-5 fexzk- izfr iSd 310.35 1461¼v½ 02.04.2018 19 ,flDyksohj vkbs Va eVsa 3% 1 xzke 10.19 1461¼v½ 02.04.2018 20 ,flDyksohj vksjy fyD;bw ZM 400 fexzk-@ 1 fefy- 1.24 1461¼v½ 02.04.2018 5 fefy- 21 ,flDyksohj xkys h 200 fexzk- 1 xkys h 6.63 1461¼v½ 02.04.2018 22 ,flDyksohj xkys h 400 fexzk- 1 xkys h 12.04 1461¼v½ 02.04.2018 23 ,flDyksohj bta SD'ku d s fy, ikmMj 250 fexzk- izfr iSd 347.72 1461¼v½ 02.04.2018 24 ,flDyksohj bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 449.12 1461¼v½ 02.04.2018 25 ,Mus kslkbu bta SD'ku 3 fexzk-@fefy- 1 fefy- 96.35 1461¼v½ 02.04.2018 26 ,Mªus kykbu bta SD'ku 1 fexzk-@fefy- 1 fefy- 15.32 1461¼v½ 02.04.2018 27 ,ycMsa ktkys vksjy fyD;bw ZM 200 fexzk-@5 fefy- 1 fefy- 1.56 1461¼v½ 02.04.2018 28 ,ycMsa ktkys xkys h 400 fexkz- 1 xkys h 7.54 1461¼v½ 02.04.2018 29 ,ykIs;fwjukys xkys h 100 fexzk- 1 xkys h 1.86 1461¼v½ 02.04.2018 30 ,ykIs;fwjukys xkys h 300 fexzk- 1 xkys h 7.32 1461¼v½ 02.04.2018 31 ,yizksLVkfMy bta SD'ku 0-5 fexzk-@fefy- 1 fefy- 5542.19 1461¼v½ 02.04.2018 32 ,YVIsyl bta SD'ku d s fy, ikmMj izfr iSd 18588.12 1461¼v½ 02.04.2018 20 fexzk-¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3 33 ,YVIsyl bta SD'ku d s fy, ikmMj izfr iSd 38810.18 1461¼v½ 02.04.2018 50 fexzk- 34 ,fe;kMs sjkus bta SD'ku 50 fexzk-@fefy- 1 fefy- 21.83 3983¼v½ 13.08.2018 35 ,fe;kMs sjkus xkys h 100 fexzk- 1 xkys h 5.59 1461¼v½ 02.04.2018 36 ,fe;kMs sjkus xkys h 200 fexzk- 1 xkys h 11.08 1461¼v½ 02.04.2018 37 ,fefVªfIVykbu xkys h 10 fexzk- 1 xkys h 2.24 1461¼v½ 02.04.2018 38 ,fefVªfIVykbu xkys h 25 fexzk- 1 xkys h 2.21 1461¼v½ 02.04.2018 39 ,fefVªfIVykbu xkys h 50 fexzk- 1 xkys h 5.68 1461¼v½ 02.04.2018 40 ,fefVªfIVykbu xkys h 75 fexzk- 1 xkys h 5.49 1461¼v½ 02.04.2018 41 ,EykfsMikbu xkys h 10 fexzk- 1 xkys h 4.96 1461¼v½ 02.04.2018 42 ,EykfsMikbu xkys h 2-5 fexzk- 1 xkys h 1.62 1461¼v½ 02.04.2018 43 ,EykfsMikbu xkys h 5 fexzk- 1 xkys h 2.55 1461¼v½ 02.04.2018 44 ,ekDs lhflfyu dSIlyw 250 fexzk- 1 dSIlyw 2.16 1461¼v½ 02.04.2018 45 ,ekDs lhflfyu vksjy fyD;bw ZM 250 fexzk-@ 1 fefy- 1.32 1461¼v½ 02.04.2018 5 fefy- 46 ,ekDs lhflfyu dSIlyw 500 fexzk- 1 dSIlyw 6.32 1461¼v½ 02.04.2018 47 ,ekDs lhflfyu ¼,½ $ MªkbZ flji 125 fexzk- ¼,½ $ 1 fefy- 2.12 1461¼v½ 02.04.2018 Dykoqykfud ,flM ¼ch½ 31-25 fexzk-¼ch½@5 fefy- 48 ,ekDs lhflfyu ¼,½ $ vksjy fyD;bw ZM 200 fexzzk-¼,½ $ 1 fefy- 1.77 1461¼v½ 02.04.2018 Dykoqykfud ,flM ¼ch½ 28-5 fexzk-¼ch½@5 fefy- 49 ,ekDs lhflfyu ¼,½ $ bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 88.10 1461¼v½ 02.04.2018 Dykoqykfud ,flM ¼ch½ ¼,½ $ 100 fexzk- ¼ch½ 50 ,ekDs lhflfyu ¼,½ $ xkys h 500 fexzk- ¼,½ $ 1 xkys h 17.58 1461¼v½ 02.04.2018 Dykoqykfud ,flM ¼ch½ 125 fexzk- ¼ch½ 51 ,ekDs lhflfyu ¼,½ $ bta SD'ku d s fy, ikmMj 1 xzke ¼,½ izfr iSd 122.90 1461¼v½ 02.04.2018 Dykoqykfud ,flM ¼ch½ $ 200 fexzk- ¼ch½ 52 ,EQkVs fsjflu bta SD'ku d s fy, ikmMj 3983¼v½ 13.08.2018 izfr iSd 3844.83 ch&fyfiM@fyikslkes y 50 fexzk- 53 ,EQkVs fsjflu bta SD'ku d s fy, ikmMj izfr iSd 303.11 1461¼v½ 02.04.2018 ch&dkWuous 'kuy 50 fexzk- 54 ,Eihflfyu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 20.89 1461¼v½ 02.04.2018 55 ,Eihflfyu bta SD'ku d s fy, ikmMj izfr iSd 12.87 1461¼v½ 02.04.2018 500 fexzk- 56 ,Va h&Mh bEequkXs ykcs qfyu bta SD'ku 300 ,elhth izfr iSd 2088.88 1461¼v½ 02.04.2018 57 ,Va h&Mh bEequkXs ykcs qfyu bta SD'ku 150 ,elhth izfr ok;y 1628.21 1461¼v½ 02.04.2018 58 ,Va h&jcs ht bta SD'ku 150 vkbZ;@w fefy- 1 fefy- 2715.04 1461¼v½ 02.04.2018 bEequkXs ykcs qfyu 59 ,Va h&jcs ht bta SD'ku 300 vkbZ;@w fefy- 1 fefy- 95.72 1461¼v½ 02.04.2018 bEequkXs ykcs qfyu 60 ,Va h&VVs ul 250 vkbZ; izfr iSd 1087.55 5636¼v½ 02.11.2018 bEequkXs ykcs qfyu 61 vlsZfud VªhvkWDlkbM bta SD'ku 1 fexzk-@fefy- 1 fefy- 53.14 1461¼v½ 02.04.2018 62 vVsZeFs kj ¼,½ vksjy fyD;bw ZM 80 fexzzk-¼,½ $ 1 fefy- 3.95 1461¼v½ 02.04.2018 $yqeQs kVªhu ¼ch½ 480 fexzk-¼ch½@5 fefy-4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 63 vVsZeFs kj ¼,½ xkys h 20 fexzk- ¼,½ $ 1 xkys h 12.25 1461¼v½ 02.04.2018 $yqeQs kVªhu ¼ch½ 120 fexzk- ¼ch½ 64 vVsZeFs kj ¼,½ xkys h 40 fexzk- ¼,½ $ 1 xkys h 15.79 1461¼v½ 02.04.2018 $yqeQs kVªhu ¼ch½ 240 fexzk- ¼ch½ 65 vVsZeFs kj ¼,½ xkys h 80 fexzk- ¼,½ $ 1 xkys h 22.67 1461¼v½ 02.04.2018 $yqeQs kVªhu ¼ch½ 480 fexzk- ¼ch½ 66 vVsZlquVs bta SD'ku d s fy, ikmMj izfr iSd 407.23 1461¼v½ 02.04.2018 120 fexzk- 67 vVsZlquVs bta SD'ku d s fy, ikmMj izfr iSd 213.90 1461¼v½ 02.04.2018 60 fexzk- 68 vVsZlquVs ¼,½ $ xkys h 100 fexzk- ¼,½ $ 1 xkys h dkEs ch iSd 28.87 1461¼v½ 02.04.2018 lYQkMkWDlhu & ¼750 fexzk- $ 37-5 fexzk-½ ¼ch½ fifjeFs kkekbu ¼ch½ 69 vVsZlquVs ¼,½ $ xkys h 150 fexzk- ¼,½ $ 2 xkys h dkEs ch iSd 39.19 1461¼v½ 02.04.2018 lYQkMkWDlhu & ¼500 fexzk- $ 25 fexzk-½ ¼ch½ fifjeFs kkekbu ¼ch½ 70 vVsZlquVs ¼,½ $ xkys h 200 fexzk- ¼,½ $ 2 xkys h dkEs ch iSd 35.73 1461¼v½ 02.04.2018 lYQkMkWDlhu & ¼750 fexzk- $ 37-5 fexzk-½ ¼ch½ fifjeFs kkekbu ¼ch½ 71 vVsZlquVs ¼,½ $ xkys h 25 fexzk- ¼,½ $ 1 xkys h ¼250 dkEs ch iSd 19.24 1461¼v½ 02.04.2018 lYQkMkWDlhu & fexzk- $ 12-5 fexzk-½ ¼ch½ fifjeFs kkekbu ¼ch½ 72 vVsZlquVs ¼,½ $ 1 xkys h 50 fexzk- ¼,½ $ 1 xkys h dkEs ch iSd 20.77 1461¼v½ 02.04.2018 lYQkMkWDlhu & ¼500 fexzk $ 25 fexzk-½ ¼ch½ fifjeFs kkekbu ¼ch½ 73 ,LdksZfcd ,flM xkys h 100 fexzk- 1 xkys h 0.19 1461¼v½ 02.04.2018 ¼foVkfeu lh½ 74 ,LdksZfcd ,flM xkys h 500 fexzk- 1 xkys h 0.89 1461¼v½ 02.04.2018 ¼foVkfeu lh½ 75 ,Vktus kohj xkys h 300 fexzk- ¼,½ $ 1 xkys h 96.61 1461¼v½ 02.04.2018 ¼,½$fjVkus sohj ¼ch½ 100 fexzk- ¼ch½ 76 ,Vus kys kys xkys h 100 fexzk- 1 xkys h 3.41 1461¼v½ 02.04.2018 77 ,Vus kys kys xkys h 50 fexzk- 1 xkys h 1.75 1461¼v½ 02.04.2018 78 ,VksjokLVkfVu xkys h 10 fexzk- 1 xkys h 5.37 1461¼v½ 02.04.2018 79 ,VksjokLVkfVu xkys h 20 fexzk- 1 xkys h 13.00 1461¼v½ 02.04.2018 80 ,VksjokLVkfVu xkys h 40 fexzk- 1 xkys h 18.88 1461¼v½ 02.04.2018 81 ,VªkD;fwj;e bta SD'ku 10 fexzk-@fefy- izfr iSd 51.30 1461¼v½ 02.04.2018 82 ,Vªkis kbu vkbs Va eVsa 1% 1 xzke 3.70 1461¼v½ 02.04.2018 83 ,Vªkis kbu bta SD'ku 0-6 fexzk-@fefy- 1 fefy- 4.10 1461¼v½ 02.04.2018 84 ,Vªkis kbu MªkIsl 1% 1 fefy- 3.36 1461¼v½ 02.04.2018 85 ,tkfFk;kis zhu xkys h 50 fexzk- 1 xkys h 9.93 1461¼v½ 02.04.2018 86 ,ftFkzkes kblhu dSIlyw 250 fexzk- 1 dSIlyw 10.28 1461¼v½ 02.04.2018 87 ,ftFkzkes kblhu dSIlyw 500 fexzk- 1 dSIlyw 16.22 1461¼v½ 02.04.2018 88 ,ftFkzkes kblhu vksjy fyD;bw ZM 200 fexzk-@ 1 fefy- 3.01 1461¼v½ 02.04.2018 5 fefy- 89 ,ftFkzkes kblhu xkys h 250 fexzk- 1 xkys h 10.33 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5 90 ,ftFkzkes kblhu xkys h 500 fexzk- 1 xkys h 20.84 1461¼v½ 02.04.2018 91 ,ftFkzkes kblhu bta SD'ku d s fy, ikmMj izfr iSd 188.15 1461¼v½ 02.04.2018 500 fexzk- 92 cSDykQs us xkys h 10 fexzk- 1 xkys h 10.52 1461¼v½ 02.04.2018 93 cSDykQs us xkys h 20 fexzk- 1 xkys h 14.48 1461¼v½ 02.04.2018 94 cSDykQs us xkys h 5 fexzk- 1 xkys h 5.42 1461¼v½ 02.04.2018 95 chlhth oSDlhu izfr Mkts 5.83 1769¼v½ 26.04.2018 96 ctSa kfFku bta SD'ku d s fy, ikmMj izfr iSd 11.89 1461¼v½ 02.04.2018 cSutkbZyifsuflfyu 12 yk[k ;fwuV 97 ctSa kfFku bta SD'ku d s fy, ikmMj izfr iSd 7.87 1461¼v½ 02.04.2018 cSutkbZyifsuflfyu 6 yk[k ;fwuV 98 cus tk,s y isjkDlkbM Øhe 2-5% 1 xzke 2.29 1461¼v½ 02.04.2018 99 cus tk,s y isjkDlkbM tSy 2-5% 1 xzke 3.67 1461¼v½ 02.04.2018 100 cus tkby ifsuflfyu bta SD'ku d s fy, ikmMj izfr iSd 5.09 1461¼v½ 02.04.2018 10 yk[k ;fwuV 101 chVkeFs klkus Øhe 0-05% 1 xzke 0.57 1461¼v½ 02.04.2018 102 chVkeFs klkus Øhe 0-1% 1 xzke 0.82 1461¼v½ 02.04.2018 103 chVkeFs klkus tSy 0-05% 1 xzke 0.52 1461¼v½ 02.04.2018 104 chVkeFs klkus yk's ku 0-1% 1 fefy- 0.80 1461¼v½ 02.04.2018 105 chVkeFs klkus yk's ku 0-5% 1 fefy- 0.52 1461¼v½ 02.04.2018 106 chVkeFs klkus bta SD'ku 4 fexzk-@fefy- 1 fefy- 4.11 1461¼v½ 02.04.2018 107 fcdkyqVkekbM xkys h 50 fexzk- 1 xkys h 67.14 1461¼v½ 02.04.2018 108 fclkdkfWMy lqIikfstVªh 5 fexzk- 1 lqIikfstVªh 8.25 1461¼v½ 02.04.2018 109 fclkdkfWMy xkys h 5 fexzk- 1 xkys h 0.98 1461¼v½ 02.04.2018 110 cy;s kes kbflu bta SD'ku d s fy, ikmMj izfr iSd 607.49 1461¼v½ 02.04.2018 15 ;fwuV 111 ckVs sZtkfec bta SD'ku d s fy, ikmMj izfr iSd 12036.26 1461¼v½ 02.04.2018 2 fexzk- 112 cqMslkus kbM uts y Liz s 100 ,elhth@Mkts 1 Mkts 0.89 1461¼v½ 02.04.2018 113 cqMslkus kbM uts y Liz s 50 ,elhth@Mkts 1 Mkts 0.99 1461¼v½ 02.04.2018 114 cqMslkus kbM jslfijVs kWjh lkys q'ku QkWj ;tw bu 1 fefy- 10.48 1461¼v½ 02.04.2018 ucs qykbtj 0-5 fexzk-@fefy- 115 cqMslkus kbM jslfijVs kWjh lkys q'ku QkWj ;tw bu 1 fefy- 12.64 1461¼v½ 02.04.2018 ucs qykbtj 1 fexzk-@fefy- 116 cMq slkus kbM bugys ”s ku ¼,eMhvkb½Z ifzr ehVj 1.24 1028¼v½ 26.02.2019 100 ,elhth@Mkts Mkts 117 cMq slkus kbM bugys ”s ku ¼,eMhvkb½Z ifzr ehVj 1.54 1028¼v½ 26.02.2019 200 ,elhth@Mkts Mkts 118 cMq slkus kbM bugys ”s ku ¼Mhihvkb½Z ifzr Mkts 1.95 1028¼v½ 26.02.2019 100 ,elhth@Mkts 119 cMq slkus kbM bugys ”s ku ¼Mhihvkb½Z ifzr Mkts 2.83 1028¼v½ 26.02.2019 200 ,elhth@Mkts 120 cMq slkus kbM ¼,½ $ bugys ”s ku ¼,eMhvkb½Z 100 ,elhth ¼,½ ifzr ehVj 1.85 1028¼v½ 26.02.2019 Qkes kVsZ sjksy ¼ch½ $ 6 ,elhth ¼ch½ Mkts 121 cMq slkus kbM ¼,½ $ bugys ”s ku ¼,eMhvkb½Z 200 ,elhth ¼,½ ifzr ehVj 2.62 1028¼v½ 26.02.2019 Qkes kVsZ sjksy ¼ch½ $ 6 ,elhth ¼ch½ Mkts6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 122 cMq slkus kbM ¼,½ $ bugys ”s ku ¼,eMhvkb½Z 400 ,elhth ¼,½ ifzr ehVj 2.98 1028¼v½ 26.02.2019 Qkes kVsZ sjksy ¼ch½ $ 6 ,elhth ¼ch½ Mkts 123 cMq slkus kbM ¼,½ $ bugys ”s ku ¼Mhihvkb½Z 100 ,elhth ¼,½ ifzr Mkts 3.71 1028¼v½ 26.02.2019 Qkes kVsZ sjksy ¼ch½ $ 6 ,elhth ¼ch½ 124 cMq slkus kbM ¼,½ $ bugys ”s ku ¼Mhihvkb½Z 200 ,elhth ¼,½ ifzr Mkts 4.93 1028¼v½ 26.02.2019 Qkes kVsZ sjksy ¼ch½ $ 6 ,elhth ¼ch½ 125 cMq slkus kbM ¼,½ $ bugys ”s ku ¼Mhihvkb½Z 400 ,elhth ¼,½ ifzr Mkts 6.30 1028¼v½ 26.02.2019 Qkes kVsZ sjksy ¼ch½ $ 6 ,elhth ¼ch½ 126 cqfiokdus bta SD'ku 0-25% 1 fefy- 2.40 1461¼v½ 02.04.2018 127 cqfiokdus bta SD'ku 0-5% d s lkFk 7-5% 1 fefy- 6.08 1461¼v½ 02.04.2018 Xydw kts 128 cqfiokdus bta SD'ku 0-50% 1 fefy- 3.84 1461¼v½ 02.04.2018 129 dSQhu bta SD'ku 20 fexzk-@fefy- 1 fefy- 245.64 1461¼v½ 02.04.2018 130 dSQhu vksjy fyD;bw ZM 20 fexzk-@fefy- 1 fefy- 208.63 1461¼v½ 02.04.2018 131 dSykekbu yk's ku ¼vkbiZ h d s vuqlkj½ 1 fefy- 0.83 1461¼v½ 02.04.2018 132 dSfY'k;e QkWyhuVs xkys h 15 fexzk- 1 xkys h 39.92 1461¼v½ 02.04.2018 133 dSfY'k;e Xyqdkus Vs bta SD'ku 100 fexzk-@fefy- 1 fefy- 0.54 1461¼v½ 02.04.2018 134 dSifslVkckbu xkys h 500 fexzk- 1 xkys h 123.68 1461¼v½ 02.04.2018 135 dSiz;s kes kbflu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 338.98 1461¼v½ 02.04.2018 136 dkckZektkikbu vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 0.19 1461¼v½ 02.04.2018 137 dkckZektkikbu lhvkj xkys h 200 fexzk- 1 xkys h 1.52 1461¼v½ 02.04.2018 138 dkckZektkikbu lhvkj xkys h 400 fexzk- 1 xkys h 2.99 1461¼v½ 02.04.2018 139 dkckZektkikbu xkys h 100 fexzk- 1 xkys h 0.67 1461¼v½ 02.04.2018 140 dkckZektkikbu xkys h 200 fexzk- 1 xkys h 1.36 1461¼v½ 02.04.2018 141 dkckZektkikbu xkys h 400 fexzk- 1 xkys h 3.23 1461¼v½ 02.04.2018 142 dkfcZektkys xkys h 10 fexzk- 1 xkys h 3.62 1461¼v½ 02.04.2018 143 dkfcZektkys xkys h 5 fexzk- 1 xkys h 1.86 1461¼v½ 02.04.2018 144 dkcksZIykfVu bta SD'ku 10 fexzk-@fefy- 1 fefy- 52.08 1461¼v½ 02.04.2018 145 dkcksZDlheFs khylys kykts MªkIsl 0-5% 1 fefy- 12.50 1461¼v½ 02.04.2018 146 dkcksZDlheFs khylys kykts MªkIsl 1% 1 fefy- 17.33 1461¼v½ 02.04.2018 147 lQs kMªkDs lhy dSIlyw 500 fexzk- 1 dSIlyw 7.00 1461¼v½ 02.04.2018 148 lQs kMªkDs lhy vksjy fyD;bw ZM 125 fexzk-@5 fefy- 1 fefy- 0.62 1461¼v½ 02.04.2018 149 lQs kMªkDs lhy xkys h 1 xzke 1 xkys h 6.15 1461¼v½ 02.04.2018 150 lQs kMªkDs lhy xkys h 500 fexzk- 1 xkys h 3.95 1461¼v½ 02.04.2018 151 lQs ktkfsyu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 24.03 1461¼v½ 02.04.2018 152 lQs ktkfsyu bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 15.23 1461¼v½ 02.04.2018 153 lfsQDlhe dSIlyw 200 fexzk- 1 dSIlyw 14.12 1461¼v½ 02.04.2018 154 lfsQDlhe dSIlyw 400 fexzk- 1 dSIlyw 28.61 1461¼v½ 02.04.2018 155 lfsQDlhe vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 2.11 1461¼v½ 02.04.2018 156 lfsQDlhe vksjy fyD;bw ZM 50 fexzk-@5 fefy- 1 fefy- 1.42 1461¼v½ 02.04.2018 157 lfsQDlhe xkys h 400 fexzk- 1 xkys h 21.59 1461¼v½ 02.04.2018 158 lfsQDlhe xkys h 200 fexzk- 1 xkys h 9.39 1461¼v½ 02.04.2018 159 lQs kVs Ds lkbe bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 33.59 1461¼v½ 02.04.2018 160 lQs kVs Ds lkbe bta SD'ku d s fy, ikmMj 250 fexzk- izfr iSd 15.27 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 7 161 lQs kVs Ds lkbe bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 20.08 1461¼v½ 02.04.2018 162 lQs VkftMkbe bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 204.82 1461¼v½ 02.04.2018 163 lQs VkftMkbe bta SD'ku d s fy, ikmMj 250 fexzk- izfr iSd 63.70 1461¼v½ 02.04.2018 164 lQs Vªh;kDlkus bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 52.76 1461¼v½ 02.04.2018 165 lQs Vªh;kDlkus bta SD'ku d s fy, ikmMj 2 xzke izfr iSd 125.41 1461¼v½ 02.04.2018 166 lQs Vªh;kDlkus bta SD'ku d s fy, ikmMj 250 fexzk- izfr iSd 24.15 1461¼v½ 02.04.2018 167 lQs Vªh;kDlkus bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 44.12 1461¼v½ 02.04.2018 168 lfsVªftu dSIlyw 10 fexzk- 1 dSIlyw 2.33 1461¼v½ 02.04.2018 169 lfsVªftu vksjy fyD;bw ZM 5 fexzk-@5 fefy- 1 fefy- 0.58 1461¼v½ 02.04.2018 170 lfsVªftu xkys h 10 fexzk- 1 xkys h 1.62 1461¼v½ 02.04.2018 171 lfsVªekbM lkys q'ku 20% ¼d'a kuVªVs QkWj 1 fefy- 0.31 1461¼v½ 02.04.2018 fMyq'ku½ 172 Dyksjkecqfly xkys h 2 fexzk- 1 xkys h 36.12 1461¼v½ 02.04.2018 173 Dyksjkecqfly xkys h 5 fexzk- 1 xkys h 81.17 1461¼v½ 02.04.2018 174 DyksjgDs lkMhu lkys q'ku 5% ¼d'a kuVªVs QkWj 1 fefy- 0.15 1461¼v½ 02.04.2018 fMyq'ku½ 175 DyksjkDs ohu vksjy fyD;bw ZM 50 fexzk-@5 fefy- 1 fefy- 0.29 1461¼v½ 02.04.2018 176 DyksjkDs ohu xkys h 150 fexzk- 1 xkys h 0.77 1461¼v½ 02.04.2018 177 DyksjQus hjkekbu xkys h 4 fexzk- 1 xkys h 0.09 1461¼v½ 02.04.2018 178 dkWyds fsYlQsjkys dSIlyw 1000 vkbZ; w 1 dSIlyw 4.67 1461¼v½ 02.04.2018 179 dkWyds fsYlQsjkys dSIlyw 60000 vkbZ; w 1 dSIlyw 28.90 1461¼v½ 02.04.2018 180 dkWyds fsYlQsjkys vksjy fyD;bw ZM 400 vkbZ;@w fefy- 1 fefy- 2.30 1461¼v½ 02.04.2018 181 dkWyds fsYlQsjkys xkys h 1000 vkbZ; w 1 xkys h 3.67 1461¼v½ 02.04.2018 182 dkWyds fsYlQsjkys xkys h 60000 vkbZ; w 1 xkys h 23.73 1461¼v½ 02.04.2018 183 flizk¶s ykDs lkflu vkbs Va eVsa 0-3% 1 xzke 1.11 1461¼v½ 02.04.2018 184 flizk¶s ykDs lkflu MªkIsl 0-30% 1 fefy- 1.49 1461¼v½ 02.04.2018 185 flizk¶s ykDs lkflu bta SD'ku 200 fexzk-@100 fefy- 1 fefy- 0.17 1461¼v½ 02.04.2018 186 flizk¶s ykDs lkflu vksjy fyD;bw ZM 250 fexzk-@5 fefy- 1 fefy- 0.62 1461¼v½ 02.04.2018 187 flizk¶s ykDs lkflu xkys h 250 fexzk- 1 xkys h 2.03 1461¼v½ 02.04.2018 188 flizk¶s ykDs lkflu xkys h 500 fexzk- 1 xkys h 3.57 1461¼v½ 02.04.2018 189 fllIyfsVu bta SD'ku 1 fexzk-@fefy- 1 fefy- 6.74 1461¼v½ 02.04.2018 190 DysjhFkzkes kblhu vksjy fyD;bw ZM 125 fexkz-@5 fefy- 1 fefy- 4.22 1461¼v½ 02.04.2018 191 DysjhFkzkes kblhu xkys h 250 fexzk- 1 xkys h 27.40 1461¼v½ 02.04.2018 192 DysjhFkzkes kblhu xkys h 500 fexzk- 1 xkys h 48.30 1461¼v½ 02.04.2018 193 DyhuMkekblhu dSIlyw 150 fexzk- 1 dSIlyw 14.16 1461¼v½ 02.04.2018 194 DyhuMkekblhu dSIlyw 300 fexzk- 1 dSIlyw 23.12 1461¼v½ 02.04.2018 195 DyhuMkekblhu xkys h 300 fexzk- 1 xkys h 14.92 1461¼v½ 02.04.2018 196 Dykcs ktes xkys h 10 fexzk- 1 xkys h 8.84 1461¼v½ 02.04.2018 197 Dykcs ktes xkys h 5 fexzk- 1 xkys h 5.03 1461¼v½ 02.04.2018 198 DykQs kftekbu dSIlyw 100 fexzk- 1 dSIlyw 2.42 1461¼v½ 02.04.2018 199 DykQs kftekbu dSIlyw 50 fexzk- 1 dSIlyw 1.42 1461¼v½ 02.04.2018 200 DykfseQus dSIlyw 100 fexzk- 1 dSIlyw 54.47 1461¼v½ 02.04.20188 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 201 DykfseQus dSIlyw 50 fexzk- 1 dSIlyw 29.97 1461¼v½ 02.04.2018 202 DykfseQus xkys h 100 fexzk- 1 xkys h 11.95 1461¼v½ 02.04.2018 203 DykfseQus xkys h 50 fexzk- 1 xkys h 8.15 1461¼v½ 02.04.2018 204 Dykes hizkekbu xkys h 10 fexzk- 1 xkys h 2.46 1461¼v½ 02.04.2018 205 Dykes hizkekbu xkys h 25 fexzk- 1 xkys h 5.43 1461¼v½ 02.04.2018 206 Dykes hizkekbu xkys h 75 fexzk- 1 xkys h 14.04 1461¼v½ 02.04.2018 207 Dykus ktis ke xkys h 0-25 fexzk- 1 xkys h 1.79 1461¼v½ 02.04.2018 208 Dykus ktis ke xkys h 0-5 fexzk- 1 xkys h 3.04 1461¼v½ 02.04.2018 209 Dykus ktis ke xkys h 1 fexzk- 1 xkys h 4.14 1461¼v½ 02.04.2018 210 DykfsiMkxs zys xkys h 75 fexzk- 1 xkys h 6.80 1461¼v½ 02.04.2018 211 DykfsVªektkys Øhe 1% 1 xzke 2.85 3983¼v½ 13.08.2018 212 DykfsVªektkys MªkIsl 1% 1 fefy- 2.96 1461¼v½ 02.04.2018 213 DykfsVªektkys yk's ku 1% 1 fefy- 3.50 1461¼v½ 02.04.2018 214 DykfsVªektkys isljh 100 fexzk- 1 isljh 8.50 1461¼v½ 02.04.2018 215 DykDs lkflfyu dSIlyw 250 fexzk- 1 dSIlyw 1.11 1461¼v½ 02.04.2018 216 DykDs lkflfyu dSIlyw 500 fexzk- 1 dSIlyw 1.86 1461¼v½ 02.04.2018 217 DykDs lkflfyu xkys h 250 fexzk- 1 xkys h 1.69 1461¼v½ 02.04.2018 218 DykDs lkflfyu bta SD'ku d s fy, ikmMj 250 fexzk- izfr iSd 4.35 1461¼v½ 02.04.2018 219 Dykts kikbu xkys h 100 fexzk- 1 xkys h 7.58 1461¼v½ 02.04.2018 220 Dykts kikbu xkys h 25 fexzk- 1 xkys h 2.46 1461¼v½ 02.04.2018 221 Dykts kikbu xkys h 50 fexzk- 1 xkys h 4.70 1461¼v½ 02.04.2018 222 dkxs qy's ku QSDVj IX bta SD'ku d s fy, ikmMj 600 vkbZ; w izfr iSd 12057.74 1461¼v½ 02.04.2018 223 dkxss qy's ku QSDVj VIII bta SD'ku d s fy, ikmMj 250 vkbZ; w izfr iSd 3655.22 1461¼v½ 02.04.2018 224 dkxs qy's ku QSDVj VIII bta SD'ku d s fy, ikmMj 500 vkbZ; w izfr iSd 8969.65 1461¼v½ 02.04.2018 225 dkys phflu xkys h 0-5 fexzk- 1 xkys h 3.04 1461¼v½ 02.04.2018 226 dk&s Vªk;ekDs lktkys vksjy fyD;bw ZM 200 fexzzk-¼,½ $ 1 fefy- 0.21 1461¼v½ 02.04.2018 lYQkeFs kkWDlklys 40 fexzk- ¼ch½@5 fefy- ¼,½$VªheFs kkis zhe ¼ch½] 227 dk&s Vªk;ekDs lktkys xkys h 400 fexzk- ¼,½ $ 80 fexzk- 1 xkys h 0.51 1461¼v½ 02.04.2018 lYQkeFs kkWDlklys ¼ch½ ¼,½$VªheFs kkis zhe ¼ch½] 228 dk&s Vªk;ekDs lktkys xkys h 800 fexzk- ¼,½ $ 160 fexzk- ¼ch½ 1 xkys h 1.32 2399¼v½ 12.06.2018 lYQkeFs kkWDlklys ¼,½$VªheFs kkis zhe ¼ch½] 229 lkbDykQs kslQkekbM xkys h 50 fexzk- 1 xkys h 3.97 1461¼v½ 02.04.2018 230 lkbDykQs kslQkekbM bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 78.11 1461¼v½ 02.04.2018 231 lkbDykslfsju dSIlyw 250 fexzk- 1 dSIlyw 53.13 1461¼v½ 02.04.2018 232 lkbDykslfsju xkys h 250 fexzk- 1 xkys h 45.68 1461¼v½ 02.04.2018 233 lkbDyksLikfsju dSIlyw 100 fexzk- 1 dSIlyw 100.31 1461¼v½ 02.04.2018 234 lkbDyksLikfsju dSIlyw 25 fexzk- 1 dSIlyw 26.92 1461¼v½ 02.04.2018 235 lkbDyksLikfsju dSIlyw 50 fexzk- 1 dSIlyw 51.52 1461¼v½ 02.04.2018 236 lkbDyksLikfsju bta SD'ku 50 fexzk-@fefy- 1 fefy- 263.96 1461¼v½ 02.04.2018 237 lkbDyksLikfsju vksjy fyD;bw ZM 100 fexzk-@fefy- 1 fefy- 92.50 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 9 238 lkbVkfslu vfcZukslkbM bta SD'ku 100 fexzk-@fefy- izfr iSd 194.43 1461¼v½ 02.04.2018 239 lkbVkfslu vfcZukslkbM bta SD'ku d s fy, ikmMj 1000 fexzk- izfr iSd 1048.65 1461¼v½ 02.04.2018 240 lkbVkfslu vfcZukslkbM bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 501.20 1461¼v½ 02.04.2018 241 MkdkckZftu bta SD'ku d s fy, ikmMj 200 fexzk- izfr iSd 429.93 1461¼v½ 02.04.2018 242 MkdkckZftu bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 969.87 1461¼v½ 02.04.2018 243 Mis lkus xkys h 100 fexzk- 1 xkys h 0.23 1461¼v½ 02.04.2018 244 Mk:ukohj xkys h 600 fexzk- 1 xkys h 163.35 1461¼v½ 02.04.2018 245 MslQsjhvkDs lkekbu bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 157.37 1461¼v½ 02.04.2018 246 MDs lkeFs kklkus xkys h 0-5 fexzk- 1 xkys h 0.19 1461¼v½ 02.04.2018 247 MDs lkeFs kklkus bta SD'ku 4 fexzk-@fefy- izfr iSd ¼10 13.48 1461¼v½ 02.04.2018 fefy-½ 248 MDs lkeFs kklkus bta SD'ku 4 fexzk-@fefy- izfr iSd ¼2 9.12 1028¼v½ 26.02.2019 fefy-½ 249 MDs lkeFs kklkus bta SD'ku 4 fexzk-@fefy- izfr iSd ¼20 25.83 1461¼v½ 02.04.2018 fefy-½ 250 MDs lkeFs kklkus bta SD'ku 4 fexzk-@fefy- izfr iSd ¼30 34.52 1461¼v½ 02.04.2018 fefy-½ 251 MDs lkVªku&40 bta SD'ku 10% 1 fefy- 0.83 3983¼v½ 13.08.2018 252 Mk;tis ke bta SD'ku 5 fexzk-@fefy- 1 fefy- 5.93 1461¼v½ 02.04.2018 253 Mk;tis ke vksjy fyD;bw ZM 2 fexzk-@5 fefy- 1 fefy- 2.68 1461¼v½ 02.04.2018 254 Mk;tis ke lqIikfstVªh 5 fexzk- 1 lqIikfstVªh 5.85 1461¼v½ 02.04.2018 255 Mk;tis ke xkys h 2 fexzk- 1 xkys h 1.47 1461¼v½ 02.04.2018 256 Mk;tis ke xkys h 5 fexzk- 1 xkys h 1.39 1461¼v½ 02.04.2018 257 fMDykQs us d dSIlyw 50 fexzk- 1 dSIlyw 0.60 1461¼v½ 02.04.2018 258 fMDykQs us d bta SD'ku 25 fexzk-@fefy- 1 fefy- 1.43 1461¼v½ 02.04.2018 259 fMDykQs us d xkys h 50 fexzk- 1 xkys h 1.87 1461¼v½ 02.04.2018 260 fMlkbDykes kbu bta SD'ku 10 fexzk-@fefy-¼10 fefy- 1 fefy- 2.01 1461¼v½ 02.04.2018 ,Ma 30 fefy- iSd½ 261 fMlkbDykes kbu bta SD'ku 10 fexzk-@fefy-¼1fefy- 1 fefy- 3.12 1461¼v½ 02.04.2018 ,Ma 2 fefy- idS ½ 262 fMlkbDykes kbu vksjy lkys q'ku 10 fexzk-@5 fefy- 1 fefy- 0.16 1461¼v½ 02.04.2018 263 fMlkbDykes kbu xkys h 10 fexzk- 1 xkys h 0.11 1461¼v½ 02.04.2018 264 MkbZbFkk;ydkckZets kbu vksjy fyD;bw ZM 120 fexzk-@5 fefy- 1 fefy- 0.48 1461¼v½ 02.04.2018 265 MkbZbFkk;ydkckZets kbu xkys h 100 fexzk- 1 xkys h 1.38 1461¼v½ 02.04.2018 266 MkbZbFkk;ydkckZets kbu xkys h 50 fexzk- 1 xkys h 0.55 1461¼v½ 02.04.2018 267 MkbxkfsDlu bta SD'ku 0-25 fexzk-@fefy- 1 fefy- 3.26 1461¼v½ 02.04.2018 268 MkbxkfsDlu vksjy fyD;bw ZM 0-05 fexzk-@ fefy- 1 fefy- 1.24 3241¼v½ 04.07.2018 269 MkbxkfsDlu xkys h 0-25 fexzk- 1 xkys h 1.17 1461¼v½ 02.04.2018 270 MkbykDs lkukbM Qwjk,s V xkys h 500 fexzk- 1 xkys h 1.03 1461¼v½ 02.04.2018 271 MkbyfV;ktes dSIlyw 90 fexzk- 1 dSIlyw 9.40 1461¼v½ 02.04.2018 272 MkbyfV;ktes bta SD'ku 5 fexzk-@fefy- 1 fefy- 3.09 1461¼v½ 02.04.2018 273 MkbyfV;ktes ,lvkj xkys h 90 fexzk- 1 xkys h 9.13 1461¼v½ 02.04.2018 274 MkbyfV;ktes xkys h 30 fexzk- 1 xkys h 2.35 1461¼v½ 02.04.2018 275 MkbyfV;ktes xkys h 60 fexzk- 1 xkys h 4.78 1461¼v½ 02.04.201810 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 276 fMesjdkizkys bta SD'ku 50 fexzk-@fefy- 1 fefy- 195.86 5633¼v½ 02.11.2018 277 Mkbukis zksLVkus tSy 0-5 fexzk- 1 xzke 79.33 1461¼v½ 02.04.2018 278 Mkbukis zksLVkus xkys h 0-5 fexzk- 1 xkys h 48.98 1461¼v½ 02.04.2018 279 MkbQFkfsj;k ,VhVa kDs lhu 10000 vkbZ; w izfr iSd 1282.59 1461¼v½ 02.04.2018 280 Mkcs qVkekbu bta SD'ku 50 fexzk-@fefy- izfr iSd 36.70 1461¼v½ 02.04.2018 281 MkslVs kDlys bta SD'ku d s fy, ikmMj 20 fexzk- izfr iSd 2929.38 1461¼v½ 02.04.2018 282 MkslVs kDlys bta SD'ku d s fy, ikmMj 80 fexzk- izfr iSd 11137.71 1461¼v½ 02.04.2018 283 Mkes ifsjMkus vksjy fyD;bw ZM 1 fexzk-@fefy- 1 fefy- 1.05 1461¼v½ 02.04.2018 284 Mkes ifsjMkus xkys h 10 fexzk- 1 xkys h 2.37 1461¼v½ 02.04.2018 285 Mkus is ts kby xkys h 10 fexzk- 1 xkys h 15.70 1461¼v½ 02.04.2018 286 Mkus is ts kby xkys h 5 fexzk- 1 xkys h 11.00 1461¼v½ 02.04.2018 287 Mkis kekbu bta SD'ku 40 fexzk-@fefy- 1 fefy- 5.53 1461¼v½ 02.04.2018 288 MkDs lk:s fclhu bta SD'ku 2 fexzk-@fefy- 1 fefy- 35.14 1461¼v½ 02.04.2018 289 MkDs lhlkblyhu dSIlyw 100 fexzk- 1 dSIlyw 2.45 1461¼v½ 02.04.2018 290 MkDs lhlkblyhu xkys h 100 fexzk- 1 xkys h 0.95 1461¼v½ 02.04.2018 291 MhihVh$fgc$gis ch izfr 0-1 78.60 1461¼v½ 02.04.2018 oSDlhu fefy- 292 MhihVh oSDlhu izfr 0-5 13.86 1461¼v½ 02.04.2018 fefy- 293 bQkohjtsa dSIlyw 200 fexzk- 1 dSIlyw 23.56 1461¼v½ 02.04.2018 294 bQkohjtsa dSIlyw 600 fexzk- 1 dSIlyw 61.38 1461¼v½ 02.04.2018 295 bQkohjtsa xkys h 200 fexzk- 1 xkys h 22.19 1461¼v½ 02.04.2018 296 bQkohjtsa xkys h 600 fexzk- 1 xkys h 69.50 1461¼v½ 02.04.2018 297 bukykizhy xkys h 2-5 fexzk- 1 xkys h 1.89 1461¼v½ 02.04.2018 298 bukykizhy xkys h 5 fexzk- 1 xkys h 3.14 1461¼v½ 02.04.2018 299 bukDs lkikfju bta SD'ku 40 fexzk-@0-4 fefy- 0-1 fefy- 99.48 1461¼v½ 02.04.2018 300 bukDs lkikfju bta SD'ku 60 fexzk-@0-6 fefy- 0-1 fefy- 99.48 1461¼v½ 02.04.2018 301 buVds kohj xkys h 0-5 fexzk- 1 xkys h 78.08 1461¼v½ 02.04.2018 302 buVds kohj xkys h 1 fexzk- 1 xkys h 124.06 1461¼v½ 02.04.2018 303 ,fjFkzkis kbs Vhu bta SD'ku 10000 vkbZ;@w fefy- izfr iSd 2545.89 1461¼v½ 02.04.2018 304 ,fjFkzkis kbs Vhu bta SD'ku 2000 vkbZ;@w fefy- izfr iSd 603.00 1461¼v½ 02.04.2018 305 blhVkykis zke xkys h 10 fexzk- 1 xkys h 7.93 1461¼v½ 02.04.2018 306 blhVkykis zke xkys h 20 fexzk- 1 xkys h 12.52 1461¼v½ 02.04.2018 307 blhVkykis zke xkys h 5 fexzk- 1 xkys h 4.47 1461¼v½ 02.04.2018 308 blekys kys bta SD'ku 10 fexzk-@fefy- 1 fefy- 21.20 1461¼v½ 02.04.2018 309 bFkkecqVkys xkys h 200 fexzk- 1 xkys h 1.03 1461¼v½ 02.04.2018 310 bFkkecqVkys xkys h 400 fexzk- 1 xkys h 2.35 1461¼v½ 02.04.2018 311 bFkkecqVkys xkys h 600 fexzk- 1 xkys h 3.46 1461¼v½ 02.04.2018 312 bFkkecqVkys xkys h 800 fexzk- 1 xkys h 4.14 1461¼v½ 02.04.2018 313 bFkhuysLVkMhvkys xkys h 0-01 fexzk- 1 xkys h 2.30 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 11 314 bFkhuysLVkMhvkys xkys h 0-05 fexzk- 1 xkys h 3.67 1461¼v½ 02.04.2018 315 bFkhuysLVkMhvkys xkys h 0-03 fexzk- ¼,½$0-15 fexzk ¼ch½ 1 xkys h 3.38 1461¼v½ 02.04.2018 ¼,½$ysokus kxs sZLVªys ¼ch½ 316 bFkhukekbM xkys h 250 fexzk- 1 xkys h 15.45 1461¼v½ 02.04.2018 317 bVkis kslkbM dSIlyw 50 fexzk- 1 dSIlyw 53.21 1461¼v½ 02.04.2018 318 bVkis kslkbM bta SD'ku 20 fexzk-@fefy- 1 fefy- 35.09 1461¼v½ 02.04.2018 319 Qus Vkukby bta SD'ku 50 ,elhth@fefy- 1 fefy- 22.22 1461¼v½ 02.04.2018 320 fQyxzkLVhe bta SD'ku 300 ,elhth izfr iSd 1342.98 1461¼v½ 02.04.2018 321 ¶ydw kus ktkys dSIlyw 100 fexzk- 1 dSIlyw 24.72 1461¼v½ 02.04.2018 322 ¶ydw kus ktkys dSIlyw 150 fexzk- 1 dSIlyw 18.15 1461¼v½ 02.04.2018 323 ¶ydw kus ktkys dSIlyw 200 fexzk- 1 dSIlyw 35.73 1461¼v½ 02.04.2018 324 ¶ydw kus ktkys vksjy fyD;bw ZM 50 fexzk-@5 fefy- 1 fefy- 2.56 1461¼v½ 02.04.2018 325 ¶ydw kus ktkys xkys h 100 fexzk- 1 xkys h 7.81 1461¼v½ 02.04.2018 326 ¶ydw kus ktkys xkys h 150 fexzk- 1 xkys h 11.59 1461¼v½ 02.04.2018 327 ¶ydw kus ktkys xkys h 200 fexzk- 1 xkys h 18.38 1461¼v½ 02.04.2018 328 ¶ydw kus ktkys xkys h 400 fexzk- 1 xkys h 30.57 1461¼v½ 02.04.2018 329 ¶ydw kus ktkys bta SD'ku 200 fexzk-@100 fefy- izfr iSd 104.15 1461¼v½ 02.04.2018 330 ¶yuw kfjtkbu xkys h 10 fexzk- 1 xkys h 4.63 1461¼v½ 02.04.2018 331 ¶yuw kfjtkbu xkys h 5 fexzk- 1 xkys h 2.70 1461¼v½ 02.04.2018 332 ¶yDw lVs kbu dSIlyw 10 fexzk- 1 dSIlyw 2.91 1461¼v½ 02.04.2018 333 ¶yDw lVs kbu dSIlyw 20 fexzk- 1 dSIlyw 3.57 1461¼v½ 02.04.2018 334 ¶yDw lVs kbu dSIlyw 40 fexzk- 1 dSIlyw 5.42 1461¼v½ 02.04.2018 335 ¶yDw lVs kbu dSIlyw 60 fexzk- 1 dSIlyw 9.58 1461¼v½ 02.04.2018 336 ¶yDw lVs kbu xkys h 10 fexzk- 1 xkys h 2.44 1461¼v½ 02.04.2018 337 ¶yDw lVs kbu xkys h 20 fexzk- 1 xkys h 3.88 1461¼v½ 02.04.2018 338 ¶yDw lVs kbu xkys h 40 fexzk- 1 xkys h 5.22 1461¼v½ 02.04.2018 339 ¶yDw lVs kbu xkys h 60 fexzk- 1 xkys h 7.24 1461¼v½ 02.04.2018 340 ¶yQw us ktkbu fMikVs bta SD'ku 25 fexzk-@fefy- 1 fefy- 48.96 1461¼v½ 02.04.2018 341 Qkfsyd ,flM dSIlyw 5 fexzk- 1 dSIlyw 5.52 1461¼v½ 02.04.2018 342 Qkfsyd ,flM xkys h 5 fexzk- 1 xkys h 1.36 1461¼v½ 02.04.2018 343 Qqjksles kbM vksjy fyD;bw ZM 10 fexzk-@fefy- 1 fefy- 2.71 3241¼v½ 04.07.2018 344 Qqjksles kbM xkys h 40 fexzk- 1 xkys h 0.49 1461¼v½ 02.04.2018 345 Qqjksles kbM bta SD'ku 10 fexzk-@fefy- 1 fefy- 1.62 1461¼v½ 02.04.2018 346 QqflfMd ,flM Øhe 2% 1 xzke 8.93 1461¼v½ 02.04.2018 347 xkMkcs us Vs bta SD'ku 529 fexzk-@fefy- 1 fefy- 106.66 1461¼v½ 02.04.2018 348 xkulhDyksohj dSIlyw 250 fexzk- 1 dSIlyw 117.65 1461¼v½ 02.04.2018 349 xkulhDyksohj bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 1651.52 1461¼v½ 02.04.2018 350 tfsQfVfuc xkys h 250 fexzk- 1 xkys h 419.44 1461¼v½ 02.04.2018 351 tes flVkckbu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 5191.88 1461¼v½ 02.04.2018 352 tes flVkckbu bta SD'ku d s fy, ikmMj 200 fexzk- izfr iSd 1146.62 1461¼v½ 02.04.2018 353 tVsa kekbflu MªkIsl 0-3% 1 fefy- 0.89 1461¼v½ 02.04.201812 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 354 tVsa kekbflu bta SD'ku 10 fexzk-@fefy- 1 fefy- 3.11 1461¼v½ 02.04.2018 355 tVsa kekbflu bta SD'ku 40 fexzk-@fefy- izfr iSd ¼10 17.58 1461¼v½ 02.04.2018 fefy-½ 356 tVsa kekbflu bta SD'ku 40 fexzk-@fefy- izfr iSd ¼2 8.23 1028¼v½ 26.02.2019 fefy-½ 357 tVsa kekbflu bta SD'ku 40 fexzk-@fefy- izfr iSd ¼20 26.65 1461¼v½ 02.04.2018 fefy-½ 358 tVsa kekbflu bta SD'ku 40 fexzk-@fefy- izfr iSd ¼30 29.17 1461¼v½ 02.04.2018 fefy-½ 359 XyhehfijkbM xkys h 1 fexzk- 1 xkys h 3.51 1461¼v½ 02.04.2018 360 XyhehfijkbM xkys h 2 fexzk- 1 xkys h 5.58 1461¼v½ 02.04.2018 361 Xydw kts bta SD'ku 25% 1 fefy- 0.17 1461¼v½ 02.04.2018 362 Xydw kts bta SD'ku 50% 1 fefy- 0.48 1461¼v½ 02.04.2018 363 Xydw kts bta SD'ku 5% 1000 fefy- 62.86 1461¼v½ 02.04.2018 Xykl 364 Xydw kts bta SD'ku 5% 1000 fefy- 50.73 1461¼v½ 02.04.2018 ukWu Xykl 365 Xydw kts bta SD'ku 5% 100 fefy- 17.64 1461¼v½ 02.04.2018 Xykl 366 Xydw kts bta SD'ku 5% 100 fefy- 15.97 1461¼v½ 02.04.2018 ukWu Xykl 367 Xydw kts bta SD'ku 5% 250 fefy- 24.38 1461¼v½ 02.04.2018 Xykl 368 Xydw kts bta SD'ku 5% 250 fefy- 22.02 1461¼v½ 02.04.2018 ukWu Xykl 369 Xydw kts bta SD'ku 5% 500 fefy- 34.60 1461¼v½ 02.04.2018 Xykl 370 Xydw kts bta SD'ku 5% 500 fefy- 29.86 1461¼v½ 02.04.2018 ukWu Xykl 371 Xydw kts bta SD'ku 10% izfr iSd 25.27 1461¼v½ 02.04.2018 ¼1000 fefy-½ 372 Xydw kts bta SD'ku 10% izfr iSd 27.49 1461¼v½ 02.04.2018 ¼500 fefy-½ 373 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 1000 fefy- 63.26 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ Xykl 374 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 1000 fefy- 51.12 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ ukWu Xykl 375 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 100 fefy- 17.69 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ Xykl 376 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 100 fefy- 15.99 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ ukWu Xykl 377 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 250 fefy- 24.48 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ Xykl 378 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9%¼ch½ 250 fefy- 22.10 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ ukWu Xykl 379 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- 34.77 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ Xykl¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 13 380 Xydw kts ¼,½ $ lkfsM;e bta SD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- 30.04 1461¼v½ 02.04.2018 DyksjkbM ¼ch½ ukWu Xykl 381 XyVw kjkyMgs kbM lkys q'ku 2% 1 fefy- 0.06 1461¼v½ 02.04.2018 382 fXyljhu vksjy fyD;bw ZM 1 fefy- 0.15 1461¼v½ 02.04.2018 383 fXyljkby VªkbfZuVªVs bta SD'ku 5 fexzk-@fefy- 1 fefy- 6.42 1461¼v½ 02.04.2018 384 fXyljkby VªkbfZuVªVs lcfyxa q,y xkys h 0-5 fexzk- 1 xkys h 1.77 1461¼v½ 02.04.2018 385 Xykbdkis kbjkys Vs bta SD'ku 0-2 fexzk-@fefy- 1 fefy- 12.02 1461¼v½ 02.04.2018 386 xzhlkQs qyfou xkys h 125 fexzk- 1 xkys h 0.80 1461¼v½ 02.04.2018 387 xzhlkQs qyfou xkys h 250 fexzk- 1 xkys h 1.56 1461¼v½ 02.04.2018 388 xzhlkQs qyfou xkys h 375 fexzk- 1 xkys h 4.21 1461¼v½ 02.04.2018 389 ges kMs k;ylhl ¶yMw ykblsal d s vuqlkj 1 fefy- 0.04 1461¼v½ 02.04.2018 390 gys kis fsjMkys bta SD'ku 5 fexzk-@fefy- 1 fefy- 5.70 1461¼v½ 02.04.2018 391 gys kis fsjMkys vksjy fyD;bw ZM 2 fexzk-@5 fefy- 1 fefy- 2.01 1461¼v½ 02.04.2018 392 gys kis fsjMkys xkys h 1-5 fexzk- 1 xkys h 1.62 1461¼v½ 02.04.2018 393 gys kis fsjMkys xkys h 10 fexzk- 1 xkys h 4.32 1461¼v½ 02.04.2018 394 gys kis fsjMkys xkys h 20 fexzk- 1 xkys h 4.82 1461¼v½ 02.04.2018 395 gys kis fsjMkys xkys h 5 fexzk- 1 xkys h 3.37 1461¼v½ 02.04.2018 396 gys kFs kus bugys 's ku 1 fefy- 5.73 1461¼v½ 02.04.2018 397 gis kfju bta SD'ku 1000 vkbZ;@w fefy- 1 fefy- 15.96 1461¼v½ 02.04.2018 398 gis kfju bta SD'ku 5000 vkbZ;@w fefy- 1 fefy- 39.61 1461¼v½ 02.04.2018 399 gis kVkbfVl ch izfr iSd 5390.60 1461¼v½ 02.04.2018 bEequkXs ykcs qfyu 400 gSikVkbfVl ch oSDlhu 1 fefy- 76.64 1461¼v½ 02.04.2018 401 gkes kVªkis kbu MªkIsl 2% 1 fefy- 6.08 1461¼v½ 02.04.2018 402 gkeksZu fjfyftxa ble sa 52 fexzk- ysokus kxs sZLVsªy 'kkfey 1 vkbZ;Mw h 3785.52 1461¼v½ 02.04.2018 vkbZ;Mw h g S 403 g~;qeu dkfsjvkfsud bta SD'ku 1000 vkbZ; w izfr iSd 207.98 1461¼v½ 02.04.2018 xkus kMkVs ªkfsiu 404 g~;qeu dkfsjvkfsud bta SD'ku 5000 vkbZ; w izfr iSd 408.44 1461¼v½ 02.04.2018 xkus kMkVs ªkfsiu 405 g~;qeu ukWeZy 1 fefy- 150.97 1461¼v½ 02.04.2018 bEequkXs ykcs qfyu 406 gkbMªkDs yksjkFs kkbtkbM xkys h 12-5 fexzk- 1 xkys h 0.96 1461¼v½ 02.04.2018 407 gkbMªkDs yksjkFs kkbtkbM xkys h 25 fexzk- 1 xkys h 1.65 1461¼v½ 02.04.2018 408 gkbMªkDs yksjkFs kkbtkbM xkys h 50 fexzk- 1 xkys h 0.08 1461¼v½ 02.04.2018 409 gkbMªkds kVs hZlkus xkys h 10 fexzk- 1 xkys h 5.76 1461¼v½ 02.04.2018 410 gkbMªkds kVs hZlkus xkys h 5 fexzk- 1 xkys h 2.96 1461¼v½ 02.04.2018 411 gkbMªkds kVs hZlkus bta SD'ku 100 fexzk- izfr iSd 38.08 1461¼v½ 02.04.2018 412 gkbMªkds kVs hZlkus bta SD'ku 200 fexzk- izfr iSd 58.71 1461¼v½ 02.04.2018 413 gkbMªkds kVs hZlkus bta SD'ku d s fy, ikmMj 100 fexzk- izfr iSd 38.08 1461¼v½ 02.04.2018 414 gkbMªkts u isjkDs lkbM lkys q'ku 6% 1 fefy- 0.04 1461¼v½ 02.04.2018 415 gkbMªkDs lhDyksjkDs ohu xkys h 200 fexzk- 1 xkys h 5.80 1461¼v½ 02.04.2018 416 gkbMªkDs lhDyksjkDs ohu xkys h 400 fexzk- 1 xkys h 11.69 1461¼v½ 02.04.201814 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 417 gkbMªkDs lhizkis kby bta SD'ku 2% 1 fefy- 36.70 1461¼v½ 02.04.2018 eFs kkbylys qykts 418 gkbMªkDs lh;fwj;k dSIlyw 500 fexzk- 1 dSIlyw 12.54 1461¼v½ 02.04.2018 419 gk;kslhu cqVhyczkes kbM bta SD'ku 20 fexzk-@fefy- 1 fefy- 10.21 1461¼v½ 02.04.2018 420 gk;kslhu cqVhyczkes kbM xkys h 10 fexzk- 1 xkys h 2.91 1461¼v½ 02.04.2018 421 vkbZcqizkQs qu dSIlyw 400 fexzk- 1 dSIlyw 1.03 1461¼v½ 02.04.2018 422 vkbZcqizkQs qu xkys h 200 fexzk- 1 xkys h 0.38 1461¼v½ 02.04.2018 423 vkbZcqizkQs qu xkys h 400 fexzk- 1 xkys h 0.68 1461¼v½ 02.04.2018 424 vkbZcqizkQs qu vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 0.19 1461¼v½ 02.04.2018 425 vkbZQksLQkekbM bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 354.11 1461¼v½ 02.04.2018 426 vkbZQksLQkekbM bta SD'ku d s fy, ikmMj 2 xzke izfr iSd 929.49 1461¼v½ 02.04.2018 427 befsVuhc dSIlyw 100 fexzk- 1 dSIlyw 75.97 1461¼v½ 02.04.2018 428 befsVuhc dSIlyw 400 fexzk- 1 dSIlyw 249.96 1461¼v½ 02.04.2018 429 befsVuhc xkys h 100 fexzk- 1 xkys h 77.73 1461¼v½ 02.04.2018 430 befsVuhc xkys h 400 fexzk- 1 xkys h 225.00 1461¼v½ 02.04.2018 431 balqfyu ¼lkys qcy½ bta SD'ku 40 vkbZ;@w fefy- 1 fefy- 14.73 1461¼v½ 02.04.2018 432 bVa jefsM,V ,fDVxa bta SD'ku 40 vkbZ;@w fefy- 1 fefy- 14.73 1461¼v½ 02.04.2018 ¼,uih,p½ balqfyu 433 bvkgs Ds lkys bta SD'ku 300 fexzk- vk;kfsMu@fefy- 1 fefy- 16.27 1461¼v½ 02.04.2018 434 vkbZizkVªkfsi;e bugys 's ku ¼,eMhvkbZ@Mhihvkb½Z 20 1 Mkts 0.60 1461¼v½ 02.04.2018 ,elhth@Mkts 435 vkbZizkVªkfsi;e jslfijVs kWjh lkys q'ku QkWj ;tw bu 1 fefy- 2.48 1461¼v½ 02.04.2018 ucs qykbtj 250 ,elhth@fefy- 436 vk;ju lqØkts bta SD'ku 20 fexzk-@fefy- 1 fefy- 52.60 1461¼v½ 02.04.2018 437 vkbZlk¶s yqjus bugys 's ku 1 fefy- 10.23 1461¼v½ 02.04.2018 438 vkbZlkfsuftM xkys h 100 fexzk- 1 xkys h 0.67 1461¼v½ 02.04.2018 439 vkbZlkfsuftM xkys h 300 fexzk- 1 xkys h 1.17 1461¼v½ 02.04.2018 440 vkbZlkslkfscZM 5 xkys h 20 fexzk- 1 xkys h 3.21 1461¼v½ 02.04.2018 ekus kus hVªVs 441 vkbZlkslkfscZM fMfuVªVs xkys h 10 fexzk- 1 xkys h 0.72 1461¼v½ 02.04.2018 442 vkbZlkslkfscZM fMfuVªVs xkys h 5 fexzk- 1 xkys h 0.74 1461¼v½ 02.04.2018 443 vkbZlkslkfscZM 5 & ,lvkj dISlyw 30 fexzk- 1 dSIlyw 3.43 1461¼v½ 02.04.2018 ekus kus hVªVs 444 vkbZlkslkfscZM 5 & ,lvkj dISlyw 60 fexzk- 1 dSIlyw 3.41 1461¼v½ 02.04.2018 ekus kus hVªVs 445 vkbZlkslkfscZM 5 & ,lvkj xkys h 30 fexzk- 1 xkys h 4.79 1461¼v½ 02.04.2018 ekus kus hVªVs 446 vkbZlkslkfscZM 5 & ,lvkj xkys h 60 fexzk- 1 xkys h 6.25 1461¼v½ 02.04.2018 ekus kus hVªVs 447 vkbZlkslkfscZM 5 & xkys h 10 fexzk- 1 xkys h 1.92 1461¼v½ 02.04.2018 ekus kus hVªVs 448 bLik?kqyk xzUs ;yw l@gLd@ikmMj 1 xzke 0.76 1461¼v½ 02.04.2018 449 vkbZ;Mw h dVa fsauxa dkWij ykblsal d s :i e sa 1 vkbZ;Mw h 281.35 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 15 450 tkiuht bulQs kfyfVl 4 ,elhth l s 6 ,elhth izfr iSd 682.64 1461¼v½ 02.04.2018 oSDlhu 451 tkiuht bulQs kfyfVl 3 ,elhth rd izfr iSd 520.08 1461¼v½ 02.04.2018 oSDlhu 452 dSukekblhu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 38.27 1461¼v½ 02.04.2018 453 dSukekblhu bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 20.88 1461¼v½ 02.04.2018 454 dSukekblhu bta SD'ku d s fy, ikmMj 750 fexzk- izfr iSd 35.67 1461¼v½ 02.04.2018 455 dSVkekbu bta SD'ku 10 fexzk-@fefy- 1 fefy- 10.36 1461¼v½ 02.04.2018 456 dSVkekbu bta SD'ku 50 fexzk-@fefy- 1 fefy- 10.23 1461¼v½ 02.04.2018 457 ycs Vs kykys bta SD'ku 5 fexzk-@fefy- 1 fefy- 49.61 1461¼v½ 02.04.2018 458 ySDVkys kts vksjy fyD;bw ZM 10 xzke@15 fefy- 1 fefy- 1.07 1461¼v½ 02.04.2018 459 yfseoqMkbu ¼,½ $ xkys h 150 fexzk- ¼,½ $ 200 fexzk- 1 xkys h 15.27 1461¼v½ 02.04.2018 ufsojkikbu ¼ch½ $ ¼ch½ $ 30 fexzk- ¼lh½ LVkoqMkbu ¼lh½ 460 yfseoqMkbu ¼,½ $ xkys h 150 fexzk- ¼,½ $ 300 fexzk- 1 xkys h 19.63 1461¼v½ 02.04.2018 ftMkcs qMkbu ¼ch½ ¼ch½ 461 yfseoqMkbu ¼,½ fMLizfslcy xkys h 30 fexzk- ¼,½ $ 1 xkys h 4.84 1461¼v½ 02.04.2018 $ufsojkikbu ¼ch½ 50 fexzk-¼ch½ $ 6 fexzk- ¼lh½ $LVkoqMkbu ¼lh½ 462 ,y&,Lisjtkbul bta SD'ku d s fy, ikmMj 10000 d;s w izfr iSd 1571.02 1461¼v½ 02.04.2018 463 ,y&,Lisjtkbul bta SD'ku d s fy, ikmMj 5000 d;s w izfr iSd 1014.08 1461¼v½ 02.04.2018 464 y¶s yqukes kbM xkys h 10 fexzk- 1 xkys h 9.80 1461¼v½ 02.04.2018 465 y¶s yqukes kbM xkys h 20 fexzk- 1 xkys h 19.12 1461¼v½ 02.04.2018 466 yVs ªkts kys xkys h 2-5 fexzk- 1 xkys h 39.90 1461¼v½ 02.04.2018 467 ysofsVjklVs e bta SD'ku 100 fexzk-@fefy- 1 fefy- 21.35 1461¼v½ 02.04.2018 468 ysofsVjklVs e bZvkj xkys h 750 fexzk- 1 xkys h 17.02 1461¼v½ 02.04.2018 469 ysofsVjklVs e xkys h 250 fexzk- 1 xkys h 5.72 1461¼v½ 02.04.2018 470 ysofsVjklVs e xkys h 500 fexzk- 1 xkys h 11.57 1461¼v½ 02.04.2018 471 ysofsVjklVs e xkys h 750 fexzk- 1 xkys h 17.79 1461¼v½ 02.04.2018 472 ysofsVjklVs e vksjy fyD;bw ZM 100 fexzk-@fefy- 1 fefy- 3.57 1461¼v½ 02.04.2018 473 ysokMs kis k ¼,½ lhvkj xkys h 100 fexzk-¼,½ $ 1 xkys h 3.26 1461¼v½ 02.04.2018 $dkfcZMkis k ¼ch½ 25 fexzk- ¼ch½ 474 ysokMs kis k ¼,½ xkys h 100 fexzk- ¼,½ $ 10 fexzk- 1 xkys h 1.52 1461¼v½ 02.04.2018 $dkfcZMkis k ¼ch½ ¼ch½ 475 ysokMs kis k ¼,½ xkys h 100 fexzk- ¼,½ $ 25 fexzk- 1 xkys h 2.21 1461¼v½ 02.04.2018 $dkfcZMkis k ¼ch½ ¼ch½ 476 ysokMs kis k ¼,½ xkys h 250 fexzk- ¼,½ $ 25 fexzk- 1 xkys h 3.66 1461¼v½ 02.04.2018 $dkfcZMkis k ¼ch½ ¼ch½ 477 ysokMs kis k ¼,½ lhvkj xkys h 200 fexzk-¼,½ $ 1 xkys h 4.02 1461¼v½ 02.04.2018 $dkfcZMkis k ¼ch½ 50 fexzk- ¼ch½ 478 ysok¶s ykDs lklhu xkys h 250 fexzk- 1 xkys h 4.32 1461¼v½ 02.04.2018 479 ysok¶s ykDs lklhu xkys h 750 fexzk- 1 xkys h 10.70 1461¼v½ 02.04.2018 480 ysok¶s ykDs lklhu xkys h 500 fexzk- 1 xkys h 7.89 1461¼v½ 02.04.2018 481 ysokus kxs sZLVªys xkys h 0-75 fexzk- 1 xkys h 22.53 1461¼v½ 02.04.201816 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 482 ysokFs kkbjkDs lhu xkys h 100 ,elhth 1 xkys h 1.17 1461¼v½ 02.04.2018 483 ysokFs kkbjkDs lhu xkys h 112 ,elhth 1 xkys h 1.40 1461¼v½ 02.04.2018 484 ysokFs kkbjkDs lhu xkys h 12-5 ,elhth 1 xkys h 1.32 1461¼v½ 02.04.2018 485 ysokFs kkbjkDs lhu xkys h 125 ,elhth 1 xkys h 1.50 1461¼v½ 02.04.2018 486 ysokFs kkbjkDs lhu xkys h 150 ,elhth 1 xkys h 1.51 1461¼v½ 02.04.2018 487 ysokFs kkbjkDs lhu xkys h 25 ,elhth 1 xkys h 1.28 1461¼v½ 02.04.2018 488 ysokFs kkbjkDs lhu xkys h 50 ,elhth 1 xkys h 0.96 1461¼v½ 02.04.2018 489 ysokFs kkbjkDs lhu xkys h 62-5 ,elhth 1 xkys h 1.37 1461¼v½ 02.04.2018 490 ysokFs kkbjkDs lhu xkys h 75 ,elhth 1 xkys h 1.27 1461¼v½ 02.04.2018 491 ysokFs kkbjkDs lhu xkys h 88 ,elhth 1 xkys h 1.50 1461¼v½ 02.04.2018 492 fyXukds us bta SD'ku 2% 1 fefy- 0.96 1461¼v½ 02.04.2018 493 fyXukds us bta SD'ku 2% ¼izts jofsVo Qzh QkWj IV 1 fefy- 0.95 1461¼v½ 02.04.2018 ;tw 494 fyXukds us bta SD'ku 1% izfr iSd 7.77 1461¼v½ 02.04.2018 495 fyXukds us VkWfidy QkWeZ 2&5% 1 xzke vkSj 1.05 1461¼v½ 02.04.2018 1 fefy- 496 fyXukds us bta SD'ku 5% Xydw kts 7-5% d s 1 fefy- 3.60 1461¼v½ 02.04.2018 lkFk 497 fyXukds us ¼,½ $ bta SD'ku 1%¼,½ $ 1%200000 1 fefy- 0.44 1461¼v½ 02.04.2018 ,Mªus kykbu ¼ch½ ¼5 ,elhth@fefy-½ ¼ch½ 498 fyXukds us ¼,½ $ bta SD'ku 2% ¼,½ $ 1%200000 ¼5 1 fefy- 0.90 1461¼v½ 02.04.2018 ,Mªus kykbu ¼ch½ ,elhth@fefy-½ ¼ch½ 499 ykbutkfsyM xkys h 600 fexzk- 1 xkys h 32.33 1461¼v½ 02.04.2018 500 fyfFk;e xkys h 300 fexzk- 1 xkys h 1.43 1461¼v½ 02.04.2018 501 yis sjkekbM dSIlyw 2 fexzk- 1 dSIlyw 3.50 1461¼v½ 02.04.2018 502 yis sjkekbM xkys h 2 fexzk- 1 xkys h 1.93 1461¼v½ 02.04.2018 503 ykfsiukohj ¼,½ xkys h 100 fexzk- ¼,½ $ 25 fexzk- 1 xkys h 23.01 1461¼v½ 02.04.2018 $fjVkus kohj ¼ch½ ¼ch½ 504 ykfsiukohj ¼,½ xkys h 200 fexzk- ¼,½ $ 50 fexzk- 1 xkys h 44.59 1461¼v½ 02.04.2018 $fjVkus kohj ¼ch½ ¼ch½ 505 yksjktis ke bta SD'ku 2 fexzk-@fefy- 1 fefy- 7.61 1461¼v½ 02.04.2018 506 yksjktis ke xkys h 1 fexzk- 1 xkys h 2.02 1461¼v½ 02.04.2018 507 yksjktis ke xkys h 2 fexzk- 1 xkys h 2.46 1461¼v½ 02.04.2018 508 eSxa fuf'k;e lYQVs bta SD'ku 500 fexzk-@fefy- 1 fefy- 4.67 1461¼v½ 02.04.2018 509 efsuVkys bta SD'ku 10% 1 fefy- 0.16 1461¼v½ 02.04.2018 510 efsuVkys bta SD'ku 20% 1 fefy- 0.29 1461¼v½ 02.04.2018 511 fetyl :cys k oSDlhu izfr iSd ¼0- 86.52 1461¼v½ 02.04.2018 5 fefy-½ 512 fetyl oSDlhu oSDlhu izfr iSd ¼0- 49.90 1461¼v½ 02.04.2018 5 fefy-½ 513 esous Mktkys vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 0.76 1461¼v½ 02.04.2018 514 esous Mktkys xkys h 100 fexzk- 1 xkys h 2.87 1461¼v½ 02.04.2018 515 eMs ªkDs lh izkxs sLVsjkus xkys h 10 fexzk- 1 xkys h 5.27 1461¼v½ 02.04.2018 ,lVs Vs¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 17 516 eQs us kfed ,flM vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 0.51 1461¼v½ 02.04.2018 517 eQs us fsed ,flM xkys h 250 fexzk- 1 xkys h 1.89 1461¼v½ 02.04.2018 518 eQs us fsed ,flM xkys h 500 fexzk- 1 xkys h 2.40 1461¼v½ 02.04.2018 519 e¶s ykDs ohu xkys h 250 fexzk- 1 xkys h 49.89 1461¼v½ 02.04.2018 520 eXs yqekbu MkbVªhtk,s V bta SD'ku 60% MCY;@w oh 1 fefy- 8.09 1461¼v½ 02.04.2018 521 eXs yqekbu MkbVªhtk,s V bta SD'ku 76% MCY;@w oh 1 fefy- 9.34 1461¼v½ 02.04.2018 522 eys Qkyku xkys h 2 fexzk- 1 xkys h 96.01 1461¼v½ 02.04.2018 523 eys Qkyku xkys h 5 fexzk- 1 xkys h 164.67 1461¼v½ 02.04.2018 524 esluk bta SD'ku 100 fexzk-@fefy- 1 fefy- 16.41 1461¼v½ 02.04.2018 525 eVs QkWfeZu bEeMs Vs fjfyt xkys h 500 fexzk- 1 xkys h 1.47 1461¼v½ 02.04.2018 526 eVs QkWfeZu dVa ªkys M fjfyt xkys h 1000 fexzk- 1 xkys h 3.57 1461¼v½ 02.04.2018 527 eVs QkWfeZu dVa ªkys M fjfyt xkys h 500 fexzk- 1 xkys h 1.87 1461¼v½ 02.04.2018 528 eVs QkWfeZu dVa ªkys M fjfyt xkys h 750 fexzk- 1 xkys h 2.35 1461¼v½ 02.04.2018 529 eVs QkWfeZu bEeMs Vs fjfyt xkys h 1000 fexzk- 1 xkys h 3.52 1461¼v½ 02.04.2018 530 eVs QkWfeZu bEeMs Vs fjfyt xkys h 750 fexzk- 1 xkys h 2.97 1461¼v½ 02.04.2018 531 eFs kkVs ªDs lVs bta SD'ku 25 fexzk-@fefy- 1 fefy- 47.07 1461¼v½ 02.04.2018 532 eFs kkVs ªDs lVs bta SD'ku 50 fexzk-@fefy- 1 fefy- 39.20 1461¼v½ 02.04.2018 533 eFs kkVs ªDs lVs xkys h 10 fexzk- 1 xkys h 11.89 1461¼v½ 02.04.2018 534 eFs kkVs ªDs lVs xkys h 2-5 fexzk- 1 xkys h 4.68 1461¼v½ 02.04.2018 535 eFs kkVs ªDs lVs xkys h 7-5 fexzk- 1 xkys h 11.34 1461¼v½ 02.04.2018 536 eFs kkVs ªDs lVs xkys h 5 fexzk- 1 xkys h 8.20 1461¼v½ 02.04.2018 537 eSfFkyMkis k xkys h 250 fexzk- 1 xkys h 2.39 1461¼v½ 02.04.2018 538 eSfFkyMkis k xkys h 500 fexzk- 1 xkys h 4.58 1461¼v½ 02.04.2018 539 eSfFkyxs ksZeVs ªhu bta SD'ku 0-2 fexzk-@fefy- 1 fefy- 13.97 1461¼v½ 02.04.2018 540 eSfFkyxs ksZeVs ªhu xkys h 0-125 fexzk- 1 xkys h 7.75 1461¼v½ 02.04.2018 541 eSfFkyiMzs uhlkys kus xkys h 16 fexzk- 1 xkys h 8.73 1461¼v½ 02.04.2018 542 eSfFkyiMzs uhlkys kus xkys h 8 fexzk- 1 xkys h 4.99 1461¼v½ 02.04.2018 543 eSfFkyiMzs uhlkys kus bta SD'ku 40 fexzk-@fefy- 1 fefy- 52.81 1461¼v½ 02.04.2018 544 eVs kDs ykis zkekbM bta SD'ku 5 fexzk-@fefy- ¼10 fefy- 1 fefy- 1.39 1461¼v½ 02.04.2018 iSd½ 545 eVs kDs ykis zkekbM bta SD'ku 5 fexzk-@fefy- ¼2 fefy- 1 fefy- 2.29 1461¼v½ 02.04.2018 iSd½ 546 eVs kDs ykis zkekbM vksjy fyD;bw ZM 5 fexzk-@5 fefy- 1 fefy- 0.43 1461¼v½ 02.04.2018 547 eVs kDs ykis zkekbM xkys h 10 fexzk- 1 xkys h 1.14 1461¼v½ 02.04.2018 548 eVs kis zkys kys dSIlyw 25 fexzk- 1 dSIlyw 4.14 1461¼v½ 02.04.2018 549 eVs kis zkys kys dSIlyw 50 fexzk- 1 dSIlyw 6.31 1461¼v½ 02.04.2018 550 eVs kis zkys kys ,lvkj xkys h 25 fexzk- 1 xkys h 3.95 1461¼v½ 02.04.2018 551 eVs kis zkys kys ,lvkj xkys h 50 fexzk- 1 xkys h 5.65 1461¼v½ 02.04.2018 552 eVs kis zkys kys xkys h 25 fexzk- 1 xkys h 3.04 1461¼v½ 02.04.2018 553 eVs kis zkys kys xkys h 50 fexzk- 1 xkys h 4.61 1461¼v½ 02.04.2018 554 eVs ªkfsuMktkys bta SD'ku 500 fexzk-@100 fefy- 1 fefy- 0.13 1461¼v½ 02.04.2018 555 eVs ªkfsuMktkys vksjy fyD;bw ZM 200 fexzk-@5 fefy- 1 fefy- 0.29 1461¼v½ 02.04.201818 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 556 eVs ªkfsuMktkys xkys h 200 fexzk- 1 xkys h 0.45 3983¼v½ 13.08.2018 557 eVs ªkfsuMktkys xkys h 400 fexzk- 1 xkys h 0.83 3983¼v½ 13.08.2018 558 feMktkys e bta SD'ku 1 fexzk-@fefy- 1 fefy- 5.78 1461¼v½ 02.04.2018 559 feMktkys e bta SD'ku 5 fexzk-@fefy- 1 fefy- 14.20 1461¼v½ 02.04.2018 560 feMktkys e xkys h 7-5 fexzk- 1 xkys h 21.97 1461¼v½ 02.04.2018 561 feQis zhLVkus xkys h 200 fexzk- 1 xkys h 314.84 1461¼v½ 02.04.2018 562 felkis zksLVkys xkys h 100 ,elhth 1 xkys h 8.52 1461¼v½ 02.04.2018 563 felkis zksLVkys xkys h 200 ,elhth 1 xkys h 16.34 1461¼v½ 02.04.2018 564 ekQs hZu bta SD'ku 10 fexzk-@fefy- 1 fefy- 23.24 1461¼v½ 02.04.2018 565 ekQs hZu bta SD'ku 15 fexzk-@fefy- 1 fefy- 29.00 1461¼v½ 02.04.2018 566 ekQs hZu ,lvkj xkys h 30 fexzk- 1 xkys h 5.33 1461¼v½ 02.04.2018 567 ekQs hZu xkys h 10 fexzk- 1 xkys h 5.21 1461¼v½ 02.04.2018 568 ekDs lh¶ykDs lklhu xkys h 400 fexzk- 1 xkys h 24.79 1461¼v½ 02.04.2018 569 ekbdZ kQs us kys Vs ekQs fsVy xkys h 250 fexzk- 1 xkys h 40.63 1461¼v½ 02.04.2018 570 ekbdZ kQs us kys Vs ekQs fsVy xkys h 500 fexzk- 1 xkys h 80.38 1461¼v½ 02.04.2018 571 ,u&,flVkbyflLVus bta SD'ku 200 fexzk-@fefy- 1 fefy- 21.93 1461¼v½ 02.04.2018 572 ,u&,flVkbyflLVus lpVs 200 fexzk- 1 xzke 8.80 1461¼v½ 02.04.2018 573 ukykDs lkus bta SD'ku 0-4 fexzk-@fefy- 1 fefy- 84.90 1461¼v½ 02.04.2018 574 ukVkekblhu MªkIsl 5% 1 fefy- 22.32 1461¼v½ 02.04.2018 575 fuvksLVhtekbu bta SD'ku 0-5 fexzk-@fefy- 1 fefy- 4.26 1461¼v½ 02.04.2018 576 fuvksLVhtekbu xkys h 15 fexzk- 1 xkys h 4.57 1461¼v½ 02.04.2018 577 usohjkikbu vksjy fyD;bw ZM 50 fexzk-@5 fefy- 1 fefy- 0.82 1461¼v½ 02.04.2018 578 usohjkikbu xkys h 200 fexzk- 1 xkys h 14.01 1461¼v½ 02.04.2018 579 fuQfsMikbu dSIlyw 10 fexzk- 1 dSIlyw 0.84 1461¼v½ 02.04.2018 580 fuQfsMikbu xkys h 10 fexzk- 1 xkys h 1.21 1461¼v½ 02.04.2018 581 fuVªkQs qjku's ku vksjy fyD;bw ZM 25 fexzk-@5 fefy- 1 fefy- 0.80 1461¼v½ 02.04.2018 582 fuVªkQs qjku's ku xkys h 100 fexzk- 1 xkys h 7.08 1461¼v½ 02.04.2018 583 fuVªkQs qjku's ku dSIlyw 100 fexzk- 1 dSIlyw 7.69 1461¼v½ 02.04.2018 584 ukbZVªl vkWDlkbM ?ku ehVj 228.65 5634¼v½ 020.11.2018 bugys 's ku 585 uksjkMªus kykbu bta SD'ku 2 fexzk-@fefy- 1 fefy- 25.21 1461¼v½ 02.04.2018 586 uksjfsFkLVsjkus xkys h 5 fexzk- 1 xkys h 5.00 1461¼v½ 02.04.2018 587 vkes is zktkys dSIlyw 10 fexzk- 1 dSIlyw 2.07 1461¼v½ 02.04.2018 588 vkes is zktkys dSIlyw 20 fexzk- 1 dSIlyw 2.44 1461¼v½ 02.04.2018 589 vkes is zktkys dSIlyw 40 fexzk- 1 dSIlyw 4.83 1461¼v½ 02.04.2018 590 vkes is zktkys vksjy fyD;bw ZM d s fy, ikmMj 1 xzke 1.20 1461¼v½ 02.04.2018 20 fexzk- 591 vkes is zktkys xkys h 10 fexzk- 1 xkys h 4.34 1461¼v½ 02.04.2018 592 vkes is zktkys xkys h 20 fexzk- 1 xkys h 4.82 1461¼v½ 02.04.2018 593 vkes is zktkys xkys h 40 fexzk- 1 xkys h 8.16 1461¼v½ 02.04.2018 594 vkus MulVs ªkus bta SD'ku 2 fexzk-@fefy- 1 fefy- 5.72 1461¼v½ 02.04.2018 595 vkus MulVs ªkus vksjy fyD;bw ZM 2 fexzk-@5 fefy- 1 fefy- 1.11 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 19 596 vkus MulVs ªkus xkys h 4 fexzk- 1 xkys h 4.60 1461¼v½ 02.04.2018 597 vkus MulVs ªkus xkys h 8 fexzk- 1 xkys h 9.55 1461¼v½ 02.04.2018 598 vksjy fjgkbM'ªs ku ykblsal d s :i e sa 1 xzke 0.87 2399¼v½ 12.06.2018 lkYVl 599 vksjy fjgkbM'ªs ku ykblsal d s :i e sa 1 fefy- 0.14 1461¼v½ 02.04.2018 lkYVl 600 vkDs lkyhIykVhu bta SD'ku 100 fexzk- ¼ykblsal d s :i izfr iSd 4373.47 1461¼v½ 02.04.2018 e½sa 601 vkDs lkyhIykVhu bta SD'ku 50 fexzk- ¼ykblsal d s :i izfr iSd 2543.51 3983¼v½ 13.08.2018 e½sa 602 vkWDlhtu bugys 's ku ¼efsMfluy xSl½ ?ku ehVj 17.17 5634¼v½ 020.11.2018 603 vkWDlhVkslhu bta SD'ku 10 vkbZ;@w fefy- 1 fefy- 38.55 1461¼v½ 02.04.2018 604 vkWDlhVkslhu bta SD'ku 5 vkbZ;@w fefy- 1 fefy- 17.27 1461¼v½ 02.04.2018 605 ids fyVkDlys bta SD'ku 100 fexzk-@16-7 fefy- 1 fefy- 218.41 1461¼v½ 02.04.2018 606 ids fyVkDlys bta SD'ku 30 fexzk-@5 fefy- 1 fefy- 218.41 1461¼v½ 02.04.2018 607 ius Vkis zktkys bta SD'ku 40 fexzk- izfr iSd 43.57 1461¼v½ 02.04.2018 608 ikjk&,feukslkfyflfyd xzUs ;yw l ¼ykblsal d s :i e½sa 1 xzke 2.78 1461¼v½ 02.04.2018 ,flM 609 isjkflVkekys vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 0.50 1461¼v½ 02.04.2018 610 isjkflVkekys vksjy fyD;bw ZM 120 fexzk-@5 fefy- 1 fefy- 0.52 1461¼v½ 02.04.2018 611 isjkflVkekys vksjy fyD;bw ZM 125 fexzk-@5 fefy- 1 fefy- 0.33 1461¼v½ 02.04.2018 612 isjkflVkekys vksjy fyD;bw ZM 150 fexzk-@5 fefy- 1 fefy- 0.57 1461¼v½ 02.04.2018 613 isjkflVkekys vksjy fyD;bw ZM 250 fexzk-@5 fefy- 1 fefy- 0.59 1461¼v½ 02.04.2018 614 isjkflVkekys vksjy fyD;bw ZM 500 fexzk-@5 fefy- 1 fefy- 0.63 1461¼v½ 02.04.2018 615 isjkflVkekys vksjy fyD;bw ZM 650 fexzk-@5 fefy- 1 fefy- 0.51 1461¼v½ 02.04.2018 616 isjkflVkekys xkys h 500 fexzk- 1 xkys h 0.89 1461¼v½ 02.04.2018 617 isjkflVkekys xkys h 650 fexzk- 1 xkys h 1.80 1461¼v½ 02.04.2018 618 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 3.00 1461¼v½ 02.04.2018 ¼0-5 fefy-½ 619 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 4.11 1461¼v½ 02.04.2018 ¼1 fefy-½ 620 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 6.31 1461¼v½ 02.04.2018 ¼2 fefy-½ 621 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 8.52 1461¼v½ 02.04.2018 ¼3 fefy-½ 622 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 10.73 1461¼v½ 02.04.2018 ¼4 fefy-½ 623 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 12.94 1461¼v½ 02.04.2018 ¼5 fefy-½ 624 isjkflVkekys bta SD'ku 150 fexzk-@fefy- izfr iSd 17.35 1461¼v½ 02.04.2018 ¼7 fefy-½ 625 isjkflVkekys lqIikfstVªh 170 fexzk- izfr 7.53 1461¼v½ 02.04.2018 lqIikfstVªh 626 isjkflVkekys lqIikfstVªh 80 fexzk- izfr 6.37 1461¼v½ 02.04.2018 lqIikfstVªh 627 iSjkflVkekys 100 fexzk-@fefy- vksjy fyD;wbZM 1 fefy- 1.58 5633¼v½ 02.11.2018 ¼iMs ªkfVd½20 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 628 iSXyVs Ms bVa jQsjkWu bta SD'ku 180 ,elhth izfr iSd 7743.81 1461¼v½ 02.04.2018 ,YQk 2 , 629 iSXyVs Ms bVa jQsjkWu bta SD'ku 100 ,elhth izfr iSd 15310.45 1461¼v½ 02.04.2018 ,YQk 2 ch 630 iSXyVs Ms bVa jQsjkWu bta SD'ku 120 ,elhth izfr iSd 14258.36 1461¼v½ 02.04.2018 ,YQk 2 ch 631 iSXyVs Ms bVa jQsjkWu bta SD'ku 80 ,elhth izfr iSd 12240.27 1461¼v½ 02.04.2018 ,YQk 2 ch 632 ifsuflykekbu dSIlyw 250 fexzk- 1 dSIlyw 14.55 1461¼v½ 02.04.2018 633 iesZFkzhu Øhe 1% 1 xzke 1.57 1461¼v½ 02.04.2018 634 iesZFkzhu Øhe 5% 1 xzke 1.70 1461¼v½ 02.04.2018 635 iesZFkzhu tSy 5% 1 xzke 1.43 1461¼v½ 02.04.2018 636 iesZFkzhu yk's ku 1% 1 xzke 0.89 1461¼v½ 02.04.2018 637 iesZFkzhu yk's ku 5% 1 fefy- 0.95 1461¼v½ 02.04.2018 638 Qus hjkekbu bta SD'ku 22-75 fexzk-@fefy- 1 fefy- 1.49 1461¼v½ 02.04.2018 ¼2 fefy-½ 639 Qus hjkekbu bta SD'ku 22-75 fexzk-@fefy- 1 fefy- 1.11 1461¼v½ 02.04.2018 ¼10 fefy-½ 640 Qus kcs kjfcVkus bta SD'ku 200 fexzk-@fefy- 1 fefy- 18.76 1461¼v½ 02.04.2018 641 Qus kcs kjfcVkus xkys h 30 fexzk- 1 xkys h 1.20 1461¼v½ 02.04.2018 642 Qus kcs kjfcVkus xkys h 60 fexzk- 1 xkys h 1.73 1461¼v½ 02.04.2018 643 Qus kcs kjfcVkus vksjy fyD;bw ZM 20 fexzk-@5 fefy- 1 fefy- 0.43 1461¼v½ 02.04.2018 644 Qus hyQs jhu MªkIsl 10% 1 fefy- 7.91 1461¼v½ 02.04.2018 645 Qus hyQs jhu MªkIsl 5% 1 fefy- 3.65 1461¼v½ 02.04.2018 646 Qus hVkbs u dSIlyw 100 fexzk- 1 dSIlyw 1.49 1461¼v½ 02.04.2018 647 Qus hVkbs u dSIlyw 300 fexzk- 1 dSIlyw 3.73 1461¼v½ 02.04.2018 648 Qus hVkbs u bZvkj dISlyw 300 fexzk- 1 dSIlyw 3.73 1461¼v½ 02.04.2018 649 Qus hVkbs u bta SD'ku 25 fexzk-@fefy- 1 fefy- 2.46 1461¼v½ 02.04.2018 650 Qus hVkbs u bta SD'ku 50 fexzk-@fefy- 1 fefy- 5.26 1461¼v½ 02.04.2018 651 Qus hVkbs u vksjy fyD;bw ZM 125 fexzk-@5 fefy- 1 fefy- 0.88 1461¼v½ 02.04.2018 652 Qus hVkbs u vksjy fyD;bw ZM 30 fexzk-@5 fefy- 1 fefy- 0.30 1768¼v½ 26.04.2018 653 Qus hVkbs u bZvkj xkys h 300 fexzk- 1 xkys h 5.68 1461¼v½ 02.04.2018 654 Qus hVkbs u xkys h 100 fexzk- 1 xkys h 1.52 1461¼v½ 02.04.2018 655 Qus hVkbs u xkys h 300 fexzk- 1 xkys h 4.64 1461¼v½ 02.04.2018 656 Qus hVkbs u xkys h 50 fexzk- 1 xkys h 0.73 1461¼v½ 02.04.2018 657 QkbVkes us kMhvkus bta SD'ku 10 fexzk-@fefy- 1 fefy- 46.86 1461¼v½ 02.04.2018 ¼foVkfeu d1s ½ 658 QkbVkes us kMhvkus xkys h 10 fexzk- 1 xkys h 14.21 5633¼v½ 02.11.2018 ¼foVkfeu d1s ½ 659 fiykds kjfiu MªkIsl 2% 1 fefy- 9.89 1461¼v½ 02.04.2018 660 fiykds kjfiu MªkIsl 4% 1 fefy- 11.43 1461¼v½ 02.04.2018 661 fiisjkflfyu ¼,½ bta SD'ku d s fy, ikmMj 1 xzke ¼,½ izfr iSd 86.51 1461¼v½ 02.04.2018 $Vts kcs Ds Ve ¼ch½ $ 125 fexzk- ¼ch½ 662 fiisjkflfyu ¼,½ bta SD'ku d s fy, ikmMj 2 xzke ¼,½ izfr iSd 204.65 1461¼v½ 02.04.2018 $Vts kcs Ds Ve ¼ch½ $ 250 fexzk- ¼ch½¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 21 663 fiisjkflfyu ¼,½ bta SD'ku d s fy, ikmMj 4 xzke ¼,½ izfr iSd 429.90 1461¼v½ 02.04.2018 $Vts kcs Ds Ve ¼ch½ $ 500 fexzk- ¼ch½ 664 ikVs fs'k;e DyksjkbM bta SD'ku 150 fexzk-@fefy- 1 fefy- 2.38 1461¼v½ 02.04.2018 665 ikVs fs'k;e DyksjkbM vksjy fyD;bw ZM 500 fexzk-@5 fefy- 1 fefy- 0.28 1461¼v½ 02.04.2018 666 ikVs fs'k;e ijexsa uVs fØLVy QkWj VkWfidy lkys q'ku 1 xzke 0.43 1461¼v½ 02.04.2018 667 ikWfoMu vk;kMs hu lkys q'ku 4% 1 fefy- 1.70 1461¼v½ 02.04.2018 668 ikWfoMu vk;kMs hu lkys q'ku 7-5% 1 fefy- 0.76 1461¼v½ 02.04.2018 669 ikWfoMu vk;kMs hu lkys q'ku 10% 1 fefy- 0.91 6252¼v½ 21.12.2018 670 ikWfoMu vk;kMs hu lkys q'ku 5% 1 fefy- 0.38 1461¼v½ 02.04.2018 671 izkfyMkDs lhe DyksjkbM bta SD'ku 25 fexzk-@fefy- 1 fefy- 3.65 1461¼v½ 02.04.2018 ¼2&ih,,e½ 672 iMzs fulkys kus MªkIsl 1% 1 fefy- 3.28 1461¼v½ 02.04.2018 673 iMzs fulkys kus bta SD'ku 20 fexzk-@2 fefy- 1 fefy- 3.50 1461¼v½ 02.04.2018 674 iMzs fulkys kus vksjy fyD;bw ZM 15 fexzk-@5 fefy- 1 fefy- 0.74 1461¼v½ 02.04.2018 675 iMzs fulkys kus vksjy fyD;bw ZM 5 fexzk-@5 fefy- 1 fefy- 0.42 1461¼v½ 02.04.2018 676 iMzs fulkys kus xkys h 10 fexzk- 1 xkys h 0.95 1461¼v½ 02.04.2018 677 iMzs fulkys kus xkys h 20 fexzk- 1 xkys h 1.91 1461¼v½ 02.04.2018 678 iMzs fulkys kus xkys h 40 fexzk- 1 xkys h 2.75 1461¼v½ 02.04.2018 679 iMzs fulkys kus xkys h 5 fexzk- 1 xkys h 0.55 1461¼v½ 02.04.2018 680 ifzseDl balfqyu 30%70 bta SD'ku 40 vkbZ;@w fefy- 1 fefy- 14.73 1461¼v½ 02.04.2018 bta SD'ku ¼jxs qyj% ,uih,p½ 681 izhykds us ¼,½ $ Øhe 2-5% ¼,½ $ 2-5% ¼ch½ 1 xzke 20.01 1461¼v½ 02.04.2018 fyXukds us ¼ch½ 682 izhekDohu xkys h 15 fexzk- 1 xkys h 4.48 1461¼v½ 02.04.2018 683 izhekDohu xkys h 2-5 fexzk- 1 xkys h 1.52 1461¼v½ 02.04.2018 684 izhekDohu xkys h 7-5 fexzk- 1 xkys h 2.07 1461¼v½ 02.04.2018 685 izkds kckfZtu dSIlyw 50 fexzk- 1 dSIlyw 33.83 1461¼v½ 02.04.2018 686 izkds kckfZtu xkys h 50 fexzk- 1 xkys h 46.10 1461¼v½ 02.04.2018 687 izkis kjkdus MªkIsl 0-5% 1 fefy- 9.76 1461¼v½ 02.04.2018 688 izkis kQs kys bta SD'ku 10 fexzk-@fefy- 1 fefy- 7.07 1461¼v½ 02.04.2018 689 izkis zkukys kys dSIlyw 40 fexzk- 1 dSIlyw 3.72 1461¼v½ 02.04.2018 690 izkis zkukys kys dSIlyw 80 fexzk- 1 dSIlyw 5.65 1461¼v½ 02.04.2018 691 izkis zkukys kys xkys h 10 fexzk- 1 xkys h 1.14 1461¼v½ 02.04.2018 692 izkis zkukys kys xkys h 40 fexzk- 1 xkys h 2.70 1461¼v½ 02.04.2018 693 izkis zkukys kys xkys h 80 fexzk- 1 xkys h 4.89 1461¼v½ 02.04.2018 694 izkVs kekbu bta SD'ku 10 fexzk-@fefy- 1 fefy- 9.05 1461¼v½ 02.04.2018 695 ikbjkftukekbM vksjy fyD;bw ZM 250 fexzk-@5 fefy- 1 fefy- 0.60 1461¼v½ 02.04.2018 696 ikbjkftukekbM xkys h 1000 fexzk- 1 xkys h 9.23 1461¼v½ 02.04.2018 697 ikbjkftukekbM xkys h 1500 fexzk- 1 xkys h 10.22 1461¼v½ 02.04.2018 698 ikbjkftukekbM xkys h 500 fexzk- 1 xkys h 4.14 1461¼v½ 02.04.2018 699 ikbjkftukekbM xkys h 750 fexzk- 1 xkys h 6.30 1461¼v½ 02.04.201822 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 700 ikbfjMkDs lhu xkys h 100 fexzk- 1 xkys h 5.47 1461¼v½ 02.04.2018 701 ikbfjMkDs lhu xkys h 10 fexzk- 1 xkys h 0.11 1461¼v½ 02.04.2018 702 Dquus bta SD'ku 300 fexzk-@fefy- 1 fefy- 9.95 1461¼v½ 02.04.2018 703 Dquus xkys h 300 fexzk- 1 xkys h 5.60 1461¼v½ 02.04.2018 704 jfsct oSDlhu izfr iSd 334.42 1461¼v½ 02.04.2018 705 jkyVxs zkohj xkys h 400 fexzk- 1 xkys h 153.15 1461¼v½ 02.04.2018 706 jkfeizhy dSIlyw 2-5 fexzk- 1 dSIlyw 4.63 1461¼v½ 02.04.2018 707 jkfeizhy dSIlyw 5 fexzk- 1 dSIlyw 7.23 1461¼v½ 02.04.2018 708 jkfeizhy xkys h 2-5 fexzk- 1 xkys h 4.87 1461¼v½ 02.04.2018 709 jkfeizhy xkys h 5 fexzk- 1 xkys h 7.67 1461¼v½ 02.04.2018 710 jkfufVfMu vksjy fyD;bw ZM 75 fexzk-@5 fefy- 1 fefy- 0.71 3983¼v½ 13.08.2018 711 jkfufVfMu xkys h 150 fexzk- 1 xkys h 0.72 1461¼v½ 02.04.2018 712 jkfufVfMu bta SD'ku 25 fexzk-@fefy- 1 fefy- 1.58 1461¼v½ 02.04.2018 713 fjckfofju dSIlyw 200 fexzk- 1 dSIlyw 81.86 1461¼v½ 02.04.2018 714 fjQkcqVhu dSIlyw 150 fexzk- 1 dSIlyw 38.82 1461¼v½ 02.04.2018 715 fjQkcqVhu xkys h 150 fexzk- 1 xkys h 36.25 1461¼v½ 02.04.2018 716 fjQefiflu dSIlyw 150 fexzk- 1 dSIlyw 1.96 1461¼v½ 02.04.2018 717 fjQefiflu dSIlyw 300 fexzk- 1 dSIlyw 3.72 1461¼v½ 02.04.2018 718 fjQefiflu dSIlyw 450 fexzk- 1 dSIlyw 4.83 1461¼v½ 02.04.2018 719 fjQefiflu dSIlyw 600 fexzk- 1 dSIlyw 11.35 1461¼v½ 02.04.2018 720 fjQefiflu vksjy fyD;bw ZM 100 fexzk-@5 fefy- 1 fefy- 0.38 1461¼v½ 02.04.2018 721 fjQefiflu xkys h 150 fexzk- 1 xkys h 1.58 1461¼v½ 02.04.2018 722 fjQefiflu xkys h 300 fexzk- 1 xkys h 2.87 1461¼v½ 02.04.2018 723 fjxa j ySDVVs bta SD'ku 1000 fefy- izfr iSd 78.06 1461¼v½ 02.04.2018 724 fjxa j ySDVVs bta SD'ku 100 fefy- izfr iSd 20.44 1461¼v½ 02.04.2018 725 fjxa j ySDVVs bta SD'ku 250 fefy- izfr iSd 34.85 1461¼v½ 02.04.2018 726 fjxa j ySDVVs bta SD'ku 500 fefy- izfr iSd 44.41 1461¼v½ 02.04.2018 727 fjlifsjMkus vksjy fyD;bw ZM 1 fexzk-@ fefy- 1 fefy- 1.89 1461¼v½ 02.04.2018 728 fjlifsjMkus xkys h 1 fexzk- 1 xkys h 3.01 1461¼v½ 02.04.2018 729 fjlifsjMkus xkys h 2 fexzk- 1 xkys h 4.82 1461¼v½ 02.04.2018 730 fjlifsjMkus xkys h 4 fexzk- 1 xkys h 9.79 1461¼v½ 02.04.2018 731 fjVkus kohj dSIlyw 100 fexzk- 1 dSIlyw 27.62 1461¼v½ 02.04.2018 732 fjVkus kohj xkys h 100 fexzk- 1 xkys h 28.40 1461¼v½ 02.04.2018 733 fjVqDlheso bta SD'ku 10 fexzk-@fefy- 1 fefy- 742.27 1461¼v½ 02.04.2018 734 lys cqVkekys dSIlyw 4 fexzk- 1 dSIlyw 0.59 1461¼v½ 02.04.2018 735 lys cqVkekys bugys 's ku ¼,eMhvkbZ@Mhihvkb½Z 1 Mkts 0.39 1461¼v½ 02.04.2018 100 ,elhth@Mkts 736 lys cqVkekys vksjy fyD;bw ZM 2 fexzk-@5 fefy- 1 fefy- 0.15 1461¼v½ 02.04.2018 737 lys cqVkekys jslfijVs kWjh lkys q'ku QkWj ;tw bu 1 fefy- 0.69 1461¼v½ 02.04.2018 ucs qykbtj 5 fexzk-@fefy- 738 lys cqVkekys xkys h 2 fexzk- 1 xkys h 0.16 1461¼v½ 02.04.2018 739 lys cqVkekys xkys h 4 fexzk- 1 xkys h 0.18 1461¼v½ 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 23 740 lys hflfyd ,flM vkbs Va eVsa 6% 1 xzke 1.76 1461¼v½ 02.04.2018 741 lsok¶s ywjku bugys 's ku 1 fefy- 29.27 3983¼v½ 13.08.2018 742 flYoj lYQkMkbftu Øhe 1% 1 xzke 0.29 1461¼v½ 02.04.2018 743 LuSd ous kes ,Va hlsje bta SD'ku d s fy, ikmMj 10 fefy- 545.31 1461¼v½ 02.04.2018 ykbvkfsQykftM iSd ikWyhoys Vsa 744 LuSd ous kes ,Va hlsje bta SD'ku izfr iSd ¼10 423.47 1461¼v½ 02.04.2018 lkys qcy@fyD;bw M fefy-½ ikWyhoys Vsa 745 lkfsM;e ckbdkcksZuVs bta SD'ku 7-5% 1 fefy- 1.37 1461¼v½ 02.04.2018 746 lkfsM;e ckbdkcksZuVs bta SD'ku 8-4% 1 fefy- 1.26 1461¼v½ 02.04.2018 747 lkfsM;e DyksjkbM bta SD'ku 0-9% 1000 fefy- 58.08 1461¼v½ 02.04.2018 Xykl 748 lkfsM;e DyksjkbM bta SD'ku 0-9% 1000 fefy- 45.81 1461¼v½ 02.04.2018 ukWu Xykl 749 lkfsM;e DyksjkbM bta SD'ku 0-9% 100 fefy- 17.18 1461¼v½ 02.04.2018 Xykl 750 lkfsM;e DyksjkbM bta SD'ku 0-9% 100 fefy- 15.47 1461¼v½ 02.04.2018 ukWu Xykl 751 lkfsM;e DyksjkbM bta SD'ku 0-9% 250 fefy- 23.16 1461¼v½ 02.04.2018 Xykl 752 lkfsM;e DyksjkbM bta SD'ku 0-9% 250 fefy- 20.80 1461¼v½ 02.04.2018 ukWu Xykl 753 lkfsM;e DyksjkbM bta SD'ku 0-9% 500 fefy- 32.20 1461¼v½ 02.04.2018 Xykl 754 lkfsM;e DyksjkbM bta SD'ku 0-9% 500 fefy- 27.41 1461¼v½ 02.04.2018 ukWu Xykl 755 lkfsM;e ukbVªkis :lkbM bta SD'ku 10 fexzk-@fefy- 1 fefy- 25.26 1461¼v½ 02.04.2018 756 lkfsM;e oys izk,s V bta SD'ku 100 fexzk-@fefy- 1 fefy- 5.64 1461¼v½ 02.04.2018 757 lkfsM;e oys izk,s V vksjy fyD;bw ZM 200 fexzk-@5 fefy- 1 fefy- 0.57 1461¼v½ 02.04.2018 758 lkfsM;e oys izk,s V lhvkj xkys h 300 fexzk- 1 xkys h 6.16 1461¼v½ 02.04.2018 759 lkfsM;e oys izk,s V lhvkj xkys h 500 fexzk- 1 xkys h 9.54 1461¼v½ 02.04.2018 760 lkfsM;e oys izk,s V xkys h 200 fexzk- 1 xkys h 3.03 1461¼v½ 02.04.2018 761 lkfsM;e oys izk,s V xkys h 300 fexzk- 1 xkys h 3.89 1461¼v½ 02.04.2018 762 lkfsM;e oys izk,s V xkys h 500 fexzk- 1 xkys h 6.79 1461¼v½ 02.04.2018 763 lkQs kcs qohj xkys h 400 fexzk- 1 xkys h 653.21 1461¼v½ 02.04.2018 764 lkes kVksLVkVhu bta SD'ku d s fy, ikmMj 3 fexzk- izfr iSd 1550.94 1461¼v½ 02.04.2018 765 Lihjkus kys Ds Vkus xkys h 25 fexzk- 1 xkys h 1.87 1461¼v½ 02.04.2018 766 Lihjkus kys Ds Vkus xkys h 50 fexzk- 1 xkys h 3.72 1461¼v½ 02.04.2018 767 LVkofqMu ¼,½ $ xkys h 30 fexzk-¼,½ $ 150 fexzk- ¼ch½ 1 xkys h 9.34 1461¼v½ 02.04.2018 ykfeofqMu ¼ch½ 768 LVªIsVkfsdukl bta SD'ku 1500000 vkbZ; w izfr iSd 1751.76 1461¼v½ 02.04.2018 769 LVªIsVkfsdukl bta SD'ku 7]50]000 vkbZ; w izfr iSd 1232.06 1461¼v½ 02.04.2018 770 LVªIsVkes kbflu bta SD'ku d s fy, ikmMj 750 fexzk- izfr iSd 8.59 1461¼v½ 02.04.2018 771 LVªIsVkes kbflu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 10.21 1461¼v½ 02.04.201824 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 772 lfDluhy dkfsyu bta SD'ku 50 fexzk-@fefy- 1 fefy- 4.73 1461¼v½ 02.04.2018 773 lqØkyQVs vksjy fyD;bw ZM 1 xzke 1 fefy- 0.69 1461¼v½ 02.04.2018 774 lYQklkyktkbu xkys h 500 fexzk- 1 xkys h 3.90 1461¼v½ 02.04.2018 775 lqekVªhIVu xkys h 25 fexzk- 1 xkys h 32.58 1461¼v½ 02.04.2018 776 lqekVªhIVu xkys h 50 fexzk- 1 xkys h 50.43 1461¼v½ 02.04.2018 777 ljQDs VkVa lLi'sa ku QkWj buVªkVªkpys ifzr iSd e sa ifzr 65.46 1461¼v½ 02.04.2018 buLVkby's ku ¼ykblsal d s :i e½sa fefy- QksLQkfsyfiM~l 778 VkØkfsyeql dSIlyw 0-5 fexzk- 1 dSIlyw 21.64 1461¼v½ 02.04.2018 779 VkØkfsyeql dSIlyw 1 fexzk- 1 dSIlyw 38.23 1461¼v½ 02.04.2018 780 VkØkfsyeql dSIlyw 2 fexzk- 1 dSIlyw 74.89 1461¼v½ 02.04.2018 781 VkekDs lhQus xkys h 10 fexzk- 1 xkys h 2.52 1461¼v½ 02.04.2018 782 VkekDs lhQus xkys h 20 fexzk- 1 xkys h 2.85 1461¼v½ 02.04.2018 783 Vys felkVZu xkys h 20 fexzk- 1 xkys h 3.57 1461¼v½ 02.04.2018 784 Vys felkVZu xkys h 40 fexzk- 1 xkys h 6.45 1461¼v½ 02.04.2018 785 Vys felkVZu xkys h 80 fexzk- 1 xkys h 9.83 1461¼v½ 02.04.2018 786 Ves kts kys kes kbM dSIlyw 100 fexzk- 1 dSIlyw 2039.10 1461¼v½ 02.04.2018 787 Ves kts kys kes kbM dSIlyw 20 fexzk- 1 dSIlyw 583.68 1461¼v½ 02.04.2018 788 Ves kts kys kes kbM dSIlyw 250 fexzk- 1 dSIlyw 4586.31 1461¼v½ 02.04.2018 789 Ves kts kys kes kbM xkys h 100 fexzk- 1 xkys h 1513.59 1461¼v½ 02.04.2018 790 Ves kts kys kes kbM xkys h 20 fexzk- 1 xkys h 366.71 1461¼v½ 02.04.2018 791 Ves kts kys kes kbM xkys h 250 fexzk- 1 xkys h 3746.29 1461¼v½ 02.04.2018 792 Vus kQs ksohj xkys h 300 fexzk- 1 xkys h 46.18 1461¼v½ 02.04.2018 793 Vus kQs ksohj ¼,½ $ xkys h 300 fexzk- ¼,½ $ 300 fexzk- 1 xkys h 43.93 1461¼v½ 02.04.2018 ykfeoMq kbu ¼ch½ ¼ch½ 794 Vus kQs ksohj ¼,½ $ xkys h 300 fexzk- ¼,½ $ 300 fexzk- 1 xkys h 100.87 1461¼v½ 02.04.2018 ykfeoMq kbu ¼ch½ ¼ch½ $ 600 fexzk- ¼lh½ $bQkohjtsa ¼lh½ 795 VVs ul VkWDlkbM bta SD'ku izfr iSd 10.37 5727¼v½ 13.11.2018 ¼0-5 fefy-½ 796 VVs ul VkWDlkbM bta SD'ku izfr iSd 22.34 5727¼v½ 13.11.2018 ¼5 fefy-½ 797 FkkyhMkes kbM dSIlyw 100 fexzk- 1 dSIlyw 59.79 1461¼v½ 02.04.2018 798 FkkyhMkes kbM dSIlyw 50 fexzk- 1 dSIlyw 34.54 1461¼v½ 02.04.2018 799 Fkh;kekbu bta SD'ku 100 fexzk-@fefy- 1 fefy- 24.27 1461¼v½ 02.04.2018 800 Fkh;kekbu xkys h 100 fexzk- 1 xkys h 3.67 1461¼v½ 02.04.2018 801 Fkhvkis us VkWu bta SD'ku d s fy, ikmMj 0-5 xzke izfr iSd 39.86 1461¼v½ 02.04.2018 802 Fkhvkis us VkWu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 48.37 1461¼v½ 02.04.2018 803 fVekys kys MªkIsl 0-25% 1 fefy- 5.05 1461¼v½ 02.04.2018 804 fVekys kys MªkIsl 0-5% 1 fefy- 11.67 1461¼v½ 02.04.2018 805 fVvkVs ªkfsi;e bugys 's ku ¼MhihvkbZ½ 18 ,elhth@ 1 Mkts 2.17 1028¼v½ 26.02.2019 Mkts 806 fVvkVs ªkfsi;e bugys 's ku ¼,eMhvkbZ½ 9 ,elhth@ 1 Mkts 9.09 1028¼v½ 26.02.2019 Mkts¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 25 807 VªkekMkys dSIlyw 50 fexzk- 1 dSIlyw 4.42 1461¼v½ 02.04.2018 808 VªkekMkys bta SD'ku 50 fexzk-@fefy- ¼20 fefy- 1 fefy- 1.22 1461¼v½ 02.04.2018 iSd½ 809 VªkekMkys bta SD'ku 50 fexzk-@fefy- ¼2 fefy- 1 fefy- 10.25 1461¼v½ 02.04.2018 iSd rd½ 810 VªkekMkys xkys h 100 fexzk- 1 xkys h 19.25 1461¼v½ 02.04.2018 811 VªkekMkys xkys h 50 fexzk- 1 xkys h 7.89 1461¼v½ 02.04.2018 812 VªkekMkys dSIlyw 100 fexzk- 1 dSIlyw 9.39 1461¼v½ 02.04.2018 813 VªkuDs lkfed ,flM bta SD'ku 100 fexzk-@fefy- 1 fefy- 14.62 1461¼v½ 02.04.2018 814 VªkuDs lkfed ,flM xkys h 500 fexzk- 1 xkys h 17.00 1461¼v½ 02.04.2018 815 VªkLVqtqec bta SD'ku 440 fexzk-@50 fefy- izfr iSd 58867.50 1461¼v½ 02.04.2018 816 VªhgDs lhQus hMhy xkys h 2 fexzk- 1 xkys h 1.19 1461¼v½ 02.04.2018 817 VªkfsidkekbM vkbZ Mªkis 1% 1 fefy- 9.84 1461¼v½ 02.04.2018 818 ous dkes kblhu bta SD'ku d s fy, ikmMj 1 xzke izfr iSd 465.74 1461¼v½ 02.04.2018 819 ous dkes kblhu bta SD'ku d s fy, ikmMj 250 fexzk- izfr iSd 217.00 1461¼v½ 02.04.2018 820 ous dkes kblhu bta SD'ku d s fy, ikmMj 500 fexzk- izfr iSd 280.13 1461¼v½ 02.04.2018 821 ods qjkfsu;e bta SD'ku d s fy, ikmMj 10 fexzk- izfr iSd 185.03 1461¼v½ 02.04.2018 822 ods qjkfsu;e bta SD'ku d s fy, ikmMj 4 fexzk- izfr iSd 89.30 1461¼v½ 02.04.2018 823 osjkikfey bta SD'ku 2-5 fexzk-@fefy- 1 fefy- 1.14 1461¼v½ 02.04.2018 824 osjkikfey xkys h 40 fexzk- 1 xkys h 0.73 1461¼v½ 02.04.2018 825 osjkikfey xkys h 80 fexzk- 1 xkys h 1.36 1461¼v½ 02.04.2018 826 fouOykLVhu bta SD'ku 1 fexzk-@fefy- 1 fefy- 20.08 1461¼v½ 02.04.2018 827 fouØhLVhu bta SD'ku 1 fexzk-@fefy- 1 fefy- 51.00 1461¼v½ 02.04.2018 828 foVkfeu , dSIlyw 50000 vkbZ; w 1 dSIlyw 0.54 1461¼v½ 02.04.2018 829 foVkfeu , bta SD'ku 50000 vkbZ;@w fefy- 1 fefy- 1.87 1461¼v½ 02.04.2018 830 foVkfeu , xkys h 50000 vkbZ; w 1 xkys h 0.69 1461¼v½ 02.04.2018 831 okjQfju xkys h 1 fexzk- 1 xkys h 2.37 1461¼v½ 02.04.2018 832 okjQfju xkys h 2 fexzk- 1 xkys h 2.61 1461¼v½ 02.04.2018 833 okjQfju xkys h 3 fexzk- 1 xkys h 3.05 1461¼v½ 02.04.2018 834 okjQfju xkys h 5 fexzk- 1 xkys h 2.31 1461¼v½ 02.04.2018 835 okVj QkWj bta SD'ku bta SD'ku izfr iSd 2.28 1461¼v½ 02.04.2018 ¼10 fefy-½ 836 okVj QkWj bta SD'ku bta SD'ku izfr iSd 2.20 1461¼v½ 02.04.2018 ¼5 fefy-½ 837 okbV iSVªkfsy;e tys h 100% 1 xzke 0.09 1461¼v½ 02.04.2018 838 ,Dlhykes Vs ktkys kbu uts y MªkIsl 0-05% 1 fefy- 3.85 1461¼v½ 02.04.2018 839 ,Dlhykes Vs ktkys kbu uts y MªkIsl 0-1% 1 fefy- 5.09 1461¼v½ 02.04.2018 840 ftMksoqMkbu dSIlyw 300 fexzk- 1 dSIlyw 2.02 1461¼v½ 02.04.2018 841 ftMksoqMkbu xkys h 300 fexzk- 1 xkys h 13.95 1461¼v½ 02.04.2018 842 ftMksoqMkbu ¼,½ $ xkys h 300 fexzk- ¼,½ $ 150 fexzk- 1 xkys h 19.72 1461¼v½ 02.04.2018 ykfeoMq kbu ¼ch½ $ ¼ch½ $ 200 fexzk- ¼lh½ ufsojkikbu ¼lh½ 843 ftda lYQVs fMLizfslcy xkys h 20 fexzk- 1 xkys h 3.07 1461¼v½ 02.04.201826 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 844 tkys Ms ªkfsud ,flM bta SD'ku d s fy, ikmMj 4 fexzk- izfr iSd 4111.38 1461¼v½ 02.04.2018 845 tkys fiMes dSIlyw 5 fexzk- 1 dSIlyw 7.19 1461¼v½ 02.04.2018 846 tkys fiMes xkys h 10 fexzk- 1 xkys h 8.26 1461¼v½ 02.04.2018 847 tkys fiMes xkys h 5 fexzk- 1 xkys h 5.27 1461¼v½ 02.04.2018 uksV%- ¼d½ vf/kdre ewY; fnukad 01-04-2019 ls ykxw gSa (vf/kdre ewY;ksa esa 2017 dh vis{kk o”kZ 2018 ds fy, 4.2662 izfr’kr dh Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ dh nj ‘kkfey gSa)A ¼[k½ िविनम(cid:5)ितय(cid:8) िजनका आिधकतम मू(cid:16)य (cid:17)ित पैक के आधार पर िनधा(cid:5)(cid:22)रत (cid:23)कया गया ह,ै उनके fdlh vU; iSd vkdkj ds fy, fofuekZrk vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 11¼3½ के अ(cid:29)(cid:30)ग(cid:5)त bldh fofufeZfr;ksa ds fy, fo’ks”k ewY; vuqeksnukFkZ ,uihih, ls laidZ djsxkA fcØh ewY; ds fu/kkZj.k gsrq foi.ku vkdM+s lqlaxr rkSj ij izkekf.kd gksus pkfg,A lksfM;e oSyijks,V dh fofufeZfr esa lksfM;e oSyijks,V vkSj osyizksbd ,flM nksuksa dk lfEeJ.k gS tks dfFkr izcyrk ds lksfM;e oSyijks,V ds vuq:i gSA ¼x½ fdlh vU; vuqlwfpr fofufeZfr ds ckjs esa ftlds fy, vf/kdre ewY; Åij of.kZr ugha fd;k gS] fofuekZrk viuh fofufeZfr;ksa ds fy, fo’ks”k ewY; ds vuqeksnukFkZ laxr lwpuk lfgr ,uihih, ls laidZ djsxkA fcØh ewY; ds fu/kkZj.k gsrq foi.ku vkdM+s lqlaxr rkSj ij izkekf.kd gksus pkfg,A ¼?k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds czkaMsM ;k tsusfjd ;k nksuksa :ikarjksa dks csp jgs vuqlwfpr fofufeZfr;ksa ds lHkh fofuekZrk] mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ¼oLrq ,oa lsok dj] tks ykxw gksa] ;fn dksbZ gS½ ls vf/kd lHkh ,slh fofufeZfr;ksa dh dher dk v/kkseq[kh iqujh{k.k djsaxsA ¼M+½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 13(2) ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o”kZ 2018 ds fy, 4.2662 izfr’kr dh nj ls Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ksa dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la’kksf/kr dj ldrs gSa ¼p½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSA ¼N½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsa rFkk mldh dkWih jkT; vkS”kf/k fu;a=dksa vkSj fofuekZrk forjd dks tkjh djsaA ¼t½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds 24 (4) ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA ¼>½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ds fy, fofufnZ”V vuqlwfpr fofufeZfr;ksa ds fofufnZ”V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvksa }kjk ,d ubZ vkS”kf/k dks ykap djrk gS rks mls igys vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds rgr lwph II esa fofufnZ”V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼.k½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 27 ¼V½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n’kkZ;s vf/kdre ewY; vkSj ‘krks± dk ikyu ugha djrh gSa rks os vko’;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf’k dks tek djus ds fy, nk;h gksaxsA ¼B½ bl vkns’k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof”V esa fofufnZ”V ,slh fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre vkSj [kqnjk ewY; fu/kkZfjr vkns’k ;fn dksbZ gks] tks bl vkns’k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk;saxsA [dka- la-@197@65@2019@,Q@Qk- la- 8¼65½@2019@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs’kd MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 29th March, 2019 S.O. 1485(E).—In exercise of the powers, conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column No. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of goods and services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Price Revision as per Annual Wholesale Price Index (WPI) @ 4.2662% increase. Sl. Medicines Dosage form and Strength Unit Ceiling Existing S.O. No. & No. price (wef Date 1.4.2019 with WPI @ 4.2662%) (1) (2) (3) (4) (5) 6(a) 6(b) 1 5-aminosalicylic Acid Suppository 500 mg 1 Suppository 16.55 1461(E) 02.04.2018 Retention Enema 2 5-aminosalicylic Acid Tablet 400 mg 1 Tablet 7.31 1461(E) 02.04.2018 3 5-Fluorouracil Injection 250 mg/5 ml 1 ml 2.29 1461(E) 02.04.2018 4 6-Mercaptopurine Tablet 50mg 1 Tablet 6.32 1461(E) 02.04.2018 5 Abacavir Tablet 300 mg 1 Tablet 46.15 1461(E) 02.04.2018 6 Abacavir (A) + Lamivudine (B) Tablet 60 mg(A) + 30 mg(B) 1 Tablet 19.65 1461(E) 02.04.2018 7 Abacavir (A) + Lamivudine (B) Tablet 600 mg(A)+ 1 Tablet 89.18 1461(E) 02.04.2018 300 mg(B) 8 Acetazolamide Capsule 250 mg 1 Capsule 4.43 1461(E) 02.04.2018 9 Acetazolamide Tablet 250 mg 1 Tablet 3.58 1461(E) 02.04.2018 10 Acetylsalicylic acid Effervescent/ Dispersible/ 1 Tablet 0.18 1461(E) 02.04.2018 Enteric coated Tablet 100 mg 11 Acetylsalicylic acid Effervescent/ Dispersible/ 1 Tablet 1.18 1461(E) 02.04.2018 Enteric coated Tablet 150 mg 12 Acetylsalicylic acid Effervescent/ Dispersible/ 1 Tablet 1.20 1461(E) 02.04.2018 Enteric coated Tablet 75 mg28 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 13 Acetylsalicylic acid Tablet 100 mg 1 Tablet 0.17 1461(E) 02.04.2018 14 Acetylsalicylic acid Tablet 150 mg 1 Tablet 0.40 1461(E) 02.04.2018 15 Acetylsalicylic acid Tablet 325mg 1 Tablet 0.54 1461(E) 02.04.2018 16 Acetylsalicylic acid Tablet 350mg 1 Tablet 0.30 1461(E) 02.04.2018 17 Acetylsalicylic acid Tablet 75 mg 1 Tablet 0.30 1461(E) 02.04.2018 18 Actinomycin D Powder for Injection 0.5mg Each Pack 310.35 1461(E) 02.04.2018 19 Acyclovir Ointment 3% 1 gm 10.19 1461(E) 02.04.2018 20 Acyclovir Oral Liquid 400 mg/5ml 1 ml 1.24 1461(E) 02.04.2018 21 Acyclovir Tablet 200 mg 1 Tablet 6.63 1461(E) 02.04.2018 22 Acyclovir Tablet 400 mg 1 Tablet 12.04 1461(E) 02.04.2018 23 Acyclovir Powder for Injection 250 mg Each Pack 347.72 1461(E) 02.04.2018 24 Acyclovir Powder for Injection 500 mg Each Pack 449.12 1461(E) 02.04.2018 25 Adenosine Injection 3mg/ml 1 ml 96.35 1461(E) 02.04.2018 26 Adrenaline Injection 1 mg/ml 1 ml 15.32 1461(E) 02.04.2018 27 Albendazole Oral Liquid 200 mg/5ml 1 ml 1.56 1461(E) 02.04.2018 28 Albendazole Tablet 400 mg 1 Tablet 7.54 1461(E) 02.04.2018 29 Allopurinol Tablet 100 mg 1 Tablet 1.86 1461(E) 02.04.2018 30 Allopurinol Tablet 300 mg 1 Tablet 7.32 1461(E) 02.04.2018 31 Alprostadil Injection 0.5 mg/ml 1 ml 5542.19 1461(E) 02.04.2018 32 Alteplase Powder for Injection 20 mg Each Pack 18588.12 1461(E) 02.04.2018 33 Alteplase Powder for Injection 50 mg Each Pack 38810.18 1461(E) 02.04.2018 34 Amiodarone Injection 50 mg/ml 1 ml 21.83 3983(E) 13.08.2018 35 Amiodarone Tablet 100 mg 1 Tablet 5.59 1461(E) 02.04.2018 36 Amiodarone Tablet 200 mg 1 Tablet 11.08 1461(E) 02.04.2018 37 Amitriptyline Tablet 10 mg 1 Tablet 2.24 1461(E) 02.04.2018 38 Amitriptyline Tablet 25 mg 1 Tablet 2.21 1461(E) 02.04.2018 39 Amitriptyline Tablet 50 mg 1 Tablet 5.68 1461(E) 02.04.2018 40 Amitriptyline Tablet 75 mg 1 Tablet 5.49 1461(E) 02.04.2018 41 Amlodipine Tablet 10 mg 1 Tablet 4.96 1461(E) 02.04.2018 42 Amlodipine Tablet 2.5 mg 1 Tablet 1.62 1461(E) 02.04.2018 43 Amlodipine Tablet 5mg 1 Tablet 2.55 1461(E) 02.04.2018 44 Amoxicillin Capsule 250 mg 1 Capsule 2.16 1461(E) 02.04.2018 45 Amoxicillin Oral Liquid 250 mg/5ml 1 ml 1.32 1461(E) 02.04.2018 46 Amoxicillin Capsule 500mg 1 Capsule 6.32 1461(E) 02.04.2018 47 Amoxicillin (A) + Clavulanic Dry Syrup 125 mg(A) + 1 ml 2.12 1461(E) 02.04.2018 acid (B) 31.25 (B)/5 ml 48 Amoxicillin (A) + Clavulanic Oral Liquid 200 mg(A) + 1 ml 1.77 1461(E) 02.04.2018 acid (B) 28.5 mg(B)/5ml 49 Amoxicillin (A) + Clavulanic Powder for Injection Each Pack 88.10 1461(E) 02.04.2018 acid (B) 500 mg(A) + 100 mg(B) 50 Amoxicillin (A) +Clavulanic Tablet 500mg(A) +125mg(B) 1 Tablet 17.58 1461(E) 02.04.2018 acid (B) 51 Amoxicillin (A) +Clavulanic Powder for Injection 1g (A) Each Pack 122.90 1461(E) 02.04.2018 acid (B) +200mg(B) 52 Amphotericin B - Lipid/ Powder for Injection 50 mg 3983(E) 13.08.2018 Each Pack 4008.86 Liposomal 53 Amphotericin B – Conventional Powder for Injection 50 mg Each Pack 303.11 1461(E) 02.04.2018 54 Ampicillin Powder for Injection 1 gm Each Pack 20.89 1461(E) 02.04.2018 55 Ampicillin Powder for Injection 500 mg Each Pack 12.87 1461(E) 02.04.2018 56 Anti-D immunoglobulin Injection 300mcg Each Pack 2088.88 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 29 57 Anti-D Immunoglobulin Injection 150mcg Each Vial 1628.21 1461(E) 02.04.2018 58 Anti-rabies immunoglobulin Injection 150 IU/ml 1 ml 2715.04 1461(E) 02.04.2018 59 Anti-rabies immunoglobulin Injection 300 IU/ml 1 ml 95.72 1461(E) 02.04.2018 60 Anti-tetanus immunoglobulin 250IU Each Pack 1087.55 5636(E) 02.11.2018 61 Arsenic Trioxide Injection 1mg/ml 1 ml 53.14 1461(E) 02.04.2018 62 Artemether (A) + Lumefantrine Oral Liquid 80 mg(A) + 1 ml 3.95 1461(E) 02.04.2018 (B) 480 mg(B) /5ml 63 Artemether (A) + Lumefantrine Tablet 20 mg(A) + 1 Tablet 12.25 1461(E) 02.04.2018 (B) 120 mg(B) 64 Artemether (A) + Lumefantrine Tablet 40 mg(A) + 1 Tablet 15.79 1461(E) 02.04.2018 (B) 240 mg(B) 65 Artemether (A) + Lumefantrine Tablet 80 mg(A) + 1 Tablet 22.67 1461(E) 02.04.2018 (B) 480 mg(B) 66 Artesunate Powder for Injection 120 mg Each Pack 407.23 1461(E) 02.04.2018 67 Artesunate Powder for Injection 60 mg Each Pack 213.90 1461(E) 02.04.2018 68 Artesunate (A) + Sulphadoxine - Tablet 100 mg(A) + 1 Tablet Combi pack 28.87 1461(E) 02.04.2018 Pyrimethamine (B) (750 mg+ 37.5 mg) (B) 69 Artesunate (A) + Sulphadoxine - Tablet 150 mg(A) + 2 Tablet Combi pack 39.19 1461(E) 02.04.2018 Pyrimethamine (B) (500 mg+ 25 mg) (B) 70 Artesunate (A) + Sulphadoxine - Tablet 200 mg(A) + 2 Tablet Combi pack 35.73 1461(E) 02.04.2018 Pyrimethamine (B) (750 mg+ 37.5 mg) (B) 71 Artesunate (A) + Sulphadoxine - Tablet 25 mg(A) + 1 Tablet Combi pack 19.24 1461(E) 02.04.2018 Pyrimethamine (B) (250 mg+ 12.5 mg) (B) 72 Artesunate (A) + Sulphadoxine - 1 Tablet 50 mg(A) + 1 Combi Pack 20.77 1461(E) 02.04.2018 Pyrimethamine (B) Tablet (500 mg+ 25 mg) (B) 73 Ascorbic Acid (Vitamin C) Tablet 100mg 1 Tablet 0.19 1461(E) 02.04.2018 74 Ascorbic Acid (Vitamin C) Tablet 500 mg 1 Tablet 0.89 1461(E) 02.04.2018 75 Atazanavir (A) + Ritonavir (B) Tablet 300 mg(A) + 1 Tablet 96.61 1461(E) 02.04.2018 100 mg(B) 76 Atenolol Tablet 100 mg 1 Tablet 3.41 1461(E) 02.04.2018 77 Atenolol Tablet 50 mg 1 Tablet 1.75 1461(E) 02.04.2018 78 Atorvastatin Tablet 10 mg 1 Tablet 5.37 1461(E) 02.04.2018 79 Atorvastatin Tablet 20 mg 1 Tablet 13.00 1461(E) 02.04.2018 80 Atorvastatin Tablet 40 mg 1 Tablet 18.88 1461(E) 02.04.2018 81 Atracurium Injection 10 mg/ml Each Pack 51.30 1461(E) 02.04.2018 82 Atropine Ointment 1% 1 gm 3.70 1461(E) 02.04.2018 83 Atropine Injection 0.6 mg/ml 1 ml 4.10 1461(E) 02.04.2018 84 Atropine Drops 1% 1 ml 3.36 1461(E) 02.04.2018 85 Azathioprine Tablet 50 mg 1 Tablet 9.93 1461(E) 02.04.2018 86 Azithromycin Capsule 250 mg 1 Capsule 10.28 1461(E) 02.04.2018 87 Azithromycin Capsule 500 mg 1 Capsule 16.22 1461(E) 02.04.2018 88 Azithromycin Oral Liquid 200 mg/5ml 1 ml 3.01 1461(E) 02.04.2018 89 Azithromycin Tablet 250mg 1 Tablet 10.33 1461(E) 02.04.2018 90 Azithromycin Tablet 500mg 1 Tablet 20.84 1461(E) 02.04.2018 91 Azithromycin Powder for Injection 500mg Each Pack 188.15 1461(E) 02.04.2018 92 Baclofen Tablet 10 mg 1 Tablet 10.52 1461(E) 02.04.2018 93 Baclofen Tablet 20 mg 1 Tablet 14.48 1461(E) 02.04.2018 94 Baclofen Tablet 5 mg 1 Tablet 5.42 1461(E) 02.04.2018 95 BCG vaccine Each Dose 5.83 1769(E) 26.04.2018 96 Benzathine benzylpenicillin Powder for Injection 12 lac Each Pack 11.89 1461(E) 02.04.2018 units30 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 97 Benzathine benzylpenicillin Powder for Injection 6 lac Each Pack 7.87 1461(E) 02.04.2018 units 98 Benzoyl Peroxide Cream 2.5% 1 gm 2.29 1461(E) 02.04.2018 99 Benzoyl Peroxide Gel 2.5% 1 gm 3.67 1461(E) 02.04.2018 100 Benzyl penicillin Powder for Injection 10 Lac Each Pack 5.09 1461(E) 02.04.2018 Units 101 Betamethasone Cream 0.05% 1 gm 0.57 1461(E) 02.04.2018 102 Betamethasone Cream 0.1% 1 gm 0.82 1461(E) 02.04.2018 103 Betamethasone Gel 0.05% 1 gm 0.52 1461(E) 02.04.2018 104 Betamethasone Lotion 0.1% 1 ml 0.80 1461(E) 02.04.2018 105 Betamethasone Lotion 0.5% 1 ml 0.52 1461(E) 02.04.2018 106 Betamethasone Injection 4 mg/ml 1 ml 4.11 1461(E) 02.04.2018 107 Bicalutamide Tablet 50 mg 1 Tablet 67.14 1461(E) 02.04.2018 108 Bisacodyl Suppository 5 mg 1 Suppository 8.25 1461(E) 02.04.2018 109 Bisacodyl Tablet 5 mg 1 Tablet 0.98 1461(E) 02.04.2018 110 Bleomycin Powder for Injection 15 Units Each Pack 607.49 1461(E) 02.04.2018 111 Bortezomib Powder for Injection 2 mg Each Pack 12036.26 1461(E) 02.04.2018 112 Budesonide Nasal Spray 100 mcg/dose 1 Dose 0.89 1461(E) 02.04.2018 113 Budesonide Nasal Spray 50 mcg/dose 1 Dose 0.99 1461(E) 02.04.2018 114 Budesonide Respiratory Solution for use 1 ml 10.48 1461(E) 02.04.2018 in Nebulizer 0.5 mg/ml 115 Budesonide Respiratory Solution for use 1 ml 12.64 1461(E) 02.04.2018 in Nebulizer 1 mg/ml 116 Budesonide Inhalation (MDI) 100 mcg/ Per Metered 1.24 1028(E) 26.02.2019 dose Dose 117 Budesonide Inhalation (MDI) 200 mcg/ Per metered 1.54 1028(E) 26.02.2019 dose Dose 118 Budesonide Inhalation (DPI) 100 mcg/ Per Dose 1.95 1028(E) 26.02.2019 dose 119 Budesonide Inhalation (DPI) 200 mcg/ Per Dose 2.83 1028(E) 26.02.2019 dose 120 Budesonide (A)+ Formoterol Inhalation (MDI) 100 mcg Per Metered 1.85 1028(E) 26.02.2019 (B) (A) + 6 mcg (B) Dose 121 Budesonide (A)+ Formoterol Inhalation (MDI) 200 mcg Per Metered 2.62 1028(E) 26.02.2019 (B) (A) + 6 mcg (B) Dose 122 Budesonide (A)+ Formoterol Inhalation (MDI) 400 mcg Per Metered 2.98 1028(E) 26.02.2019 (B) (A) + 6 mcg (B) Dose 123 Budesonide (A)+ Formoterol Inhalation (DPI) 100 mcg (A) Per Dose 3.71 1028(E) 26.02.2019 (B) + 6 mcg (B) 124 Budesonide (A)+ Formoterol Inhalation (DPI) 200 mcg (A) Per Dose 4.93 1028(E) 26.02.2019 (B) + 6 mcg (B) 125 Budesonide (A)+ Formoterol Inhalation (DPI) 400 mcg (A) Per Dose 6.30 1028(E) 26.02.2019 (B) + 6 mcg (B) 126 Bupivacaine Injection 0.25% 1 ml 2.40 1461(E) 02.04.2018 127 Bupivacaine Injection 0.5% with 1 ml 6.08 1461(E) 02.04.2018 7.5% glucose 128 Bupivacaine Injection 0.50% 1 ml 3.84 1461(E) 02.04.2018 129 Caffeine Injection 20 mg/ml 1 ml 245.64 1461(E) 02.04.2018 130 Caffeine Oral Liquid 20 mg/ml 1 ml 208.63 1461(E) 02.04.2018 131 Calamine Lotion (As per IP) 1 ml 0.83 1461(E) 02.04.2018 132 Calcium folinate Tablet 15 mg 1 Tablet 39.92 1461(E) 02.04.2018 133 Calcium gluconate Injection 100 mg/ml 1 ml 0.54 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 31 134 Capecitabine Tablet 500 mg 1 Tablet 123.68 1461(E) 02.04.2018 135 Capreomycin Powder for Injection 1 gm Each Pack 338.98 1461(E) 02.04.2018 136 Carbamazepine Oral Liquid 100 mg/5ml 1 ml 0.19 1461(E) 02.04.2018 137 Carbamazepine CR Tablet 200 mg 1 Tablet 1.52 1461(E) 02.04.2018 138 Carbamazepine CR Tablet 400 mg 1 Tablet 2.99 1461(E) 02.04.2018 139 Carbamazepine Tablet 100 mg 1 Tablet 0.67 1461(E) 02.04.2018 140 Carbamazepine Tablet 200 mg 1 Tablet 1.36 1461(E) 02.04.2018 141 Carbamazepine Tablet 400 mg 1 Tablet 3.23 1461(E) 02.04.2018 142 Carbimazole Tablet 10 mg 1 Tablet 3.62 1461(E) 02.04.2018 143 Carbimazole Tablet 5 mg 1 Tablet 1.86 1461(E) 02.04.2018 144 Carboplatin Injection 10 mg/ml 1 ml 52.08 1461(E) 02.04.2018 145 Carboxymethylcellulose Drops 0.5% 1 ml 12.50 1461(E) 02.04.2018 146 Carboxymethylcellulose Drops 1% 1 ml 17.33 1461(E) 02.04.2018 147 Cefadroxil Capsule 500 mg 1 Capsule 7.00 1461(E) 02.04.2018 148 Cefadroxil Oral Liquid 125 mg/5ml 1 ml 0.62 1461(E) 02.04.2018 149 Cefadroxil Tablet 1 gm 1 Tablet 6.15 1461(E) 02.04.2018 150 Cefadroxil Tablet 500 mg 1 Tablet 3.95 1461(E) 02.04.2018 151 Cefazolin Powder for Injection 1 gm Each Pack 24.03 1461(E) 02.04.2018 152 Cefazolin Powder for Injection 500 mg Each Pack 15.23 1461(E) 02.04.2018 153 Cefixime Capsule 200 mg 1 Capsule 14.12 1461(E) 02.04.2018 154 Cefixime Capsule 400 mg 1 Capsule 28.61 1461(E) 02.04.2018 155 Cefixime Oral Liquid 100 mg/5ml 1 ml 2.11 1461(E) 02.04.2018 156 Cefixime Oral Liquid 50 mg/5ml 1 ml 1.42 1461(E) 02.04.2018 157 Cefixime Tablet 400 mg 1 Tablet 21.59 1461(E) 02.04.2018 158 Cefixime Tablet 200mg 1 Tablet 9.39 1461(E) 02.04.2018 159 Cefotaxime Powder for Injection 1 gm Each Pack 33.59 1461(E) 02.04.2018 160 Cefotaxime Powder for Injection 250 mg Each Pack 15.27 1461(E) 02.04.2018 161 Cefotaxime Powder for Injection 500 mg Each Pack 20.08 1461(E) 02.04.2018 162 Ceftazidime Powder for Injection 1 gm Each Pack 204.82 1461(E) 02.04.2018 163 Ceftazidime Powder for Injection 250 mg Each Pack 63.70 1461(E) 02.04.2018 164 Ceftriaxone Powder for Injection 1gm Each Pack 52.76 1461(E) 02.04.2018 165 Ceftriaxone Powder for Injection 2 gm Each Pack 125.41 1461(E) 02.04.2018 166 Ceftriaxone Powder for Injection 250 mg Each Pack 24.15 1461(E) 02.04.2018 167 Ceftriaxone Powder for Injection 500 mg Each Pack 44.12 1461(E) 02.04.2018 168 Cetirizine Capsule 10 mg 1 Capsule 2.33 1461(E) 02.04.2018 169 Cetirizine Oral Liquid 5 mg/5ml 1 ml 0.58 1461(E) 02.04.2018 170 Cetirizine Tablet 10 mg 1 Tablet 1.62 1461(E) 02.04.2018 171 Cetrimide Solution 20% (concentrate 1 ml 0.31 1461(E) 02.04.2018 for dilution) 172 Chlorambucil Tablet 2 mg 1 Tablet 36.12 1461(E) 02.04.2018 173 Chlorambucil Tablet 5 mg 1 Tablet 81.17 1461(E) 02.04.2018 174 Chlorhexidine Solution 5% (Concentrate for 1 ml 0.15 1461(E) 02.04.2018 dilution) 175 Chloroquine Oral Liquid 50 mg/5ml 1 ml 0.29 1461(E) 02.04.2018 176 Chloroquine Tablet 150mg 1 Tablet 0.77 1461(E) 02.04.2018 177 Chlorpheniramine Tablet 4 mg 1 Tablet 0.09 1461(E) 02.04.2018 178 Cholecalciferol Capsule 1000 IU 1 Capsule 4.67 1461(E) 02.04.2018 179 Cholecalciferol Capsule 60000 IU 1 Capsule 28.90 1461(E) 02.04.2018 180 Cholecalciferol Oral Liquid 400 IU/ml 1 ml 2.30 1461(E) 02.04.201832 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 181 Cholecalciferol Tablet 1000 IU 1 Tablet 3.67 1461(E) 02.04.2018 182 Cholecalciferol Tablet 60000 IU 1 Tablet 23.73 1461(E) 02.04.2018 183 Ciprofloxacin Ointment 0.3% 1 gm 1.11 1461(E) 02.04.2018 184 Ciprofloxacin Drops 0.30% 1 ml 1.49 1461(E) 02.04.2018 185 Ciprofloxacin Injection 200 mg/100ml 1 ml 0.17 1461(E) 02.04.2018 186 Ciprofloxacin Oral Liquid 250 mg/5ml 1 ml 0.62 1461(E) 02.04.2018 187 Ciprofloxacin Tablet 250mg 1 Tablet 2.03 1461(E) 02.04.2018 188 Ciprofloxacin Tablet 500mg 1 Tablet 3.57 1461(E) 02.04.2018 189 Cisplatin Injection 1 mg/ml 1 ml 6.74 1461(E) 02.04.2018 190 Clarithromycin Oral Liquid 125 mg/5ml 1 ml 4.22 1461(E) 02.04.2018 191 Clarithromycin Tablet 250 mg 1 Tablet 27.40 1461(E) 02.04.2018 192 Clarithromycin Tablet 500 mg 1 Tablet 48.30 1461(E) 02.04.2018 193 Clindamycin Capsule 150 mg 1 Capsule 14.16 1461(E) 02.04.2018 194 Clindamycin Capsule 300 mg 1 Capsule 23.12 1461(E) 02.04.2018 195 Clindamycin Tablet 300 mg 1 Tablet 14.92 1461(E) 02.04.2018 196 Clobazam Tablet 10 mg 1 Tablet 8.84 1461(E) 02.04.2018 197 Clobazam Tablet 5 mg 1 Tablet 5.03 1461(E) 02.04.2018 198 Clofazimine Capsule 100 mg 1 Capsule 2.42 1461(E) 02.04.2018 199 Clofazimine Capsule 50 mg 1 Capsule 1.42 1461(E) 02.04.2018 200 Clomiphene Capsule 100 mg 1 Capsule 54.47 1461(E) 02.04.2018 201 Clomiphene Capsule 50 mg 1 Capsule 29.97 1461(E) 02.04.2018 202 Clomiphene Tablet 100mg 1 Tablet 11.95 1461(E) 02.04.2018 203 Clomiphene Tablet 50mg 1 Tablet 8.15 1461(E) 02.04.2018 204 Clomipramine Tablet 10 mg 1 Tablet 2.46 1461(E) 02.04.2018 205 Clomipramine Tablet 25 mg 1 Tablet 5.43 1461(E) 02.04.2018 206 Clomipramine Tablet 75 mg 1 Tablet 14.04 1461(E) 02.04.2018 207 Clonazepam Tablet 0.25 mg 1 Tablet 1.79 1461(E) 02.04.2018 208 Clonazepam Tablet 0.5 mg 1 Tablet 3.04 1461(E) 02.04.2018 209 Clonazepam Tablet 1 mg 1 Tablet 4.14 1461(E) 02.04.2018 210 Clopidogrel Tablet 75 mg 1 Tablet 6.80 1461(E) 02.04.2018 211 Clotrimazole Cream 1% 1 gm 2.85 3983(E) 13.08.2018 212 Clotrimazole Drops 1% 1 ml 2.96 1461(E) 02.04.2018 213 Clotrimazole Lotion 1% 1 ml 3.50 1461(E) 02.04.2018 214 Clotrimazole Pessary 100 mg 1 Pessary 8.50 1461(E) 02.04.2018 215 Cloxacillin Capsule 250mg 1 Capsule 1.11 1461(E) 02.04.2018 216 Cloxacillin Capsule 500mg 1 Capsule 1.86 1461(E) 02.04.2018 217 Cloxacillin Tablet 250mg 1 Tablet 1.69 1461(E) 02.04.2018 218 Cloxacillin Powder for Injection250mg Each Pack 4.35 1461(E) 02.04.2018 219 Clozapine Tablet 100 mg 1 Tablet 7.58 1461(E) 02.04.2018 220 Clozapine Tablet 25 mg 1 Tablet 2.46 1461(E) 02.04.2018 221 Clozapine Tablet 50 mg 1 Tablet 4.70 1461(E) 02.04.2018 222 Coagulation factor IX Powder for Injection 600 IU Each Pack 12057.74 1461(E) 02.04.2018 223 Coagulation factor VIII Powder for Injection 250 IU Each pack 3655.22 1461(E) 02.04.2018 224 Coagulation factor VIII Powder for Injection 500 IU Each Pack 8969.65 1461(E) 02.04.2018 225 Colchicine Tablet 0.5 mg 1 Tablet 3.04 1461(E) 02.04.2018 226 Co-trimoxazole Oral Liquid 200 mg(A)+ 1 ml 0.21 1461(E) 02.04.2018 (Sulphamethoxazole 40 mg(B)/5ml (A)+Trimethoprim (B)]¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 33 227 Co-trimoxazole Tablet 400 mg(A)+80 mg(B) 1 Tablet 0.51 1461(E) 02.04.2018 (Sulphamethoxazole (A)+Trimethoprim (B)] 228 Co-trimoxazole Tablet 800 mg(A)+ 1 Tablet 1.32 2399(E) 12.06.2018 (Sulphamethoxazole 160 mg(B) (A)+Trimethoprim (B)] 229 Cyclophosphamide Tablet 50 mg 1 Tablet 3.97 1461(E) 02.04.2018 230 Cyclophosphamide Powder for Injection 500 mg Each Pack 78.11 1461(E) 02.04.2018 231 Cycloserine Capsule 250 mg 1 Capsule 53.13 1461(E) 02.04.2018 232 Cycloserine Tablet 250 mg 1 Tablet 45.68 1461(E) 02.04.2018 233 Cyclosporine Capsule 100 mg 1 Capsule 100.31 1461(E) 02.04.2018 234 Cyclosporine Capsule 25 mg 1 Capsule 26.92 1461(E) 02.04.2018 235 Cyclosporine Capsule 50 mg 1 Capsule 51.52 1461(E) 02.04.2018 236 Cyclosporine Injection 50 mg/ml 1 ml 263.96 1461(E) 02.04.2018 237 Cyclosporine Oral Liquid 100 mg/ml 1 ml 92.50 1461(E) 02.04.2018 238 Cytosine arabinoside Injection 100 mg/ml Each Pack 194.43 1461(E) 02.04.2018 239 Cytosine arabinoside Powder for Injection Each Pack 1048.65 1461(E) 02.04.2018 1000 mg 240 Cytosine arabinoside Powder for Injection 500 mg Each Pack 501.20 1461(E) 02.04.2018 241 Dacarbazine Powder for Injection 200 mg Each Pack 429.93 1461(E) 02.04.2018 242 Dacarbazine Powder for Injection 500 mg Each Pack 969.87 1461(E) 02.04.2018 243 Dapsone Tablet 100 mg 1 Tablet 0.23 1461(E) 02.04.2018 244 Darunavir Tablet 600 mg 1 Tablet 163.35 1461(E) 02.04.2018 245 Desferrioxamine Powder for Injection 500mg Each pack 157.37 1461(E) 02.04.2018 246 Dexamethasone Tablet 0.5 mg 1 Tablet 0.19 1461(E) 02.04.2018 247 Dexamethasone Injection 4 mg/ml Each Pack (10 13.48 1461(E) 02.04.2018 ml) 248 Dexamethasone Injection 4 mg/ml Each Pack (2 9.12 1028(E) 26.02.2019 ml) 249 Dexamethasone Injection 4 mg/ml Each Pack (20 25.83 1461(E) 02.04.2018 ml) 250 Dexamethasone Injection 4 mg/ml Each Pack (30 34.52 1461(E) 02.04.2018 ml) 251 Dextran-40 Injection 10% 1 ml 0.83 3983(E) 13.08.2018 252 Diazepam Injection 5 mg/ml 1 ml 5.93 1461(E) 02.04.2018 253 Diazepam Oral Liquid 2 mg/5ml 1 ml 2.68 1461(E) 02.04.2018 254 Diazepam Suppository 5 mg 1 Suppository 5.85 1461(E) 02.04.2018 255 Diazepam Tablet 2 mg 1 Tablet 1.47 1461(E) 02.04.2018 256 Diazepam Tablet 5 mg 1 Tablet 1.39 1461(E) 02.04.2018 257 Diclofenac Capsule 50 mg 1 Capsule 0.60 1461(E) 02.04.2018 258 Diclofenac Injection 25 mg/ml 1 ml 1.43 1461(E) 02.04.2018 259 Diclofenac Tablet 50 mg 1 Tablet 1.87 1461(E) 02.04.2018 260 Dicyclomine Injection 10 mg/ml (10ml & 1 ml 2.01 1461(E) 02.04.2018 30ml Pack) 261 Dicyclomine Injection 10 mg/ml (1ml & 1 ml 3.12 1461(E) 02.04.2018 2ml Pack) 262 Dicyclomine Oral Solution 10mg/5ml 1 ml 0.16 1461(E) 02.04.2018 263 Dicyclomine Tablet 10mg 1 Tablet 0.11 1461(E) 02.04.2018 264 Diethylcarbamazine Oral Liquid 120 mg/5ml 1 ml 0.48 1461(E) 02.04.2018 265 Diethylcarbamazine Tablet 100 mg 1 Tablet 1.38 1461(E) 02.04.2018 266 Diethylcarbamazine Tablet 50 mg 1 Tablet 0.55 1461(E) 02.04.2018 267 Digoxin Injection 0.25 mg/ml 1 ml 3.26 1461(E) 02.04.201834 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 268 Digoxin Oral liquid 0.05 mg/ml 1 ml 1.24 3241(E) 04.07.2018 269 Digoxin Tablet 0.25 mg 1 Tablet 1.17 1461(E) 02.04.2018 270 Diloxanide furoate Tablet 500mg 1 Tablet 1.03 1461(E) 02.04.2018 271 Diltiazem Capsule 90 mg 1 Capsule 9.40 1461(E) 02.04.2018 272 Diltiazem Injection 5 mg/ml 1 ml 3.09 1461(E) 02.04.2018 273 Diltiazem SR Tablet 90 mg 1 Tablet 9.13 1461(E) 02.04.2018 274 Diltiazem Tablet 30 mg 1 Tablet 2.35 1461(E) 02.04.2018 275 Diltiazem Tablet 60 mg 1 Tablet 4.78 1461(E) 02.04.2018 276 Dimercaprol Injection 50 mg/ml 1 ml 195.86 5633(E) 02.11.2018 277 Dinoprostone Gel 0.5 mg 1 gm 79.33 1461(E) 02.04.2018 278 Dinoprostone Tablet 0.5mg 1 Tablet 48.98 1461(E) 02.04.2018 279 Diphtheria antitoxin 10000 IU Each Pack 1282.59 1461(E) 02.04.2018 280 Dobutamine Injection 50 mg/ml Each Pack 36.70 1461(E) 02.04.2018 281 Docetaxel Powder for Injection 20 mg Each Pack 2929.38 1461(E) 02.04.2018 282 Docetaxel Powder for Injection 80 mg Each Pack 11137.71 1461(E) 02.04.2018 283 Domperidone Oral Liquid 1 mg/ml 1 ml 1.05 1461(E) 02.04.2018 284 Domperidone Tablet 10 mg 1 Tablet 2.37 1461(E) 02.04.2018 285 Donepezil Tablet 10 mg 1 Tablet 15.70 1461(E) 02.04.2018 286 Donepezil Tablet 5 mg 1 Tablet 11.00 1461(E) 02.04.2018 287 Dopamine Injection 40 mg/ml 1 ml 5.53 1461(E) 02.04.2018 288 Doxorubicin Injection 2 mg/ml 1 ml 35.14 1461(E) 02.04.2018 289 Doxycycline Capsule 100 mg 1 Capsule 2.45 1461(E) 02.04.2018 290 Doxycycline Tablet 100 mg 1 Tablet 0.95 1461(E) 02.04.2018 291 DPT + Hib + Hep B vaccine Per 0.1 ml 78.60 1461(E) 02.04.2018 292 DPT vaccine Per 0.5 ml 13.86 1461(E) 02.04.2018 293 Efavirenz Capsule 200 mg 1 Capsule 23.56 1461(E) 02.04.2018 294 Efavirenz Capsule 600 mg 1 Capsule 61.38 1461(E) 02.04.2018 295 Efavirenz Tablet 200 mg 1 Tablet 22.19 1461(E) 02.04.2018 296 Efavirenz Tablet 600 mg 1 Tablet 69.50 1461(E) 02.04.2018 297 Enalapril Tablet 2.5 mg 1 Tablet 1.89 1461(E) 02.04.2018 298 Enalapril Tablet 5 mg 1 Tablet 3.14 1461(E) 02.04.2018 299 Enoxaparin Injection 40 mg/0.4ml 0.1 ml 99.48 1461(E) 02.04.2018 300 Enoxaparin Injection 60 mg/0.6ml 0.1 ml 99.48 1461(E) 02.04.2018 301 Entecavir Tablet 0.5 mg 1 Tablet 78.08 1461(E) 02.04.2018 302 Entecavir Tablet 1 mg 1 Tablet 124.06 1461(E) 02.04.2018 303 Erythropoietin Injection 10000 IU/ml Each pack 2545.89 1461(E) 02.04.2018 304 Erythropoietin Injection 2000 IU/ml Each pack 603.00 1461(E) 02.04.2018 305 Escitalopram Tablet 10 mg 1 Tablet 7.93 1461(E) 02.04.2018 306 Escitalopram Tablet 20 mg 1 Tablet 12.52 1461(E) 02.04.2018 307 Escitalopram Tablet 5 mg 1 Tablet 4.47 1461(E) 02.04.2018 308 Esmolol Injection 10mg/ml 1 ml 21.20 1461(E) 02.04.2018 309 Ethambutol Tablet 200 mg 1 Tablet 1.03 1461(E) 02.04.2018 310 Ethambutol Tablet 400 mg 1 Tablet 2.35 1461(E) 02.04.2018 311 Ethambutol Tablet 600 mg 1 Tablet 3.46 1461(E) 02.04.2018 312 Ethambutol Tablet 800 mg 1 Tablet 4.14 1461(E) 02.04.2018 313 Ethinylestradiol Tablet 0.01 mg 1 Tablet 2.30 1461(E) 02.04.2018 314 Ethinylestradiol Tablet 0.05 mg 1 Tablet 3.67 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 35 315 Ethinylestradiol (A) + Tablet 0.03 mg(A) + 0.15 1 Tablet 3.38 1461(E) 02.04.2018 Levonorgestrel (B) mg(B) 316 Ethionamide Tablet 250 mg 1 Tablet 15.45 1461(E) 02.04.2018 317 Etoposide Capsule 50 mg 1 Capsule 53.21 1461(E) 02.04.2018 318 Etoposide Injection 20 mg/ml 1 ml 35.09 1461(E) 02.04.2018 319 Fentanyl Injection 50mcg/ml 1 ml 22.22 1461(E) 02.04.2018 320 Filgrastim Injection 300 mcg Each pack 1342.98 1461(E) 02.04.2018 321 Fluconazole Capsule 100 mg 1 Capsule 24.72 1461(E) 02.04.2018 322 Fluconazole Capsule 150 mg 1 Capsule 18.15 1461(E) 02.04.2018 323 Fluconazole Capsule 200 mg 1 Capsule 35.73 1461(E) 02.04.2018 324 Fluconazole Oral Liquid 50mg/5ml 1 ml 2.56 1461(E) 02.04.2018 325 Fluconazole Tablet 100 mg 1 Tablet 7.81 1461(E) 02.04.2018 326 Fluconazole Tablet 150 mg 1 Tablet 11.59 1461(E) 02.04.2018 327 Fluconazole Tablet 200 mg 1 Tablet 18.38 1461(E) 02.04.2018 328 Fluconazole Tablet 400 mg 1 Tablet 30.57 1461(E) 02.04.2018 329 Fluconazole Injection 200 mg/100 ml Each Pack 104.15 1461(E) 02.04.2018 330 Flunarizine Tablet 10 mg 1 Tablet 4.63 1461(E) 02.04.2018 331 Flunarizine Tablet 5 mg 1 Tablet 2.70 1461(E) 02.04.2018 332 Fluoxetine Capsule 10 mg 1 Capsule 2.91 1461(E) 02.04.2018 333 Fluoxetine Capsule 20 mg 1 Capsule 3.57 1461(E) 02.04.2018 334 Fluoxetine Capsule 40 mg 1 Capsule 5.42 1461(E) 02.04.2018 335 Fluoxetine Capsule 60 mg 1 Capsule 9.58 1461(E) 02.04.2018 336 Fluoxetine Tablet 10 mg 1 Tablet 2.44 1461(E) 02.04.2018 337 Fluoxetine Tablet 20 mg 1 Tablet 3.88 1461(E) 02.04.2018 338 Fluoxetine Tablet 40 mg 1 Tablet 5.22 1461(E) 02.04.2018 339 Fluoxetine Tablet 60 mg 1 Tablet 7.24 1461(E) 02.04.2018 340 Fluphenazine Depot Injection 25 mg/ml 1 ml 48.96 1461(E) 02.04.2018 341 Folic Acid Capsule 5 mg 1 Capsule 5.52 1461(E) 02.04.2018 342 Folic Acid Tablet 5 mg 1 Tablet 1.36 1461(E) 02.04.2018 343 Furosemide Oral liquid 10 mg/ml 1 ml 2.71 3241(E) 04.07.2018 344 Furosemide Tablet 40 mg 1 Tablet 0.49 1461(E) 02.04.2018 345 Furosemide Injection 10mg/ml 1 ml 1.62 1461(E) 02.04.2018 346 Fusidic acid Cream 2% 1 gm 8.93 1461(E) 02.04.2018 347 Gadobenate Injection 529 mg/ml 1 ml 106.66 1461(E) 02.04.2018 348 Ganciclovir Capsule 250 mg 1 Capsule 117.65 1461(E) 02.04.2018 349 Ganciclovir Powder for Injection 500 mg Each Pack 1651.52 1461(E) 02.04.2018 350 Gefitinib Tablet 250 mg 1 Tablet 419.44 1461(E) 02.04.2018 351 Gemcitabine Powder for Injection 1 gm Each Pack 5191.88 1461(E) 02.04.2018 352 Gemcitabine Powder for Injection 200mg Each Pack 1146.62 1461(E) 02.04.2018 353 Gentamicin Drops 0.3% 1 ml 0.89 1461(E) 02.04.2018 354 Gentamicin Injection 10 mg/ml 1 ml 3.11 1461(E) 02.04.2018 355 Gentamicin Injection 40 mg/ml Each Pack (10 17.58 1461(E) 02.04.2018 ml) 356 Gentamicin Injection 40 mg/ml Each Pack (2 8.23 1028(E) 26.02.2019 ml) 357 Gentamicin Injection 40 mg/ml Each Pack (20 26.65 1461(E) 02.04.2018 ml) 358 Gentamicin Injection 40 mg/ml Each Pack (30 29.17 1461(E) 02.04.2018 ml)36 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 359 Glimepiride Tablet 1 mg 1 Tablet 3.51 1461(E) 02.04.2018 360 Glimepiride Tablet 2 mg 1 Tablet 5.58 1461(E) 02.04.2018 361 Glucose Injection 25% 1 ml 0.17 1461(E) 02.04.2018 362 Glucose Injection 50% 1 ml 0.48 1461(E) 02.04.2018 363 Glucose Injection 5% 1000ml Glass 62.86 1461(E) 02.04.2018 364 Glucose Injection 5% 1000ml Non- 50.73 1461(E) 02.04.2018 Glass 365 Glucose Injection 5% 100ml Glass 17.64 1461(E) 02.04.2018 366 Glucose Injection 5% 100ml Non- 15.97 1461(E) 02.04.2018 Glass 367 Glucose Injection 5% 250ml Glass 24.38 1461(E) 02.04.2018 368 Glucose Injection 5% 250ml Non- 22.02 1461(E) 02.04.2018 Glass 369 Glucose Injection 5% 500ml Glass 34.60 1461(E) 02.04.2018 370 Glucose Injection 5% 500ml Non- 29.86 1461(E) 02.04.2018 Glass 371 Glucose Injection 10% Each Pack 25.27 1461(E) 02.04.2018 (1000 ml) 372 Glucose Injection 10% Each Pack (500 27.49 1461(E) 02.04.2018 ml) 373 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 1000ml Glass 63.26 1461(E) 02.04.2018 Chloride (B) 374 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 1000ml Non- 51.12 1461(E) 02.04.2018 Chloride (B) Glass 375 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 100ml Glass 17.69 1461(E) 02.04.2018 Chloride (B) 376 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 100ml Non- 15.99 1461(E) 02.04.2018 Chloride (B) Glass 377 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 250ml Glass 24.48 1461(E) 02.04.2018 Chloride (B) 378 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 250ml Non- 22.10 1461(E) 02.04.2018 Chloride (B) Glass 379 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 500ml Glass 34.77 1461(E) 02.04.2018 Chloride (B) 380 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 500ml Non- 30.04 1461(E) 02.04.2018 Chloride (B) Glass 381 Glutaraldehyde Solution 2% 1 ml 0.06 1461(E) 02.04.2018 382 Glycerin Oral Liquid 1 ml 0.15 1461(E) 02.04.2018 383 Glyceryl Trinitrate Injection 5 mg/ml 1 ml 6.42 1461(E) 02.04.2018 384 Glyceryl Trinitrate Sublingual Tablet 0.5 mg 1 Tablet 1.77 1461(E) 02.04.2018 385 Glycopyrrolate Injection 0.2 mg/ml 1 ml 12.02 1461(E) 02.04.2018 386 Griseofulvin Tablet 125mg 1 Tablet 0.80 1461(E) 02.04.2018 387 Griseofulvin Tablet 250 mg 1 Tablet 1.56 1461(E) 02.04.2018 388 Griseofulvin Tablet 375 mg 1 Tablet 4.21 1461(E) 02.04.2018 389 Haemodialysis fluid As license 1 ml 0.04 1461(E) 02.04.2018 390 Haloperidol Injection 5 mg/ml 1 ml 5.70 1461(E) 02.04.2018 391 Haloperidol Oral Liquid 2 mg/ 5ml 1 ml 2.01 1461(E) 02.04.2018 392 Haloperidol Tablet 1.5 mg 1 Tablet 1.62 1461(E) 02.04.2018 393 Haloperidol Tablet 10 mg 1 Tablet 4.32 1461(E) 02.04.2018 394 Haloperidol Tablet 20 mg 1 Tablet 4.82 1461(E) 02.04.2018 395 Haloperidol Tablet 5 mg 1 Tablet 3.37 1461(E) 02.04.2018 396 Halothane Inhalation 1 ml 5.73 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 37 397 Heparin Injection 1000 IU/ml 1 ml 15.96 1461(E) 02.04.2018 398 Heparin Injection 5000 IU/ml 1 ml 39.61 1461(E) 02.04.2018 399 Hepatitis B immunoglobulin Each Pack 5390.60 1461(E) 02.04.2018 400 Hepatitis B vaccine 1 ml 76.64 1461(E) 02.04.2018 401 Homatropine Drops 2% 1 ml 6.08 1461(E) 02.04.2018 402 Hormone releasing IUD Contains 52 mgof 1 IUD 3785.52 1461(E) 02.04.2018 Levonorgestrel 403 Human chorionic Gonadotropin Injection 1000 IU Each Pack 207.98 1461(E) 02.04.2018 404 Human chorionic Gonadotropin Injection 5000 IU Each Pack 408.44 1461(E) 02.04.2018 405 Human Normal 1 ml 150.97 1461(E) 02.04.2018 Immunoglobulin 406 Hydrochlorothiazide Tablet 12.5 mg 1 Tablet 0.96 1461(E) 02.04.2018 407 Hydrochlorothiazide Tablet 25 mg 1 Tablet 1.65 1461(E) 02.04.2018 408 Hydrochlorothiazide Tablet 50 mg 1 Tablet 0.08 1461(E) 02.04.2018 409 Hydrocortisone Tablet 10 mg 1 Tablet 5.76 1461(E) 02.04.2018 410 Hydrocortisone Tablet 5 mg 1 Tablet 2.96 1461(E) 02.04.2018 411 Hydrocortisone Injection 100 mg Each Pack 38.08 1461(E) 02.04.2018 412 Hydrocortisone Injection 200 mg Each Pack 58.71 1461(E) 02.04.2018 413 Hydrocortisone Powder for Injection 100 mg Each Pack 38.08 1461(E) 02.04.2018 414 Hydrogen peroxide Solution 6% 1 ml 0.04 1461(E) 02.04.2018 415 Hydroxychloroquine Tablet 200 mg 1 Tablet 5.80 1461(E) 02.04.2018 416 Hydroxychloroquine Tablet 400 mg 1 Tablet 11.69 1461(E) 02.04.2018 417 Hydroxypropyl methylcellulose Injection 2% 1 ml 36.70 1461(E) 02.04.2018 418 Hydroxyurea Capsule 500 mg 1 Capsule 12.54 1461(E) 02.04.2018 419 Hyoscine butylbromide Injection 20 mg/ml 1 ml 10.21 1461(E) 02.04.2018 420 Hyoscine Butylbromide Tablet 10 mg 1 Tablet 2.91 1461(E) 02.04.2018 421 Ibuprofen Capsule 400 mg 1 Capsule 1.03 1461(E) 02.04.2018 422 Ibuprofen Tablet 200 mg 1 Tablet 0.38 1461(E) 02.04.2018 423 Ibuprofen Tablet 400 mg 1 Tablet 0.68 1461(E) 02.04.2018 424 Ibuprofen Oral Liquid 100mg/5ml 1 ml 0.19 1461(E) 02.04.2018 425 Ifosfamide Powder for Injection 1g Each Pack 354.11 1461(E) 02.04.2018 426 Ifosfamide Powder for Injection 2g Each Pack 929.49 1461(E) 02.04.2018 427 Imatinib Capsule 100 mg 1 Capsule 75.97 1461(E) 02.04.2018 428 Imatinib Capsule 400 mg 1 Capsule 249.96 1461(E) 02.04.2018 429 Imatinib Tablet 100 mg 1 Tablet 77.73 1461(E) 02.04.2018 430 Imatinib Tablet 400 mg 1 Tablet 225.00 1461(E) 02.04.2018 431 Insulin (Soluble) Injection 40 IU/ml 1 ml 14.73 1461(E) 02.04.2018 432 Intermediate Acting (NPH) Injection 40 IU/ml 1 ml 14.73 1461(E) 02.04.2018 Insulin 433 Iohexol Injection 300mgiodine/ml 1 ml 16.27 1461(E) 02.04.2018 434 Ipratropium Inhalation (MDI/DPI) 20 1 Dose 0.60 1461(E) 02.04.2018 mcg/dose 435 Ipratropium Respirator solution for use in 1 ml 2.48 1461(E) 02.04.2018 Nebulizer 250 mcg/ml 436 Iron sucrose Injection 20 mg/ml 1 ml 52.60 1461(E) 02.04.2018 437 Isoflurane Inhalation 1 ml 10.23 1461(E) 02.04.2018 438 Isoniazid Tablet 100mg 1 Tablet 0.67 1461(E) 02.04.2018 439 Isoniazid Tablet 300mg 1 Tablet 1.17 1461(E) 02.04.2018 440 Isosorbide 5 Mononitrate Tablet 20 mg 1 Tablet 3.21 1461(E) 02.04.201838 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 441 Isosorbide dinitrate Tablet 10 mg 1 Tablet 0.72 1461(E) 02.04.2018 442 Isosorbide dinitrate Tablet 5 mg 1 Tablet 0.74 1461(E) 02.04.2018 443 Isosorbide-5-mononitrate SR Capsule 30 mg 1 Capsule 3.43 1461(E) 02.04.2018 444 Isosorbide-5-mononitrate SR Capsule 60 mg 1 Capsule 3.41 1461(E) 02.04.2018 445 Isosorbide-5-mononitrate SR Tablet 30 mg 1 Tablet 4.79 1461(E) 02.04.2018 446 Isosorbide-5-mononitrate SR Tablet 60 mg 1 Tablet 6.25 1461(E) 02.04.2018 447 Isosorbide-5-mononitrate Tablet 10 mg 1 Tablet 1.92 1461(E) 02.04.2018 448 Ispaghula Granules/ Husk/ Powder 1 gm 0.76 1461(E) 02.04.2018 449 IUD containing Copper As licensed 1 IUD 281.35 1461(E) 02.04.2018 450 Japanese Encephalitis Vaccine 4mcg to 6mcg Each Pack 682.64 1461(E) 02.04.2018 451 Japanese Encephalitis Vaccine up to 3mcg Each Pack 520.08 1461(E) 02.04.2018 452 Kanamycin Powder for Injection 1 gm Each Pack 38.27 1461(E) 02.04.2018 453 Kanamycin Powder for Injection 500 mg Each Pack 20.88 1461(E) 02.04.2018 454 Kanamycin Powder for Injection 750 mg Each Pack 35.67 1461(E) 02.04.2018 455 Ketamine Injection 10 mg/ml 1 ml 10.36 1461(E) 02.04.2018 456 Ketamine Injection 50 mg/ml 1 ml 10.23 1461(E) 02.04.2018 457 Labetalol Injection 5 mg/ml 1 ml 49.61 1461(E) 02.04.2018 458 Lactulose Oral Liquid 10 g/15 ml 1 ml 1.07 1461(E) 02.04.2018 459 Lamivudine (A) + Nevirapine Tablet 150 mg(A) + 200 1 Tablet 15.27 1461(E) 02.04.2018 (B) + Stavudine (C) mg(B) + 30 mg(C) 460 Lamivudine (A) + Zidovudine Tablet 150 mg(A) + 1 Tablet 19.63 1461(E) 02.04.2018 (B) 300 mg(B) 461 Lamivudine (A)+ Nevirapine Dispersible Tablet 30 mg(A) 1 Tablet 4.84 1461(E) 02.04.2018 (B) + Stavudine (C) + 50 mg(B) + 6 mg(C) 462 L-Asparaginase Powder for Injection Each Pack 1571.02 1461(E) 02.04.2018 10000 KU 463 L-Asparaginase Powder for Injection 5000KU Each Pack 1014.08 1461(E) 02.04.2018 464 Leflunomide Tablet 10 mg 1 Tablet 9.80 1461(E) 02.04.2018 465 Leflunomide Tablet 20 mg 1 Tablet 19.12 1461(E) 02.04.2018 466 Letrozole Tablet 2.5 mg 1 Tablet 39.90 1461(E) 02.04.2018 467 Levetiracetam Injection 100 mg/ml 1 ml 21.35 1461(E) 02.04.2018 468 Levetiracetam ER Tablet 750 mg 1 Tablet 17.02 1461(E) 02.04.2018 469 Levetiracetam Tablet 250 mg 1 Tablet 5.72 1461(E) 02.04.2018 470 Levetiracetam Tablet 500 mg 1 Tablet 11.57 1461(E) 02.04.2018 471 Levetiracetam Tablet 750 mg 1 Tablet 17.79 1461(E) 02.04.2018 472 Levetiracetam Oral Liquid 100 mg/ml 1 ml 3.57 1461(E) 02.04.2018 473 Levodopa (A) + Carbidopa (B) CR Tablet 100 mg(A) + 1 Tablet 3.26 1461(E) 02.04.2018 25 mg(B) 474 Levodopa (A) + Carbidopa (B) Tablet 100 mg(A) + 1 Tablet 1.52 1461(E) 02.04.2018 10 mg(B) 475 Levodopa (A) + Carbidopa (B) Tablet 100 mg(A) + 1 Tablet 2.21 1461(E) 02.04.2018 25 mg(B) 476 Levodopa (A) + Carbidopa (B) Tablet 250 mg(A) + 1 Tablet 3.66 1461(E) 02.04.2018 25 mg(B) 477 Levodopa (A) + Carbidopa (B) CR Tablet 200 mg(A) + 1 Tablet 4.02 1461(E) 02.04.2018 50 mg(B) 478 Levofloxacin Tablet 250 mg 1 Tablet 4.32 1461(E) 02.04.2018 479 Levofloxacin Tablet 750 mg 1 Tablet 10.70 1461(E) 02.04.2018 480 Levofloxacin Tablet 500mg 1 Tablet 7.89 1461(E) 02.04.2018 481 Levonorgestrel Tablet 0.75 mg 1 Tablet 22.53 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 39 482 Levothyroxine Tablet 100 mcg 1 Tablet 1.17 1461(E) 02.04.2018 483 Levothyroxine Tablet 112mcg 1 Tablet 1.40 1461(E) 02.04.2018 484 Levothyroxine Tablet 12.5 mcg 1 Tablet 1.32 1461(E) 02.04.2018 485 Levothyroxine Tablet 125 mcg 1 Tablet 1.50 1461(E) 02.04.2018 486 Levothyroxine Tablet 150 mcg 1 Tablet 1.51 1461(E) 02.04.2018 487 Levothyroxine Tablet 25 mcg 1 Tablet 1.28 1461(E) 02.04.2018 488 Levothyroxine Tablet 50 mcg 1 Tablet 0.96 1461(E) 02.04.2018 489 Levothyroxine Tablet 62.5mcg 1 Tablet 1.37 1461(E) 02.04.2018 490 Levothyroxine Tablet 75 mcg 1 Tablet 1.27 1461(E) 02.04.2018 491 Levothyroxine Tablet 88 mcg 1 Tablet 1.50 1461(E) 02.04.2018 492 Lignocaine Injection 2% 1 ml 0.96 1461(E) 02.04.2018 493 Lignocaine Injection 2% (Preservative 1 ml 0.95 1461(E) 02.04.2018 free for IV use) 494 Lignocaine Injection 1% Each Pack 7.77 1461(E) 02.04.2018 495 Lignocaine Topical Forms 2-5% 1 gm or 1 ml 1.05 1461(E) 02.04.2018 496 Lignocaine Injection 5% with 7.5% 1 ml 3.60 1461(E) 02.04.2018 Glucose 497 Lignocaine (A) + Adrenaline Injection 1% (A) + 1:200000 1 ml 0.44 1461(E) 02.04.2018 (B) (5 mcg/ml) (B) 498 Lignocaine (A) + Adrenaline Injection 2% (A) + 1:200000 1 ml 0.90 1461(E) 02.04.2018 (B) (5mcg/ml) (B) 499 Linezolid Tablet 600 mg 1 Tablet 32.33 1461(E) 02.04.2018 500 Lithium Tablet 300 mg 1 Tablet 1.43 1461(E) 02.04.2018 501 Loperamide Capsule 2 mg 1 Capsule 3.50 1461(E) 02.04.2018 502 Loperamide Tablet 2 mg 1 Tablet 1.93 1461(E) 02.04.2018 503 Lopinavir (A) + Ritonavir (B) Tablet 100 mg(A) + 25 1 Tablet 23.01 1461(E) 02.04.2018 mg(B) 504 Lopinavir (A) + Ritonavir (B) Tablet 200 mg(A) + 50 1 Tablet 44.59 1461(E) 02.04.2018 mg(B) 505 Lorazepam injection 2 mg/ml 1 ml 7.61 1461(E) 02.04.2018 506 Lorazepam Tablet 1 mg 1 Tablet 2.02 1461(E) 02.04.2018 507 Lorazepam Tablet 2 mg 1 Tablet 2.46 1461(E) 02.04.2018 508 Magnesium Sulphate Injection 500 mg/ml 1 ml 4.67 1461(E) 02.04.2018 509 Mannitol Injection 10% 1 ml 0.16 1461(E) 02.04.2018 510 Mannitol Injection 20% 1 ml 0.29 1461(E) 02.04.2018 511 Measles Rubbela Vaccine Each Pack 86.52 1461(E) 02.04.2018 (0.5ml) 512 Measles vaccine Vaccine Each Pack 49.90 1461(E) 02.04.2018 (0.5ml) 513 Mebendazole Oral Liquid 100 mg/5ml 1 ml 0.76 1461(E) 02.04.2018 514 Mebendazole Tablet 100 mg 1 Tablet 2.87 1461(E) 02.04.2018 515 Medroxyprogesteroneacetate Tablet 10 mg 1 Tablet 5.27 1461(E) 02.04.2018 516 Mefenamic acid Oral Liquid 100 mg/5ml 1 ml 0.51 1461(E) 02.04.2018 517 Mefenamic acid Tablet 250 mg 1 Tablet 1.89 1461(E) 02.04.2018 518 Mefenamic acid Tablet 500 mg 1 Tablet 2.40 1461(E) 02.04.2018 519 Mefloquine Tablet 250 mg 1 Tablet 49.89 1461(E) 02.04.2018 520 Meglumine Diatrizoate Injection 60%w/v 1 ml 8.09 1461(E) 02.04.2018 521 Meglumine Diatrizoate Injection 76%w/v 1 ml 9.34 1461(E) 02.04.2018 522 Melphalan Tablet 2 mg 1 Tablet 96.01 1461(E) 02.04.2018 523 Melphalan Tablet 5 mg 1 Tablet 164.67 1461(E) 02.04.2018 524 Mesna Injection 100 mg/ml 1 ml 16.41 1461(E) 02.04.201840 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 525 Metformin Immediate Release Tablet 1 Tablet 1.47 1461(E) 02.04.2018 500 mg 526 Metformin Controlled Release Tablet 1 Tablet 3.57 1461(E) 02.04.2018 1000 mg 527 Metformin Controlled Release Tablet 1 Tablet 1.87 1461(E) 02.04.2018 500 mg 528 Metformin controlled Released Tablet 1 Tablet 2.35 1461(E) 02.04.2018 750 mg 529 Metformin Immediate Release Tablet 1 Tablet 3.52 1461(E) 02.04.2018 1000 mg 530 Metformin Immediate Release Tablet 1 Tablet 2.97 1461(E) 02.04.2018 750 mg 531 Methotrexate Injection 25 mg/ml 1 ml 47.07 1461(E) 02.04.2018 532 Methotrexate Injection 50 mg/ml 1 ml 39.20 1461(E) 02.04.2018 533 Methotrexate Tablet 10 mg 1 Tablet 11.89 1461(E) 02.04.2018 534 Methotrexate Tablet 2.5 mg 1 Tablet 4.68 1461(E) 02.04.2018 535 Methotrexate Tablet 7.5 mg 1 Tablet 11.34 1461(E) 02.04.2018 536 Methotrexate Tablet 5 mg 1 Tablet 8.20 1461(E) 02.04.2018 537 Methyldopa Tablet 250 mg 1 Tablet 2.39 1461(E) 02.04.2018 538 Methyldopa Tablet 500 mg 1 Tablet 4.58 1461(E) 02.04.2018 539 Methylergometrine Injection 0.2 mg/ml 1 ml 13.97 1461(E) 02.04.2018 540 Methylergometrine Tablet 0.125 mg 1 Tablet 7.75 1461(E) 02.04.2018 541 Methylprednisolone Tablet 16 mg 1 Tablet 8.73 1461(E) 02.04.2018 542 Methylprednisolone Tablet 8 mg 1 Tablet 4.99 1461(E) 02.04.2018 543 Methylprednisolone Injection 40mg/ml 1 ml 52.81 1461(E) 02.04.2018 544 Metoclopramide Injection 5 mg/ml (10 ml 1 ml 1.39 1461(E) 02.04.2018 Pack) 545 Metoclopramide Injection 5 mg/ml (2 ml 1 ml 2.29 1461(E) 02.04.2018 Pack) 546 Metoclopramide Oral Liquid 5 mg/5ml 1 ml 0.43 1461(E) 02.04.2018 547 Metoclopramide Tablet 10 mg 1 Tablet 1.14 1461(E) 02.04.2018 548 Metoprolol Capsule 25 mg 1 Capsule 4.14 1461(E) 02.04.2018 549 Metoprolol Capsule 50 mg 1 Capsule 6.31 1461(E) 02.04.2018 550 Metoprolol SR Tablet 25 mg 1 Tablet 3.95 1461(E) 02.04.2018 551 Metoprolol SR Tablet 50 mg 1 Tablet 5.65 1461(E) 02.04.2018 552 Metoprolol Tablet 25 mg 1 Tablet 3.04 1461(E) 02.04.2018 553 Metoprolol Tablet 50 mg 1 Tablet 4.61 1461(E) 02.04.2018 554 Metronidazole Injection 500mg/100ml 1 ml 0.13 1461(E) 02.04.2018 555 Metronidazole Oral Liquid 200 mg/5ml 1 ml 0.29 1461(E) 02.04.2018 556 Metronidazole Tablet 200 mg 1 Tablet 0.45 3983(E) 13.08.2018 557 Metronidazole Tablet 400 mg 1 Tablet 0.83 3983(E) 13.08.2018 558 Midazolam Injection 1 mg/ml 1 ml 5.78 1461(E) 02.04.2018 559 Midazolam Injection 5 mg/ml 1 ml 14.20 1461(E) 02.04.2018 560 Midazolam Tablet 7.5mg 1 Tablet 21.97 1461(E) 02.04.2018 561 Mifepristone Tablet 200 mg 1 Tablet 314.84 1461(E) 02.04.2018 562 Misoprostol Tablet 100 mcg 1 Tablet 8.52 1461(E) 02.04.2018 563 Misoprostol Tablet 200 mcg 1 Tablet 16.34 1461(E) 02.04.2018 564 Morphine Injection 10 mg/ml 1 ml 23.24 1461(E) 02.04.2018 565 Morphine Injection 15 mg/ml 1 ml 29.00 1461(E) 02.04.2018 566 Morphine SR Tablet 30 mg 1 Tablet 5.33 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 41 567 Morphine Tablet 10 mg 1 Tablet 5.21 1461(E) 02.04.2018 568 Moxifloxacin Tablet 400 mg 1 Tablet 24.79 1461(E) 02.04.2018 569 Mycophenolate mofetil Tablet 250 mg 1 Tablet 40.63 1461(E) 02.04.2018 570 Mycophenolate mofetil Tablet 500 mg 1 Tablet 80.38 1461(E) 02.04.2018 571 N-acetylcysteine Injection 200 mg/ml 1 ml 21.93 1461(E) 02.04.2018 572 N-acetylcysteine Sachet 200mg 1 gm 8.80 1461(E) 02.04.2018 573 Naloxone injection 0.4 mg/ml 1 ml 84.90 1461(E) 02.04.2018 574 Natamycin Drops 5% 1 ml 22.32 1461(E) 02.04.2018 575 Neostigmine injection 0.5 mg/ml 1 ml 4.26 1461(E) 02.04.2018 576 Neostigmine Tablet 15 mg 1 Tablet 4.57 1461(E) 02.04.2018 577 Nevirapine Oral Liquid 50 mg/5ml 1 ml 0.82 1461(E) 02.04.2018 578 Nevirapine Tablet 200 mg 1 Tablet 14.01 1461(E) 02.04.2018 579 Nifedipine Capsule 10 mg 1 Capsule 0.84 1461(E) 02.04.2018 580 Nifedipine Tablet 10 mg 1 Tablet 1.21 1461(E) 02.04.2018 581 Nitrofurantoin Oral Liquid 25 mg/5ml 1 ml 0.80 1461(E) 02.04.2018 582 Nitrofurantoin Tablet 100 mg 1 Tablet 7.08 1461(E) 02.04.2018 583 Nitrofurantoin Capsule 100mg 1 Capsule 7.69 1461(E) 02.04.2018 584 Nitrous Oxide Inhalation Cubic Meter 228.65 5634(E) 02.11.2018 585 Noradrenaline Injection 2 mg/ml 1 ml 25.21 1461(E) 02.04.2018 586 Norethisterone Tablet 5 mg 1 Tablet 5.00 1461(E) 02.04.2018 587 Omeprazole Capsule 10 mg 1 Capsule 2.07 1461(E) 02.04.2018 588 Omeprazole Capsule 20 mg 1 Capsule 2.44 1461(E) 02.04.2018 589 Omeprazole Capsule 40 mg 1 Capsule 4.83 1461(E) 02.04.2018 590 Omeprazole Powder for oral Liquid 20 mg 1 gm 1.20 1461(E) 02.04.2018 591 Omeprazole Tablet 10 mg 1 Tablet 4.34 1461(E) 02.04.2018 592 Omeprazole Tablet 20 mg 1 Tablet 4.82 1461(E) 02.04.2018 593 Omeprazole Tablet 40 mg 1 Tablet 8.16 1461(E) 02.04.2018 594 Ondansetron Injection 2 mg/ml 1 ml 5.72 1461(E) 02.04.2018 595 Ondansetron Oral Liquid 2 mg/5ml 1 ml 1.11 1461(E) 02.04.2018 596 Ondansetron Tablet 4 mg 1 Tablet 4.60 1461(E) 02.04.2018 597 Ondansetron Tablet 8 mg 1 Tablet 9.55 1461(E) 02.04.2018 598 Oral Rehydration Salts As Licensed 1 gm 0.87 2399(E) 12.06.2018 599 Oral Rehydration Salts As Licensed 1 ml 0.14 1461(E) 02.04.2018 600 Oxaliplatin Injection 100mg(as licensed) Each Pack 4373.47 1461(E) 02.04.2018 601 Oxaliplatin Injection 50mg(as licensed) Each Pack 2543.51 3983(E) 13.08.2018 602 Oxygen Inhalation (Medicinal gas) Cubic Meter 17.17 5634(E) 02.11.2018 603 Oxytocin Injection 10 IU/ml 1 ml 38.55 1461(E) 02.04.2018 604 Oxytocin Injection 5IU/ml 1 ml 17.27 1461(E) 02.04.2018 605 Paclitaxel Injection 100 mg/16.7 ml 1 ml 218.41 1461(E) 02.04.2018 606 Paclitaxel Injection 30 mg/ 5ml 1 ml 218.41 1461(E) 02.04.2018 607 Pantoprazole Injection 40 mg Each Pack 43.57 1461(E) 02.04.2018 608 Para-aminosalicylic acid Granules (As licensed) 1 gm 2.78 1461(E) 02.04.2018 609 Paracetamol Oral Liquid 100 mg/5ml 1 ml 0.50 1461(E) 02.04.2018 610 Paracetamol Oral Liquid 120 mg/5ml 1 ml 0.52 1461(E) 02.04.2018 611 Paracetamol Oral Liquid 125 mg/5ml 1 ml 0.33 1461(E) 02.04.2018 612 Paracetamol Oral Liquid 150 mg/5ml 1 ml 0.57 1461(E) 02.04.2018 613 Paracetamol Oral Liquid 250 mg/5ml 1 ml 0.59 1461(E) 02.04.201842 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 614 Paracetamol Oral Liquid 500 mg/5ml 1 ml 0.63 1461(E) 02.04.2018 615 Paracetamol Oral Liquid 650 mg/5ml 1 ml 0.51 1461(E) 02.04.2018 616 Paracetamol Tablet 500 mg 1 Tablet 0.89 1461(E) 02.04.2018 617 Paracetamol Tablet 650 mg 1 Tablet 1.80 1461(E) 02.04.2018 618 Paracetamol Injection 150 mg/ml Each Pack ( 0.5 3.00 1461(E) 02.04.2018 ml) 619 Paracetamol Injection 150 mg/ml Each Pack (1 4.11 1461(E) 02.04.2018 ml) 620 Paracetamol Injection 150 mg/ml Each Pack (2 6.31 1461(E) 02.04.2018 ml) 621 Paracetamol Injection 150 mg/ml Each Pack (3 8.52 1461(E) 02.04.2018 ml) 622 Paracetamol Injection 150 mg/ml Each Pack (4 10.73 1461(E) 02.04.2018 ml) 623 Paracetamol Injection 150 mg/ml Each Pack (5 12.94 1461(E) 02.04.2018 ml) 624 Paracetamol Injection 150 mg/ml Each Pack (7 17.35 1461(E) 02.04.2018 ml) 625 Paracetamol Suppository 170 mg Each 7.53 1461(E) 02.04.2018 Suppository 626 Paracetamol Suppository 80 mg Each 6.37 1461(E) 02.04.2018 Suppository 627 Paracetamol Oral Liquid 100 mg/ml (pediatric) 1 ml 1.58 5633(E) 02.11.2018 628 Pegylated interferon alfa 2a Injection 180mcg Each Pack 7743.81 1461(E) 02.04.2018 629 Pegylated interferon alfa 2b Injection 100mcg Each Pack 15310.45 1461(E) 02.04.2018 630 Pegylated interferon alfa 2b Injection 120mcg Each Pack 14258.36 1461(E) 02.04.2018 631 Pegylated interferon alfa 2b Injection 80mcg Each Pack 12240.27 1461(E) 02.04.2018 632 Penicillamine Capsule 250 mg 1 Capsule 14.55 1461(E) 02.04.2018 633 Permethrin Cream 1% 1 gm 1.57 1461(E) 02.04.2018 634 Permethrin Cream 5% 1 gm 1.70 1461(E) 02.04.2018 635 Permethrin Gel 5% 1 gm 1.43 1461(E) 02.04.2018 636 Permethrin Lotion 1% 1 gm 0.89 1461(E) 02.04.2018 637 Permethrin Lotion 5% 1 ml 0.95 1461(E) 02.04.2018 638 Pheniramine Injection 22.75 mg/ml (2ml) 1 ml 1.49 1461(E) 02.04.2018 639 Pheniramine Injection 22.75 mg/ml(10ml) 1 ml 1.11 1461(E) 02.04.2018 640 Phenobarbitone Injection 200 mg/ml 1 ml 18.76 1461(E) 02.04.2018 641 Phenobarbitone Tablet 30 mg 1 Tablet 1.20 1461(E) 02.04.2018 642 Phenobarbitone Tablet 60 mg 1 Tablet 1.73 1461(E) 02.04.2018 643 Phenobarbitone Oral liquid 20 mg/5 ml 1 ml 0.43 1461(E) 02.04.2018 644 Phenylephrine Drop 10% 1 ml 7.91 1461(E) 02.04.2018 645 Phenylephrine Drops 5% 1 ml 3.65 1461(E) 02.04.2018 646 Phenytoin Capsule 100 mg 1 Capsule 1.49 1461(E) 02.04.2018 647 Phenytoin Capsule 300 mg 1 Capsule 3.73 1461(E) 02.04.2018 648 Phenytoin ERCapsule 300 mg 1 Capsule 3.73 1461(E) 02.04.2018 649 Phenytoin injection 25 mg/ml 1 ml 2.46 1461(E) 02.04.2018 650 Phenytoin Injection 50 mg/ml 1 ml 5.26 1461(E) 02.04.2018 651 Phenytoin Oral Liquid 125 mg/5ml 1 ml 0.88 1461(E) 02.04.2018 652 Phenytoin Oral Liquid 30 mg/5ml 1 ml 0.30 1768(E) 26.04.2018 653 Phenytoin ER Tablet 300 mg 1 Tablet 5.68 1461(E) 02.04.2018 654 Phenytoin Tablet 100 mg 1 Tablet 1.52 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 43 655 Phenytoin Tablet 300 mg 1 Tablet 4.64 1461(E) 02.04.2018 656 Phenytoin Tablet 50 mg 1 Tablet 0.73 1461(E) 02.04.2018 657 Phytomenadione (Vitamin K1) Injection 10mg/ml 1 ml 46.86 1461(E) 02.04.2018 658 Phytomenadione (Vitamin K1) Tablet 10mg 1 Tablet 14.21 5633(E) 02.11.2018 659 Pilocarpine Drops 2% 1 ml 9.89 1461(E) 02.04.2018 660 Pilocarpine Drops 4% 1 ml 11.43 1461(E) 02.04.2018 661 Piperacillin (A) + Tazobactam Powder for Injection 1 g (A) Each Pack 86.51 1461(E) 02.04.2018 (B) + 125 mg(B) 662 Piperacillin (A) + Tazobactam Powder for Injection 2 g (A) Each Pack 204.65 1461(E) 02.04.2018 (B) + 250 mg(B) 663 Piperacillin (A) + Tazobactam Powder for Injection 4 g (A) Each Pack 429.90 1461(E) 02.04.2018 (B) + 500 mg(B) 664 Potassium chloride Injection 150 mg/ml 1 ml 2.38 1461(E) 02.04.2018 665 Potassium chloride Oral Liquid 500 mg/5ml 1 ml 0.28 1461(E) 02.04.2018 666 Potassium permanganate Crystals for topical solution 1 gm 0.43 1461(E) 02.04.2018 667 Povidone iodine Solution 4% 1 ml 1.70 1461(E) 02.04.2018 668 Povidone iodine Solution 7.5% 1 ml 0.76 1461(E) 02.04.2018 669 Povidone Iodine Solution 10% 1 ml 0.91 6252(E) 21.12.2018 670 Povidone Iodine Solution 5% 1 ml 0.38 1461(E) 02.04.2018 671 Pralidoxime chloride (2-PAM) Injection 25 mg/ml 1 ml 3.65 1461(E) 02.04.2018 672 Prednisolone Drops 1% 1 ml 3.28 1461(E) 02.04.2018 673 Prednisolone Injection 20 mg/2ml 1 ml 3.50 1461(E) 02.04.2018 674 Prednisolone Oral Liquid 15 mg/ 5ml 1 ml 0.74 1461(E) 02.04.2018 675 Prednisolone Oral Liquid 5 mg/ 5ml 1 ml 0.42 1461(E) 02.04.2018 676 Prednisolone Tablet 10 mg 1 Tablet 0.95 1461(E) 02.04.2018 677 Prednisolone Tablet 20 mg 1 Tablet 1.91 1461(E) 02.04.2018 678 Prednisolone Tablet 40 mg 1 Tablet 2.75 1461(E) 02.04.2018 679 Prednisolone Tablet 5 mg 1 Tablet 0.55 1461(E) 02.04.2018 680 Premix Insulin 30:70 Injection Injection 40 IU /ml 1 ml 14.73 1461(E) 02.04.2018 (Regular:NPH) 681 Prilocaine (A) + Lignocaine (B) Cream 2.5% (A) + 2.5% (B ) 1 gm 20.01 1461(E) 02.04.2018 682 Primaquine Tablet 15 mg 1 Tablet 4.48 1461(E) 02.04.2018 683 Primaquine Tablet 2.5 mg 1 Tablet 1.52 1461(E) 02.04.2018 684 Primaquine Tablet 7.5 mg 1 Tablet 2.07 1461(E) 02.04.2018 685 Procarbazine Capsule 50 mg 1 Capsule 33.83 1461(E) 02.04.2018 686 Procarbazine Tablet 50 mg 1 Tablet 46.10 1461(E) 02.04.2018 687 Proparacaine Drops 0.5% 1 ml 9.76 1461(E) 02.04.2018 688 Propofol Injection 10 mg/ml 1 ml 7.07 1461(E) 02.04.2018 689 Propranolol Capsule 40 mg 1 Capsule 3.72 1461(E) 02.04.2018 690 Propranolol Capsule 80 mg 1 Capsule 5.65 1461(E) 02.04.2018 691 Propranolol Tablet 10 mg 1 Tablet 1.14 1461(E) 02.04.2018 692 Propranolol Tablet 40 mg 1 Tablet 2.70 1461(E) 02.04.2018 693 Propranolol Tablet 80 mg 1 Tablet 4.89 1461(E) 02.04.2018 694 Protamine Injection 10 mg/ml 1 ml 9.05 1461(E) 02.04.2018 695 Pyrazinamide Oral Liquid 250 mg/5ml 1 ml 0.60 1461(E) 02.04.2018 696 Pyrazinamide Tablet 1000 mg 1 Tablet 9.23 1461(E) 02.04.2018 697 Pyrazinamide Tablet 1500 mg 1 Tablet 10.22 1461(E) 02.04.2018 698 Pyrazinamide Tablet 500 mg 1 Tablet 4.14 1461(E) 02.04.2018 699 Pyrazinamide Tablet 750 mg 1 Tablet 6.30 1461(E) 02.04.201844 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 700 Pyridoxine Tablet 100 mg 1 Tablet 5.47 1461(E) 02.04.2018 701 Pyridoxine Tablet 10mg 1 Tablet 0.11 1461(E) 02.04.2018 702 Quinine Injection 300 mg/ml 1 ml 9.95 1461(E) 02.04.2018 703 Quinine Tablet 300 mg 1 Tablet 5.60 1461(E) 02.04.2018 704 Rabies Vaccine Each Pack 334.42 1461(E) 02.04.2018 705 Raltegravir Tablet 400 mg 1 Tablet 153.15 1461(E) 02.04.2018 706 Ramipril Capsule 2.5 mg 1 Capsule 4.63 1461(E) 02.04.2018 707 Ramipril Capsule 5 mg 1 Capsule 7.23 1461(E) 02.04.2018 708 Ramipril Tablet 2.5 mg 1 Tablet 4.87 1461(E) 02.04.2018 709 Ramipril Tablet 5 mg 1 Tablet 7.67 1461(E) 02.04.2018 710 Ranitidine Oral Liquid 75 mg/5ml 1 ml 0.71 3983(E) 13.08.2018 711 Ranitidine Tablet 150 mg 1 Tablet 0.72 1461(E) 02.04.2018 712 Ranitidine Injection 25mg/ml 1 ml 1.58 1461(E) 02.04.2018 713 Ribavirin Capsule 200 mg 1 Capsule 81.86 1461(E) 02.04.2018 714 Rifabutin Capsule 150mg 1 Capsule 38.82 1461(E) 02.04.2018 715 Rifabutin Tablet 150mg 1 Tablet 36.25 1461(E) 02.04.2018 716 Rifampicin Capsule 150 mg 1 Capsule 1.96 1461(E) 02.04.2018 717 Rifampicin Capsule 300 mg 1 Capsule 3.72 1461(E) 02.04.2018 718 Rifampicin Capsule 450 mg 1 Capsule 4.83 1461(E) 02.04.2018 719 Rifampicin Capsule 600 mg 1 Capsule 11.35 1461(E) 02.04.2018 720 Rifampicin Oral Liquid 100 mg/5ml 1 ml 0.38 1461(E) 02.04.2018 721 Rifampicin Tablet 150 mg 1 Tablet 1.58 1461(E) 02.04.2018 722 Rifampicin Tablet 300 mg 1 Tablet 2.87 1461(E) 02.04.2018 723 Ringer Lactate Injection 1000ml Each Pack 78.06 1461(E) 02.04.2018 724 Ringer Lactate Injection 100ml Each Pack 20.44 1461(E) 02.04.2018 725 Ringer Lactate Injection 250ml Each Pack 34.85 1461(E) 02.04.2018 726 Ringer Lactate Injection 500ml Each Pack 44.41 1461(E) 02.04.2018 727 Risperidone Oral Liquid 1 mg/ml 1 ml 1.89 1461(E) 02.04.2018 728 Risperidone Tablet 1 mg 1 Tablet 3.01 1461(E) 02.04.2018 729 Risperidone Tablet 2 mg 1 Tablet 4.82 1461(E) 02.04.2018 730 Risperidone Tablet 4 mg 1 Tablet 9.79 1461(E) 02.04.2018 731 Ritonavir Capsule 100 mg 1 Capsule 27.62 1461(E) 02.04.2018 732 Ritonavir Tablet 100 mg 1 Tablet 28.40 1461(E) 02.04.2018 733 Rituximab Injection 10 mg/ml 1 ml 742.27 1461(E) 02.04.2018 734 Salbutamol Capsule 4 mg 1 Capsule 0.59 1461(E) 02.04.2018 735 Salbutamol Inhalation (MDI/DPI) 100 1 Dose 0.39 1461(E) 02.04.2018 mcg/dose 736 Salbutamol Oral Liquid 2 mg/5ml 1 ml 0.15 1461(E) 02.04.2018 737 Salbutamol Respirator solution for use in 1 ml 0.69 1461(E) 02.04.2018 Nebulizer 5 mg/ml 738 Salbutamol Tablet 2 mg 1 Tablet 0.16 1461(E) 02.04.2018 739 Salbutamol Tablet 4 mg 1 Tablet 0.18 1461(E) 02.04.2018 740 Salicylic acid Ointment 6% 1 gm 1.76 1461(E) 02.04.2018 741 Sevoflurane Inhalation 1 ml 29.27 3983(E) 13.08.2018 742 Silver Sulphadiazine Cream 1% 1 gm 0.29 1461(E) 02.04.2018 743 Snake venom antiserum- Powder for Injection 10 ml Pack 545.31 1461(E) 02.04.2018 Lyophilized polyvalent 744 Snake Venom Antiserum- Injection Each Pack (10 423.47 1461(E) 02.04.2018 Soluble/ Liquid Polyvalent ML)¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 45 745 Sodium Bicarbonate Injection 7.5% 1 ml 1.37 1461(E) 02.04.2018 746 Sodium Bicarbonate Injection 8.4% 1 ml 1.26 1461(E) 02.04.2018 747 Sodium Chloride Injection 0.9% 1000ml Glass 58.08 1461(E) 02.04.2018 748 Sodium Chloride Injection 0.9% 1000ml Non- 45.81 1461(E) 02.04.2018 Glass 749 Sodium Chloride Injection 0.9% 100ml Glass 17.18 1461(E) 02.04.2018 750 Sodium Chloride Injection 0.9% 100ml Non- 15.47 1461(E) 02.04.2018 Glass 751 Sodium Chloride Injection 0.9% 250ml Glass 23.16 1461(E) 02.04.2018 752 Sodium Chloride Injection 0.9% 250ml Non- 20.80 1461(E) 02.04.2018 Glass 753 Sodium Chloride Injection 0.9% 500ml Glass 32.20 1461(E) 02.04.2018 754 Sodium Chloride Injection 0.9% 500ml Non- 27.41 1461(E) 02.04.2018 Glass 755 Sodium Nitroprusside Injection 10 mg/ml 1 ml 25.26 1461(E) 02.04.2018 756 Sodium Valproate Injection 100 mg/ml 1 ml 5.64 1461(E) 02.04.2018 757 Sodium Valproate Oral Liquid 200 mg/5ml 1 ml 0.57 1461(E) 02.04.2018 758 Sodium Valproate CR Tablets 300mg 1 Tablet 6.16 1461(E) 02.04.2018 759 Sodium Valproate CR Tablets 500mg 1 Tablet 9.54 1461(E) 02.04.2018 760 Sodium Valproate Tablet 200 mg 1 Tablet 3.03 1461(E) 02.04.2018 761 Sodium Valproate Tablet 300 mg 1 Tablet 3.89 1461(E) 02.04.2018 762 Sodium Valproate Tablet 500 mg 1 Tablet 6.79 1461(E) 02.04.2018 763 Sofosbuvir Tablet 400 mg 1 Tablet 653.21 1461(E) 02.04.2018 764 Somatostatin Powder for Injection 3 mg Each pack 1550.94 1461(E) 02.04.2018 765 Spironolactone Tablet 25 mg 1 Tablet 1.87 1461(E) 02.04.2018 766 Spironolactone Tablet 50 mg 1 Tablet 3.72 1461(E) 02.04.2018 767 Stavudine (A) + Lamivudine (B) Tablet 30 mg(A) +150 mg(B) 1 Tablet 9.34 1461(E) 02.04.2018 768 Streptokinase Injection 15,00,000 IU Each Pack 1751.76 1461(E) 02.04.2018 769 Streptokinase Injection 7,50,000 IU Each Pack 1232.06 1461(E) 02.04.2018 770 Streptomycin Powder for Injection 750 mg Each Pack 8.59 1461(E) 02.04.2018 771 Streptomycin Powder for Injection 1 gm Each Pack 10.21 1461(E) 02.04.2018 772 Succinyl Choline Injection 50 mg/ml 1 ml 4.73 1461(E) 02.04.2018 773 Sucralfate Oral Liquid 1 g 1 ml 0.69 1461(E) 02.04.2018 774 Sulfasalazine Tablet 500 mg 1 Tablet 3.90 1461(E) 02.04.2018 775 Sumatriptan Tablet 25mg 1 Tablet 32.58 1461(E) 02.04.2018 776 Sumatriptan Tablet 50mg 1 Tablet 50.43 1461(E) 02.04.2018 777 Surfactant Suspension for intratracheal Per mg of 65.46 1461(E) 02.04.2018 instillation (As liensed) Phospholipids in the pack 778 Tacrolimus Capsule 0.5 mg 1 Capsule 21.64 1461(E) 02.04.2018 779 Tacrolimus Capsule 1 mg 1 Capsule 38.23 1461(E) 02.04.2018 780 Tacrolimus Capsule 2 mg 1 Capsule 74.89 1461(E) 02.04.2018 781 Tamoxifen Tablet 10 mg 1 Tablet 2.52 1461(E) 02.04.2018 782 Tamoxifen Tablet 20 mg 1 Tablet 2.85 1461(E) 02.04.2018 783 Telmisartan Tablet 20 mg 1 Tablet 3.57 1461(E) 02.04.2018 784 Telmisartan Tablet 40 mg 1 Tablet 6.45 1461(E) 02.04.2018 785 Telmisartan Tablet 80 mg 1 Tablet 9.83 1461(E) 02.04.2018 786 Temozolomide Capsule 100 mg 1 Capsule 2039.10 1461(E) 02.04.2018 787 Temozolomide Capsule 20 mg 1 Capsule 583.68 1461(E) 02.04.201846 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 788 Temozolomide Capsule 250 mg 1 Capsule 4586.31 1461(E) 02.04.2018 789 Temozolomide Tablet 100 mg 1 Tablet 1513.59 1461(E) 02.04.2018 790 Temozolomide Tablet 20 mg 1 Tablet 366.71 1461(E) 02.04.2018 791 Temozolomide Tablet 250 mg 1 Tablet 3746.29 1461(E) 02.04.2018 792 Tenofovir Tablet 300 mg 1 Tablet 46.18 1461(E) 02.04.2018 793 Tenofovir (A) + Lamivudine (B) Tablet 300 mg(A) + 300 1 Tablet 43.93 1461(E) 02.04.2018 mg(B) 794 Tenofovir (A) + Lamivudine (B) Tablet 300 mg(A) + 300 1 Tablet 100.87 1461(E) 02.04.2018 + Efavirenz (C) mg(B) + 600 mg(C) 795 Tetanus Toxoid Injection Each Pack 10.37 5727(E) 13.11.2018 (0.5ml) 796 Tetanus Toxoid Injection Each Pack 22.34 5727(E) 13.11.2018 (5 ml) 797 Thalidomide Capsule 100 mg 1 Capsule 59.79 1461(E) 02.04.2018 798 Thalidomide Capsule 50 mg 1 Capsule 34.54 1461(E) 02.04.2018 799 Thiamine Injection 100 mg/ml 1 ml 24.27 1461(E) 02.04.2018 800 Thiamine Tablet 100 mg 1 Tablet 3.67 1461(E) 02.04.2018 801 Thiopentone Powder for Injection 0.5 gm Each Pack 39.86 1461(E) 02.04.2018 802 Thiopentone Powder for Injection 1 gm Each Pack 48.37 1461(E) 02.04.2018 803 Timolol Drops 0.25% 1 ml 5.05 1461(E) 02.04.2018 804 Timolol Drops 0.5% 1 ml 11.67 1461(E) 02.04.2018 805 Tiotropium Inhalation (MDI) 9 mcg/dose Per Metered 2.17 1028(E) 26.02.2019 Dose 806 Tiotropium Inhalation (DPI) 18 mcg/dose Per Dose 9.09 1028(E) 26.02.2019 807 Tramadol Capsule 50 mg 1 Capsule 4.42 1461(E) 02.04.2018 808 Tramadol Injection 50 mg/ml (20 ml 1 ml 1.22 1461(E) 02.04.2018 Pack) 809 Tramadol Injection 50 mg/ml (upto 2 1 ml 10.25 1461(E) 02.04.2018 ml Pack) 810 Tramadol Tablet 100 mg 1 Tablet 19.25 1461(E) 02.04.2018 811 Tramadol Tablet 50 mg 1 Tablet 7.89 1461(E) 02.04.2018 812 Tramadol Capsule 100 mg 1 Capsule 9.39 1461(E) 02.04.2018 813 Tranexamic acid Injection 100 mg/ml 1 ml 14.62 1461(E) 02.04.2018 814 Tranexamic acid Tablet 500 mg 1 Tablet 17.00 1461(E) 02.04.2018 815 Trastuzumab Injection 440 mg/50 ml Each Pack 58867.50 1461(E) 02.04.2018 816 Trihexyphenidyl Tablet 2 mg 1 Tablet 1.19 1461(E) 02.04.2018 817 Tropicamide Eye Drop 1% 1 ml 9.84 1461(E) 02.04.2018 818 Vancomycin Powder for Injection 1 gm Each Pack 465.74 1461(E) 02.04.2018 819 Vancomycin Powder for Injection 250 mg Each Pack 217.00 1461(E) 02.04.2018 820 Vancomycin Powder for Injection 500 mg Each Pack 280.13 1461(E) 02.04.2018 821 Vecuronium Powder for Injection 10 mg Each Pack 185.03 1461(E) 02.04.2018 822 Vecuronium Powder for Injection 4 mg Each Pack 89.30 1461(E) 02.04.2018 823 Verapamil Injection 2.5 mg/ml 1 ml 1.14 1461(E) 02.04.2018 824 Verapamil Tablet 40 mg 1 Tablet 0.73 1461(E) 02.04.2018 825 Verapamil Tablet 80 mg 1 Tablet 1.36 1461(E) 02.04.2018 826 Vinblastine Injection 1mg/ml 1 ml 20.08 1461(E) 02.04.2018 827 Vincristine Injection 1 mg/ml 1 ml 51.00 1461(E) 02.04.2018 828 Vitamin A Capsule 50000 IU 1 Capsule 0.54 1461(E) 02.04.2018 829 Vitamin A Injection 50000 IU/ml 1 ml 1.87 1461(E) 02.04.2018 830 Vitamin A Tablet 50000 IU 1 Tablet 0.69 1461(E) 02.04.2018¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 47 831 Warfarin Tablet 1 mg 1 Tablet 2.37 1461(E) 02.04.2018 832 Warfarin Tablet 2 mg 1 Tablet 2.61 1461(E) 02.04.2018 833 Warfarin Tablet 3 mg 1 Tablet 3.05 1461(E) 02.04.2018 834 Warfarin Tablet 5 mg 1 Tablet 2.31 1461(E) 02.04.2018 835 Water for Injection Injection Each Pack (10 2.28 1461(E) 02.04.2018 ml) 836 Water for Injection Injection Each Pack (5 2.20 1461(E) 02.04.2018 ml) 837 White Petrolatum Jelly 100% 1 gm 0.09 1461(E) 02.04.2018 838 Xylometazoline Nasal Drops 0.05% 1 ml 3.85 1461(E) 02.04.2018 839 Xylometazoline Nasal Drops 0.1% 1 ml 5.09 1461(E) 02.04.2018 840 Zidovudine Capsule 300 mg 1 Capsule 2.02 1461(E) 02.04.2018 841 Zidovudine Tablet 300 mg 1 Tablet 13.95 1461(E) 02.04.2018 842 Zidovudine (A) + Lamivudine Tablet 300 mg(A) + 150 1 Tablet 19.72 1461(E) 02.04.2018 (B) + Nevirapine (C) mg(B) + 200 mg(C) 843 Zinc sulphate Dispersible Tablet 20mg 1 Tablet 3.07 1461(E) 02.04.2018 844 Zoledronic Acid Powder for Injection 4 mg Each Pack 4111.38 1461(E) 02.04.2018 845 Zolpidem Capsule 5 mg 1 Capsule 7.19 1461(E) 02.04.2018 846 Zolpidem Tablet 10 mg 1 Tablet 8.26 1461(E) 02.04.2018 847 Zolpidem Tablet 5 mg 1 Tablet 5.27 1461(E) 02.04.2018 Notes:- (a) The ceiling prices are applicable with effect from 01.4.2019 (ceiling prices are inclusive of Wholesale Price Index (WPI) @4.2662% for the year 2018 over 2017). (b) In respect of formulation where pack wise ceiling price is notified, for any other pack size manufactured, the manufacturer shall approach NPPA under para 11(3) of DPCO, 2013 for specific price approval for its formulations along with the relevant market data duly authenticated for fixation of the ceiling price. The formulation of Sodium Valproate includes combination of Sodium Valproate and Valproic Acid both together corresponding to Sodium Valproate of the stated strength. (c) In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturer shall approach NPPA for specific price approval for its formulations along with the relevant market data duly authenticated for fixation of the ceiling price. (d) All manufacturers of scheduled formulations, selling branded or generic or both the versions of scheduled formulations at price higher than the ceiling price (plus goods and services taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services taxes as applicable, if any. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if any), may revise the existing MRP of their formulations, on the basis of WPI @ 4.2662% for year 2018 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (f) The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.48 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/197/65/2019/F/F. No. 8(65)/2019/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director vkns’k ubZ fnYyh] 29 ekpZ] 2019 dk-vk 1486¼v½.—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky; }kjk tkjh dk0 vk0 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjk 4, 6, 10, 11, 14, 16, 17 vkSj 18 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k dk- vk- la[;k vkSj fnukad fofufnZ"V uhps LraHk 6¼aa½ vkSj 6¼b½ dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh lkj.kh % okf"kZd Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij la'kksf/kr ewY; @ (4.2662%) c<+kdj Ø- vuqlwfpr fofufeZfr dk uke [kqjkd :i vf/kdre dher orZeku dk- vk- la[;k vkSj la- ,oa izcyrk fnukad ¼@ 4.2662% dh bdkbZ nj ls 01-04- 2019 ls izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 6(a) 6(b) 1 ,lhVkbylkfyflfyd ,flM xkys h 300 0.22149 1462¼v½ 02.04.2018 1 xkys h fexzk 2 dSfY'k;e dkcksZuVs xkys h 250 1.91 1462¼v½ 02.04.2018 1 xkys h fexzk 3 dSfY'k;e dkcksZuVs xkys h 500 1.90 1462¼v½ 02.04.2018 1 xkys h fexzk¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 49 4 dMa kes l 1 dMa kes 8.93 1462¼v½ 02.04.2018 5 Mis lkus xkys h 50 fexzk 1 xkys h 0.23095 1462¼v½ 02.04.2018 6 MkSuk:s fcflu bta SD'ku 20 417.84 1462¼v½ 02.04.2018 izfr idS fexzk- 7 ,fFky ,Ydkgs y 70 izfr'kr 0.56 1462¼v½ 02.04.2018 1 fefy- lkys q'ku 8 bVkis kslkbM dSIlyw 100 59.25 1462¼v½ 02.04.2018 1 dSIlyw fexzk- 9 ÝkekblVs hu lYQVs Øhe 0-50% 1 xzke 0.85 1462¼v½ 02.04.2018 10 tfsaVu ok;kys Vs iVsa 1% 1 fefy- 0.06395 1462¼v½ 02.04.2018 11 vkbZlkfsutkbM flji 100 0.25295 1462¼v½ 02.04.2018 fexzk-@5 1 fefy- fefy- 12 eMs ªkDs lh izkxs sLVsjkus ,flVVs xkys h 5 fexzk 1 xkys h 2.92 1462¼v½ 02.04.2018 13 vksjy ikWyhekbfyfVl oSDlhu lkys q'ku 118.02 1462¼v½ 02.04.2018 1 fefy- ¼,y,½ 14 izkftD;uw Vys xkys h 600 28.21 1462¼v½ 02.04.2018 1 xkys h fexzk 15 fjQefiflu xkys h 450 4.34 1462¼v½ 02.04.2018 1 xkys h fexzk 16 lkfsM;e ukbZVªVs bta SD'ku 30 21.11 1462¼v½ 02.04.2018 1 fefy- fexzk-@fefy- uksV%- ¼d½ vf/kdre ewY; fnukad 01-04-2019 ls ykxw gSa (vf/kdre ewY;ksa esa 2017 dh vis{kk o”kZ 2018 ds fy, 4-2662 izfr’kr dh Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ dh nj ‘kkfey gSa)A ¼[k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa] ;fn dksbZ gS½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds mijksDr mRikn@czkaM dks csp jgs vuqlwfpr fofufeZfr;ksa ds fofuekZrk] mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher /ku oLrq ,oa lsok dj] tks ykxw gksa] ;fn dksbZ gS] ls vf/kd lHkh ,slh fofufeZfr;ksa dh dher dk v/kkseq[kh iqujh{k.k djsaxsA ¼x½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 13(2) ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o”kZ 2018 ds fy, 4-2662 izfr’kr dh nj ls Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ksa dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la’kksf/kr dj ldrs gSAa ¼घ½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gaSA ¼ङ½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsa rFkk mldh dkWih jkT; vkS”kf/k fu;a=dksa vkSj fofuekZrk forjd dks tkjh djsaA ¼च½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds 24 (4) ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA50 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼N½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ds fy, fofufnZ”V vuqlwfpr fofufeZfr;ksa ds fofufnZ”V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvksa }kjk ,d ubZ vkS”kf/k dks ykap djrk gS rks mls igys vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 2¼u ½ ds vuqlkj vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds rgr lwph II esa fofufnZ”V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼ज½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼झ½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n’kkZ;s vf/kdre ewY; vkSj ‘krks± dk ikyu ugha djrh gSa rks os vko’;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf’k dks tek djus ds fy, nk;h gksaxsA ¼ञ½ bl vkns’k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof”V esa fofufnZ”V ,slh fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre vkSj [kqnjk ewY; fu/kkZfjr vkns’k ;fn dksbZ gks] tks bl vkns’k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk,axsA [dka-la-@197@65@2019@,Q@Qk- la- 8¼65½@2019@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs’kd ORDER New Delhi, the 29th March, 2019 S.O. 1486(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column no. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of goods and services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Price Revision as per Annual Wholesale Price Index (WPI) @ 4.2662% increase. Sl. No. Medicines Dosage form and Unit Ceiling price (wef Existing S.O. No. & Strength 1.4.2019 with WPI @ Date 4.2662%) (1) (2) (3) (4) (5) 6(a) 6(b) 1 Acetyl Salicylic Tablet 300mg 1 Tablet 0.22149 1462(E) 02.04.2018 Acid 2 Calcium carbonate Tablet 250 mg 1 Tablet 1.91 1462(E) 02.04.2018 3 Calcium carbonate Tablet 500 mg 1 Tablet 1.90 1462(E) 02.04.2018 4 Condoms 1 Condom 8.93 1462(E) 02.04.2018 5 Dapsone Tablet 50 mg 1 Tablet 0.23095 1462(E) 02.04.2018 6 Daunorubicin Injection 20 mg Each Pack 417.84 1462(E) 02.04.2018 7 Ethyl Alcohol 1 ML 0.56 1462(E) 02.04.2018 70% Solution 8 Etoposide Capsules 100 mg 1 Capsule 59.25 1462(E) 02.04.2018 9 Framycetin Cream 0.50% 1 GM 0.85 1462(E) 02.04.2018 Sulphate¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 51 10 Gentian Violet 1% 1 ML 0.06395 1462(E) 02.04.2018 Paint 11 Isoniazid Syrup 100 mg/5ml 1 ML 0.25295 1462(E) 02.04.2018 12 Medroxy Tablet 5mg 1 Tablet 2.92 1462(E) 02.04.2018 Progesterone Acetate 13 Oral Poliomyelitis Solution 1 ML 118.02 1462(E) 02.04.2018 vaccine (LA) 14 Praziquantel Tablet 600 mg 1 Tablet 28.21 1462(E) 02.04.2018 15 Rifampicin Tablet 450mg 1 Tablet 4.34 1462(E) 02.04.2018 16 Sodium Nitrite Injection 30mg/ml 1 ML 21.11 1462(E) 02.04.2018 Notes:- (a) The ceiling prices are applicable with effect from 01.4.2019 (ceiling prices are inclusive of Wholesale Price Index (WPI) @4.2662% for the year 2018 over 2017). (b) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services taxes as applicable, if any. (c) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 4.2662% for year 2018 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (f) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (g) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (h) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.52 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (i) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (j) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/197/65/2019/F/F. No. 8(65)/2019/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director vkns”k ubZ fnYyh] 29 ekpZ] 2019 dk-vk- 1487¼v½.—Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 d s lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 d s iSjk 11 d s mi iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;k sa dk iz;kxs djr s gq, rFkk Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky;] ¼jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k½ d s 'kfq)&i= vkn's k dk- vk- 2062¼v½ fnukda 9 tuw ] 2016 d s lkFk ifBr dk-vk- 1993¼v½ fnukda 3 tuw ] 2016, dk-vk- 2210¼v½ fnukda 24 tuw ] 2016, dk-vk- 2578¼v½ fnukda 1 vxLr 2016, dk-vk- 3161¼v½ fnukda 6 vDrcwj 2016, dk-vk- 1051¼v½ fnukda 1 vizSy 2017, dk- vk- 2062¼v½ fnukda 30 tuw 2017, dk- vk- 1463¼v½ fnukda 02 vizSy 2018, dk- vk- 1531¼v½ fnukda 06 vizSy 2018, vkn's k d s vf/kØe.k e sa tgk¡ rd mldk lEcU/k uhp s dh lkj.kh ^d* e sa fofufeZr iSdk sa d s fo'k"sk fo'k”s krkvk sa lfgr xSj&dk¡p d s :i e sa dk-vk- 1993¼v½ fnukda 3 tuw ] 2016 e as xSj&ihohlh d s #i e sa ;Fkk of.kZr] l'akk/s ku fd;k] uhp s nh xb Z lkj.kh [k e sa fofufnZ"V fuekZrk d s fo'k”s k mRikn ,o a idSs vkdkj] mu ckrk sa d s flok; vf/kØkUr djr s g,q ftUg sa ,sl s vf/kØe.k d s iwoZ fd;k x;k g S ;k dju s dk ykis fd;k x;k gS] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkkds eYw ; lpw dkda ¼MCY;iw hvkbZ½] 2018 ij vk/kkfjr l’akk/s ku djrk gS] tSlk fd uhp s dh lkj.kh ^d* d s LrHa k ¼5½ e sa fofufnZ"V gS] vf/kdre dher dk s mDr lkj.kh d s LrHa k ¼3½ vkSj ¼4½ e sa dh xbZ Øe'k% rRLFkkuh izfof"V;k sa e sa fofufnZ"V [kqjkd :i ,o a izcyrk vkSj bdkbZ ¼;fwuV½@iSdfstxa lfgr ml lkj.kh d s LrHa k ¼2½ e sa dh xbZ rRLFkkuh izfof"V e sa fofufnZ"V vuqlfwpr fofufeZfr;k sa e sa l s izR;ds dh oLrq ,o a lsok dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre dher d s :i e sa fu;r djrh gAS lkj.kh d % okf”kZd Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij la’kksf/kr ewY; @ 4.2662% c<+kdj Ø- la- vuqlwfpr fofufeZfr dk [kqjkd :i ,oa izcyrk bdkbZ vf/kdre dher uke ¼@ 4.2662% dh nj ls 01-04-2019 ls izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 1- Xydw kts bta Ds ”ku 5% 1000 fefy xSj&dk¡p fo'k"sk 74.76 fo'k”s krkvk sa lfgr 2- Xydw kts bta Ds ”ku 5% 500 fefy xSj&dk¡p fo'k"sk 64.68 fo'k”s krkvk sa lfgr 3- Xydw kts ¼,½$lkfsM;e bta Ds ”ku 5% ¼,½$0-9% 1000 fefy xSj&dk¡p fo'k"sk 78.56 DyksjkbM ¼ch½ ¼ch½ fo'k”s krkvk sa lfgr 4- Xydw kts ¼,½$lkfsM;e bta Ds ”ku 5% ¼,½$ 0-9% 500 fefy xSj&dk¡p fo'k"sk 67.22 DyksjkbM ¼ch½ ¼ch½ fo'k”s krkvk sa lfgr 5- lkfsM;e DyksjkbM bta Ds ”ku 0-9% 100 fefy xSj&dk¡p fo'k"sk 33.06 fo'k”s krkvk sa lfgr 6- lkfsM;e DyksjkbM bta Ds ”ku 0-9% 250 fefy xSj&dk¡p fo'k"sk 48.82 fo'k”s krkvk sa lfgr 7- lkfsM;e DyksjkbM bta Ds ”ku 0-9% 500 fefy xSj&dk¡p fo'k"sk 69.13 fo'k”s krkvk sa lfgr¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 53 8- lkfsM;e DyksjkbM bta Ds ”ku 0-9% 1000 fefy xSj&dk¡p fo'k"sk 77.43 fo'k”s krkvk sa lfgr lkj.kh ^[k^ dz-la- fuekZrkvksa dk uke mRikn@czkaM dk uke ¼1½ ¼2½ ¼3½ 1- elSlZ ch- czkmu esfMdy ¼bafM;k½ izk- fyfeVsM bdks¶ysd Iyl cksry ;wjksgsM lfgr 2- eSllZ veUrk gsYFkds;j fyfeVsM LVsjhiksVZ cksry 3- elSlZ ,D;wykbQ gsYFk ds;j izk- fyfeVsM ,D;wykbQ cksry ;wjksgsM lfgr 4- eSllZ ,ycVZ MsfoM fyfeVsM ,ycVZ MsfoM cksry ;wjksgsM lfgr 5- eSllZ Msful dse fyfeVsM ,DokiYl ;wjksgsM lfgr 6- eSllZ Dysfjl ykbQ lkbalsl fyfeVsM Dysfjl cksry ;wjksgsM lfgr 7- eSllZ Ýslsfu;l dkch bafM;k izk- fyfeVsM Ýh¶ysDl csx 8- elSlZ Dysfjl vksVlwdk bafM;k izkbosV fyfeVsM ¼igys ;wuhcsx Dysfjl vksV~lqdk izkbosV fyfeVsM ds uke ls tkuk tkrk Fkk½ 9- eSllZ ,s'ko;kZ ykbQlkblsal fy¶;wt+u ;wjksgsM cksry 10- eSllZ csDlVj ¼bafM;k½ izk- fyfeVsM ok;k¶ysDl csx 11- eSllZ Dysfjl vksVlwdk bafM;k izkbosV fyfeVsM ¼igys ;wjksgsM cksry Dysfjl vksV~lqdk izkbosV fyfeVsM ds uke ls tkuk tkrk Fkk½ 12- eSllZ Ýslfu;l dkch bafM;k izk- fyfeVsM ;wjksgsM cksry uksV%- ¼d½ vf/kdre ewY; fnukad 01-04-2019 ls ykxw gSa ¼vf/kdre ewY;ksa esa 2017 dh vis{kk o”kZ 2018 ds fy, 4.2662 izfr’kr dh Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ dh nj ‘kkfey gS½A ¼[k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa] ;fn dksbZ gS½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds mijksDr mRikn@czkaM dks csp jgs vuqlwfpr fofufeZfr;ksa ds fofuekZrk] mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher /ku oLrq ,oa lsok dj] tks ykxw gksa] ;fn dksbZ gS] ls vf/kd lHkh ,slh fofufeZfr;ksa dh dher dk v/kkseq[kh iqujh{k.k djsaxsA ¼x½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 13¼2½ ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o”kZ 2018 ds fy, 4.2662 izfr’kr dh nj ls Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ksa dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la’kksf/kr dj ldrs gSa ¼?k½ vxj fofuekZrkvksa us mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;fn ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSA ¼M-½ vU; dksbZ fofuekZrk fo'ks"k fo'ks"krkvksa lfgr xSj&dk¡p iSd ds fo'ks"k vf/kdre dher ds fy, vyx ls nkok djrk gS rks mlds fy, mls fooj.k ds lkFk izekf.kr djuk gksxk fd mlds iSd esa O;kid lqfo/kkvksa tSls fd ¼i½ Lo;a fleVus vkSj Lo;a lhysfcfyVh ¼lhy yxuk½ ¼ii½ ,;j osaV ugha gksus vkSj ¼iii½ fofuekZ.k ds nkSjku lapkj@,MfefDlax Lrjksa ij lanw"k.k dh laHkkouk ugh gSa] ds leFkZu esa nLrkostksa vkSj izn’kZu lfgr ,uihih, dks vkonsu djsxkA54 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼p½ fofuekZrk viuh fofufeZfr;ksa dh fdlh Hkh vU; fo'ks"k fo'ks"krkvksa dk nkok ;k vU; iSd vkdkj ds fy, fo'ks"k ewY; fu/kkZj.k ds fy, ,uihih, esa vkosnu djsxkA ¼N½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fofuekZrk vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsxk rFkk mldh dkWih jkT; vkS”kf/k fu;a=dksa vkSj fofuekZrk forjd dks tkjh djsxkA ¼t½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjk 24 (4) ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA ¼>½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher ds fy, fofufnZ”V vuqlwfpr fofufeZfr;ksa ds fofufnZ”V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvksa }kjk ,d ubZ vkS”kf/k ykap djrk gS rks mls igys vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds rgr lwph II esa fofufnZ”V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼.k½ mi;qZDr vuqlwfpr fofufeZfr;ksa ds mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 dh lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djuh gksxhA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fofuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ls ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS] rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼V½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n’kkZ;s vf/kdre ewY; vkSj uksV dk ikyu ugha djrh gSa rks os vko’;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf’k dks tek djus ds fy, nk;h gksaxsA ¼B½ bl vkns’k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh xbZ rRLFkkuh izfof”V esa fofufnZ”V ,slh fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre ;k [kqnjk ewY; fu/kkZfjr vkns’k] ;fn dksbZ gks] tks bl vkns’k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk,axsA [dka- la-@197@65@2019@,Q@Qk- la- 8¼65½@2019@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs’kd ORDER New Delhi, the 29th March, 2019 S.O. 1487(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O 1993(E) dated 3rd June,2016 read with Corrigendum order S.O 2062 dated 9th June, 2016, S.O 2210(E) dated 24th June 2016, S.O 2578(E) dated 1st August 2016, S.O. 3161(E) dated 6th October 2016, S.O. 1051(E) dated 1st April 2017, S.O. 2062(E) dated 30th June 2017, S.O. 1463(E) dated 2nd April 2018 and S.O. 1531(E) dated 6th April 2018 in so far as they relate to formulation packs of Non-Glass with special features (mentioned as Non-PVC in S.O. 1993(E) dated 3rd June 2016) mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2018 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if any in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof:¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 55 TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 4.2662% increase. Sl. No. Medicines Dosage form and Unit Ceiling price (wef 1.4.2019 Strength with WPI @ 4.2662%) (1) (2) (3) (4) (5) 1 Glucose Injection 5% 1000ml Non Glass with 74.76 special features 2 Glucose Injection 5% 500ml Non Glass with 64.68 special features 3 Glucose (A) + Sodium Injection 5% (A) + 1000ml Non Glass with 78.56 Chloride (B) 0.9% (B) special features 4 Glucose (A) + Sodium Injection 5% (A) + 500ml Non Glass with 67.22 Chloride (B) 0.9% (B) special features 5 Sodium Chloride Injection 0.9% 100ml Non Glass with 33.06 special features 6 Sodium Chloride Injection 0.9% 250ml Non Glass with 48.82 special features 7 Sodium Chloride Injection 0.9% 500ml Non Glass with 69.13 special features 8 Sodium Chloride Injection 0.9% 1000ml Non Glass with 77.43 special features TABLE ‘B’ Sl. No. Name of Manufacturer Product /Brand Name (1) (2) (3) 1 M/s. B.Braun Medical (I) Pvt Ltd. Ecoflac Plus bottle with Eurohead 2 M/s. Amanta Healthcare Ltd. Steriport bottle 3 M/s. Aculife Healthcare Pvt Ltd. Aculife bottle with Eurohead 4 M/s. Albert David Limited Albert David bottle with Eurohead 5 M/s. Denis Chem Limited Aquapulse with Eurohead 6 M/s. Claris Life Sciences Limited Claris bottle with Eurohead 7 M/s. Fresenius Kabi India Pvt Limited Freeflex bags 8 M/s. Otsuka Pharmaceutical India Private Ltd. Unibag (previously known as Claris Otsuka Private Limited) 9 M/s. Aishwarya Lifesciences Lifusion Eurohead bottle 10 M/s. Baxter (India) Pvt. Ltd. Viaflex bags 11 M/s. Otsuka Pharmaceutical India Private Ltd. Eurohead bottle (previously known as Claris Otsuka Private Limited) 12 M/s. Fresenius Kabi India Pvt Limited Eurohead bottle (a) The ceiling prices are applicable with effect from 01.4.2019 (ceiling prices are inclusive of Wholesale Price Index (WPI) @4.2662% for the year 2018 over 2017). (b) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed56 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 4.2662% for year 2018 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) Any other manufacturer claiming separate ceiling price for Non-Glass with special feature shall apply to NPPA for separate ceiling price approval with details and demonstrate, that such pack has all of the features as (i) self collapsibility and self-sealability (ii) not having air-vent; and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels alongwith documentation and demonstration. (f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/197/65/2019/F /F. No. 8(65)/2019/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 57 vkns”k ubZ fnYyh] 29 ekpZ] 2019 dk-vk- 1488¼v½.—jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k] vkS”k/k foHkkx] jlk;u ,oa moZjd ea=ky; }kjk dksjksujh LVsaV~l ds vf/kdre ewY; fu/kkZj.k ds laca/k esa tkjh vf/klwpukvksa dk-vk- 639¼v½ fnukad 12-02-2018 vkSj 1464¼v½ fnukad 02-04-2018 tkjh esa ml lkj.kh ds LraHk ¼4½ esa fofufnZ"V vf/kdre dher ds laca/k esa ;g fu.kZ; fy;k x;k gS fd o”kZ 2017 dh vis{kk o”kZ 2018 ds fy, 4-2662 izfr’kr dh nj ls Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ij fopkj djus ds ckn ,rn~}kjk dksjksujh LVsaV~l ds of.kZr vf/kdre ewY;ksa, oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj, bl lkj.kh ds LraHk ¼4½ esa fofufnZ"V vf/kdre dher] LraHk ¼3½ esa of.kZr bdkbZ ds en~nsutj fnukad 01-04-2019 ls fuEu izdkj ls la’kksf/kr fd;k tkrk gS% lkj.kh vf/kdre ¼dksjksujh LVsaV~l½ bdkbZ dz-la- ewY; ¼Mhihlhvks] 2013 dh vuqlwph&I esa dz-la- 31½ ¼la[;k esa½ ¼#i;s esa½ ¼1½ ¼2½ ¼3½ ¼4½ 1 lkns /kkrq LVsaV 1 8]261 vkS”k/k {kkyu LVsaV ¼MhbZ,l½ ftlesa /kkfRod MhbZ,l vkSj tSo vo’kks”; 2 1 30]080 okfgdk <kapk ¼choh,l½@tSo vodze.kh; LVsaV lfEefyr gSaA uksV%- ¼d½ lHkh ekStwnk fuekZrkvksa@vk;krdksa dks dksjksujh LVsaV ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼4½ esa fofufnZ”V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds iSjkxzkQ 13(2) ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o”kZ 2018 ds fy, 4.2662 izfr’kr dh nj ls Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh dksjksujh LVsaV dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la’kksf/kr dj ldrs gSa ¼[k½ vxj fuekZrkvksa@vk;krdksa us mi;qZDr lkj.kh ds LraHk (4) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSA ¼x½ vkS”k/k ¼ewY; fu;a=.k½ vkns’k] 2013 ds 24¼4½ ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA ¼?k½ fofuekZrk@vk;krd ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n’kkZ;s vf/kdre ewY; vkSj ‘krks± dk ikyu ugha djrh gSa rks os vko’;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf’k dks tek djus ds fy, nk;h gksaxsA [dka-la-@197@65/2019@,Q@Qk- la- 8¼65½@2019@Mhih@,uihih,-&fMoh-II] vkyksd jatu] lgk;d funs'kd ORDER New Delhi, the 29th March, 2019 S.O. 1488(E).—In continuation of the notifications issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018 and S.O. 1464(E) dated 02.04.2018, regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 4.2662 percent for the year 2018 over 2017, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2019, as under:58 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] TABLE Sl No Coronary Stents Unit Ceiling Price ( Sl No. 31 in Schedule-I of the DPCO, 2013) (in Number) (in Rs.) (1) (2) (3) (4) 1 Bare Metal Stents 1 8,261 Drug Eluting Stents (DES) including metallic DES and 2 1 30,080 Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents Notes:- (a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 4.2662% for year 2018 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013. (b) The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table. (c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. [PN/197/65/2019/F/F. No. 8(65)/2019/D.P./NPPA-Div.-II] ALOK RANJAN, Assistant Director vkns’k ubZ fnYyh] 29 ekpZ] 2019 dk-vk- 1489¼v½-&Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 701¼v½ rkjh[k 10 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 5, 11 vkSj 15 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼6½ eas fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½] ¼4½] vkSj ¼5½ eas rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk] bdkbZ ¼;wfuV½ vkSj fofuekZrk vkSj foi.ku dEifu;ksa ds uke lfgr LraHk ¼2½ esa dh rRLFkkuh izfof"V esa ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh dz- vuqlwfpr fofufeZfr izcyrk bdkbZ fofuekZrk vkSj [kqnjk ewY; la- dk uke@ czkaM dk foi.ku daiuh ¼#-½ uke (1) (2) (3) (4) (5) (6) 1. lksfM;e QqflMsV $ Øhe esa ‘kkfey% 12.92 gkykscsVklksy Øhe lksfM;e QqflMsV vkbZih ds cjkcj eSllZ ,isDl QqflfMd ,flM 2% MCY;w@MCY;w] yscksjsVjht izk- fy- 1 xzke gkykscsVklksy izksfi;ksusV ;w,lih 0.05% MCY;w@MCY;w¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 59 2. esVQksfeZu $ izR;sd vfyfir fcys;MZ xksyh esa% 1 xksyh 3.58 eSllZ I;ksj ,aM XyhesihjkbM xksyh XyhesihjkbM vkbZih 0-5 fexzk-] D;ksj gsYFkds;kj izk- ¼,tqyhDl 0-5 esVQksfeZu gkbMªksDyksjkbM vkbZih ,e,Q½ fy-@ eSllZ VkWjsaV 500 fexzk- ¼izksykWxM fjfyt QkWeZ QkekZL;wfVdYl fy- esa½ 3. ,llhVkyksizke $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ jkokbu ykbQ 6.10 Dyksuktsike xksyh ,llhVkyksizke vkWDlkysV vkbZih lkbal izk- fy-@eSllZ ¼U;wlhVk feuh½ ds cjkcj ,llhVkyksizke 5 fexzk-] ,Ydse yscksjsVjht Dyksuktsike vkbZih 0-5 fexzk- fy- 4. lsQVªhDlksu $ izR;sd ok;y esa% eSllZ esizk 110.95 lycsDVe batSD’ku lsQVªhDlksu lksfM;e vkbZih ds yscksjsVjht izk- fy- ¼VSDlksu ,lch 1000 cjkcj lsQVªhDlksu 1 xzke-] 1 okW;y fexzk-½ lycsDVe lksfM;e ;w,lih ds cjkcj lycsDVe 500 fexzk- 5. lsQVªhDlksu $ izR;sd ok;y esa% eSllZ esizk 43.21 lycsDVe batSD’ku lsQVªhDlksu lksfM;e vkbZih ds yscksjsVjht izk- fy- ¼VSDlksu ,lch 250 cjkcj lsQVªhDlksu 250 fexzk-] 1 okW;y fexzk-½ lycsDVe lksfM;e ;w,lih ds cjkcj lycsDVe 125 fexzk- 6. lsQVªhDlksu $ izR;sd ok;y esa% eSllZ esizk 71.60 lycsDVe batSD’ku lsQVªhDlksu lksfM;e vkbZih ds yscksjsVjht izk- fy- ¼VSDlksu ,lch 500 cjkcj lsQVªhDlksu 500 fexzk-] 1 okW;y fexzk-½ lycsDVe lksfM;e ;w,lih ds cjkcj lycsDVe 250 fexzk- 7. ,VksjokLVkfVu $ izR;sd fQYe fyfir xksyh esa% 11.52 eSllZ fjoizk QsuksfQczsV xksyh ,VksjokLVkfVu 10 fexzk-] QkWeZqys’kul izk- fy- 1 xksyh QsuksfQczsV 160 fexzk-] @eSllZ dSfMyk QkekZL;wfVdYl fy- 8. gkbZyqjksfud ,flM izR;sd fefy- esa% izfr iSd eSllZ fojpkm 26987.40 $ fyMksdsu gkbZyqjksfud ,flM chih 24-0 esa 1 ck;ksVsd fy-@eSllZ gkbMªksDyksjkbM fexzk-] fyMksdsu gkbMªksDyksjkbM fefy- ds tk;Ml gsYFkds;j batSD’ku vkbZih 3-00 fexzk- 2 fy- izhfQYM flfjat 9. beVªhlhVkckbu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh 55.33 VsuksQksohj beVªhlhVkckbu vkbZih 200 fexzk-] eSllZ gsVsjks yScl ,ykQsukekbM xksyh VsuksQksohj ,ykQsukekbM fy-@eSllZ flIyk ¼VkQequ&bZ,e½ gsehQqekjsV ds cjkcj VsuksQksohj fy- ,ykQsukekbM 25 fexzk- 10. VsuksQksohj izR;sd fQYe fyfir esa% 1 xksyh eSllZ ekbZyu 55.33 ,ykQsukekbM $ VsuksQksohj ,ykQsukekbM QqekjsV yscksjsVjht fy- beVªhlhVkckbu ds cjkcj VsuksQksohj ,ykQsukekbM @eSllZ ekbZyu xksyh ¼VkQhlhVk½ 25 fexzk- beVªhlhVkckbu 200 QkekZL;wfVdYl izk- fexzk- fy- 11. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ekbZyu 44.29 ,ykQsukekbM xksyh yscksjsVjht fy- VsuksQksohj ,ykQsukekbM QqekjsV @eSllZ ekbZyu ds cjkcj VsuksQksohj ,ykQsukekbM QkekZL;wfVdYl izk- 25 fexzk- fy-60 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 12. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh 44.29 ,ykQsukekbM xksyh eSllZ gsVsjks yScl VsuksQksohj ,ykQsukekbM fy-@eSllZ flIyk gsehQqekjsV ds cjkcj VsuksQksohj fy- ,ykQsukekbM 25 fexzk- 13. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ gsVsjks yScl 44.29 ,ykQsukekbM xksyh fy-@eSllZ dSfMyk VsuksQksohj ,ykQsukekbM gsYFkds;j fy- gsehQqekjsV ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 14. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ gsVsjks yScl 44.29 ,ykQsukekbM xksyh fy-@eSllZ ,eD;ksj VsuksQksohj ,ykQsukekbM QkekZL;wfVdYl fy- gsehQqekjsV ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 15. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ukVdks QkekZ 44.29 ,ykQsukekbM xksyh fy-@eSllZ lu QkekZ VsuksQksohj ,ykQsukekbM QqekjsV yscksjsVjht fy- ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 16. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ukVdks QkekZ 44.29 ,ykQsukekbM xksyh fy-@eSllZ ,CcksV VsuksQksohj ,ykQsukekbM QqekjsV bafM;k fy- ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 17. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ukVdks QkekZ 44.29 ,ykQsukekbM xksyh fy- VsuksQksohj ,ykQsukekbM QqekjsV ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 18. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ukVdks QkekZ 44.29 ,ykQsukekbM xksyh fy-@eSllZ dsfMyk VsuksQksohj ,ykQsukekbM QqekjsV gsYFkds;j fy- ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 19. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ukVdks QkekZ 44.29 ,ykQsukekbM xksyh fy-@eSllZ MkW0 VsuksQksohj ,ykQsukekbM QqekjsV jsM~Mht yscksjsVjht ds cjkcj VsuksQksohj ,ykQsukekbM fy- 25 fexzk- 20. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ukVdks QkekZ 44.29 ,ykQsukekbM xksyh fy-@eSllZ ,izktj VsuksQksohj ,ykQsukekbM QqekjsV gsYFkds;j izk- fy- ds cjkcj VsuksQksohj ,ykQsukekbM 25 fexzk- 21. VsuksQksohj izR;sd fQYe fyfir xksyh esa% 1 xksyh 31.17 ,ykQsukekbM $ VsuksQksohj ,ykQsukekbM eSllZ gsVsjks yScl beVªhlhVkckbu gsehQqekjsV ds cjkcj VsuksQksohj fy-@eSllZ flIyk xksyh ,ykQsukekbM 10 fexzk-] fy- beVªhlhVkckbu 200 fexzk- uksV % ¼d½ mi;qZDr nh xbZ fofufnZ"V QkWewZys'ku ds fofuekZrk vFkkZr tks ÞubZ Mªxß Mhihlhvks] 2013 ds iSjkxzkQ 2¼;w½ ds rgr mi;qZDr nh xbZ lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 61 ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (6) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls ,d ewY; lwph ,uihih, dks vkbZihMh,e,l ds ek/;e ls tkjh djsa rFkk mldh dkiWh jkT; vkS"kf/k fu;a=dksa vkSj fofuekZrk forjdksa dks tkjh djsaA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds 24 (4) ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr vuqc) ewY; fu/kkZj.k@la'kks/ku ds fy, QkWeZ I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkZfjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds vUrxZr tSlk fd dsUnzh;@jkT; ykblsflax vkWFkksfjVh ds l{ke izkf/kdkjh }kjk esU;wQsDpfjax ykblsal eatwjh ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufeZfr;ksa vkSj fofufnZ"V 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼N½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA [dka- la-@197@65/2019@,Q@Qk- la- 8¼65½@2019@Mhih@,uihih,&fMoh-II] izlsuthr nkl] lgk;d funs'kd ORDER New Delhi, the 29th March, 2019 S.O. 1489(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE Sl. Name of the Strength Unit Manufacturer & Retail No. Formulation / Marketing Company Price Brand Name (Rs.) (1) (2) (3) (4) (5) (6) 1. Sodium Fusidate + Cream contains: 12.92 Halobetasole Sodium Fusidate IP eq. to M/s Apex Laboratories Cream Fusidic Acid 2% w/w, Private Limited Halobetasole Propionate USP 1 gm 0.05% w/w62 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 2. Metformin + Each Uncoated Bilayered 3.58 Glimepiride Tablet Tablet contains: M/s Pure and Cure (Azulix 0.5 MF) Glimepiride IP 0.5mg, Healthcare Pvt. Ltd. / 1 Tablet Metformin Hydrochloride IP M/s Torrent 500mg (As Prolonged Release Pharmaceuticals Limited Form) 3. Escitalopram + Each film coated tablet 6.10 Clonazepam Tablet contains: M/s Ravian Life Science (Newcita Mini) Escitalopram Oxalate IP eq. to 1 Tablet Pvt. Ltd. / M/s Alkem Escitalopram 5mg, Laboratories Ltd. Clonazepam IP 0.5mg 4. Ceftriaxone + Each vial contains: M/s Mapra Laboratories 110.95 Sulbactum Ceftriaxone Sodium IP eq. to Pvt. Ltd. Injection (Taxone Ceftriaxone 1gm 1 vial SB 1000mg ) Sulbactum Sodium USP eq. to Sulbactum 500mg 5. Ceftriaxone + Each vial contains: M/s Mapra Laboratories 43.21 Sulbactum Ceftriaxone Sodium IP eq. to Pvt. Ltd. Injection (Taxone Ceftriaxone 250gm 1 vial SB 250mg ) Sulbactum Sodium USP eq. to Sulbactum 125mg 6. Ceftriaxone + Each vial contains: M/s Mapra Laboratories 71.60 Sulbactum Ceftriaxone Sodium IP eq. to Pvt. Ltd. Injection (Taxone Ceftriaxone 500gm 1 vial SB 500mg ) Sulbactum Sodium USP eq. to Sulbactum 250mg 7. Atorvastatin + Each film coated Tablet 11.52 M/s Rivpra Formulations Fenofibrate Tablet contains: 1 Tablet Pvt. Ltd. / M/s Cadila Atorvastatin 10mg, Pharmaceuticals Limited Fenofibrate 160mg 8. Hyaluronic Acid + Each ml contains: Per Pack M/s Virchow Biotech 26987.40 Lidocain Hyaluronic Acid BP 24.0mg having 2 Limited. / M/s Zydus Hydrochloride Lidocain Hydrochloride IP prefilled Healthcare Limited Injection 3.00mg syringe of 1 ML Each 9. Emtricitabine + Each film coated tablet 1 Tablet 55.33 Tenofovir contains: Alafenamide tablet Emtricitabine IP 200 mg M/s Hetero Labs Ltd. / (Tafmune – EM) M/s Cipla Ltd. Tenofovir Alafenamide Hemifumarate eq. to Tenofovir Alafenamide 25 mg 10. Tenofovir Each film coated contains: 55.33 M/s Mylan Laboratories Alafenamide + Tenofovir Alafenamide Ltd. / M/s Mylan Emtricitabine fumarate eq. to Tenofovir 1 Tablet Pharmaceuticals Pvt. Tablet Alafenamide 25 mg Ltd. (TAFICITA) Emtricitabine 200mg 11. Tenofovir Each film coated tablet 1 Tablet 44.29 Alafenamide contains: M/s Mylan Laboratories Tablet Ltd./ M/s Mylan Tenofovir Alafenamide Pharmaceuticals Pvt. fumarate eq. to Tenofovir Ltd. Alafenamide 25 mg 12. Tenofovir Each film coated tablet 1 Tablet 44.29 M/s Hetero Labs Ltd./ Alafenamide contains: M/s Cipla Ltd. Tablet Tenofovir Alafenamide¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 63 Hemifumarate eq. to Tenofovir Alafenamide 25 mg 13. Tenofovir Each film coated tablet 1 Tablet M/s Hetero Labs Ltd./ 44.29 Alafenamide contains: M/s Cadila Healthcare Tablet Ltd. Tenofovir Alafenamide Hemifumarate eq. to Tenofovir Alafenamide 25 mg 14. Tenofovir Each film coated tablet 1 Tablet M/s Hetero Labs Ltd./ 44.29 Alafenamide contains: M/s Emcure Tablet Pharmaceuticals Ltd. Tenofovir Alafenamide Hemifumarate eq. to Tenofovir Alafenamide 25 mg 15. Tenofovir Each film coated tablet 1 Tablet M/ Natco Pharma Ltd. / 44.29 Alafenamide contains: M/s Sun Pharma Tablet Laboratories Ltd. Tenofovir Alafenamide fumarate eq. to Tenofovir Alafenamide 25 mg 16. Tenofovir Each film coated tablet 1 Tablet M/ Natco Pharma Ltd. / 44.29 Alafenamide contains: M/s Abbott India Ltd. Tablet Tenofovir Alafenamide fumarate eq. to Tenofovir Alafenamide 25 mg 17. Tenofovir Each film coated tablet 1 Tablet M/ Natco Pharma Ltd. 44.29 Alafenamide contains: Tablet Tenofovir Alafenamide fumarate eq. to Tenofovir Alafenamide 25 mg 18. Tenofovir Each film coated tablet 1 Tablet M/ Natco Pharma Ltd. / 44.29 Alafenamide contains: M/s Cadila Healthcare Tablet Ltd. Tenofovir Alafenamide fumarate eq. to Tenofovir Alafenamide 25 mg 19. Tenofovir Each film coated tablet 1 Tablet M/ Natco Pharma Ltd. / 44.29 Alafenamide contains: M/s Dr. Reddy’s Tablet Laboratories Ltd. Tenofovir Alafenamide fumarate eq. to Tenofovir Alafenamide 25 mg 20. Tenofovir Each film coated tablet 1 Tablet M/ Natco Pharma Ltd. / 44.29 Alafenamide contains: M/s Aprazer Healthcare Tablet Pvt. Ltd. Tenofovir Alafenamide fumarate eq. to Tenofovir Alafenamide 25 mg 21. Emtricitabine + Each film coated tablet 31.17 Tenofovir contains: Alafenamide Emtricitabine IP 200mg, M/s Hetero Labs Limited 1 Tablet Tablet Tenofovir Alafenamide / M/s Cipla Limited Hemifumarate eq. to Tenofovir Alafenamide 10mg64 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Note: (a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/197/65/2019/F/F. No. 8(65)/2019/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers